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HISTONE H2B

Robert Kendall McGinty, Ph.D.
The Rockefeller University, 2010

Post-translational modification of histones plays an integral role in regulation of
chromatin-templated processes through modulation of chromatin structure and function.
One such modification, ubiquitylation of histone H2B on lysine 120 (uH2B), has been
correlated with enhanced methylation of lysine 79 (K79) of histone H3 by K79-specific
methyltransferase, disruptor of telomeric silencing-like (Dot1L/KMT4). However, the
specific function of uH2B in this crosstalk pathway was not understood, in part due to the
challenges associated with isolating or generating homogeneously ubiquitylated H2B for
use in biochemical studies. As both modifications are integral to transcriptional
regulation and DNA damage repair, full elucidation of their functions is critical to
understanding their roles in development and disease. In this thesis, a chemical strategy is
presented for the preparation of native uH2B. Two traceless orthogonal expressed protein
ligation (EPL) reactions were used for this purpose, one employing a photolytically
removable ligation auxiliary, and the other, a cysteine-mediated ligation followed by a
desulfurization to restore the native sequence. Reconstitution of semisynthetic uH2B into
chemically defined nucleosomes, followed by biochemical analysis, revealed a direct role
for uH2B in the stimulation of Dot1L-mediated methylation of H3K79. Although

recruitment of Dot1L to the nucleosomal surface by uH2B could be excluded,
comprehensive mechanistic analysis was precluded by systematic limitations in the
ability to generate native uH2B in large-scale. To overcome this shortcoming, a highly
optimized synthesis of ubiquitylated H2B bearing a Gly76Ala point mutation
(uH2BG76A) was developed, yielding tens of milligrams of ubiquitylated protein. This
mutant was indistinguishable from native uH2B by Dot1L, allowing for detailed studies
of the resultant trans-histone crosstalk pathway. Kinetic and structure activity
relationship analyses using uH2BG76A suggest a non-canonical role for ubiquitin in the
enhancement of the chemical step of H3K79 methylation. This enhancement likely
results from an allosteric change in the nucleosome and/or Dot1L following H2B
ubiquitylation. Current work is aimed at further elucidation of the molecular mechanism
of uH2B-mediated stimulation of Dot1L and the role of uH2B in other chromatin
templated-processes.

This thesis is dedicated to my late father, Dr. Dean McGinty, for his legacy of
compassion and service and his commitment to education.
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Chapter 1: Introduction
Under the central dogma of modern biology, deoxyribonucleic acid (DNA) is charged
with the responsibility of storing the genetic material that is essential to the maintenance of life
(Crick, 1958). Each time a cell divides, the complete sequence of its DNA, its genome, is
propagated by semi-conservative replication (Meselson and Stahl, 1958), thus bestowing its
entire genetic potential on each daughter cell. Through this framework, the genetic makeup of a
cell or organism, its genotype, determines the observable and inheritable characteristics of that
cell or organism, its phenotype. Mutations in gene sequences can cause phenotypic changes,
leading to the variation essential for speciation and evolution through natural selection.
However, for nearly a century, inheritable phenotypic changes have been observed in the
absence of genotypic changes (Allis et al., 2007). The discovery of position effect variegation
(PEV) in Drosophila represents one of the early descriptions of such a phenomenon. In 1930,
Muller described inheritable phenotypic changes in the eyes of Drosophila, following X-ray
induced DNA translocations (Muller, 1930). The dosage of each gene was appropriate but the
chromosomal locations of some genes changed. Over the next several decades, it was
demonstrated that the translocation placed the a gene coding for eye color next to
transcriptionally-silenced condensed chromatin, resulting in its variegated expression (Hannah,
1951). This phenomenon, as well as others, led to the inception of the field of epigenetics – the
study of changes in gene functions that cannot be attributed to changes to the DNA sequence of
genes (Allis et al., 2007).
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1.1. Chromatin: the physiologic state of the eukaryotic genome
It is impossible to understand epigenetics without first considering the physiologic state
of the genome. In organisms ranging from yeast to humans, DNA is packaged inside the nucleus
of cells in a polymeric complex called chromatin (Figure 1.1). The fundamental unit of
chromatin is the nucleosome, containing an octamer with two copies of each of the core histone
proteins, histone H2A (H2A), histone H2B (H2B), histone H3 (H3), and histone H4 (H4),
wrapped by 146 base pairs (bps) of DNA (Luger et al., 1997a). Although the composition of the
nucleosome has long since been established (Kornberg, 1977), more recent X-ray
crystallographic investigation of the nucleosome has painted a high-resolution picture of the
histone octamer and its interactions with DNA (Davey et al., 2002; Luger et al., 1997a; Schalch
et al., 2005). Each histone is comprised of a uniquely structured α-helical histone fold domain,
which contributes to the central core of the octamer, from which an N-terminal tail protrudes
(Luger et al., 1997a). DNA is wrapped in 1.65 turns of a left-handed superhelix around this
central protein core (Luger et al., 1997a).
The nucleosomal unit repeats throughout the genome every 160-240 bp (McGhee and
Felsenfeld, 1980), with each nucleosome connected to an adjacent nucleosome through a stretch
of intervening DNA. This intervening DNA, or linker DNA, is often found in complex with a
linker histone – for example, mammalian cells have up to six subtypes of linker histone H1
(Georgel and Hansen, 2001). Linker histones may function in heterochromatic condensation, but
whether or not they are essential remains elusive due to compensation between redundant
subtypes (Georgel and Hansen, 2001).
Arrays of nucleosomes are progressively condensed through a hierarchy of higher-order
structures, ranging from extended stands to condensed mitotic chromosomes (Allis et al., 2007).
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Figure 1.1. The nucleosome is the fundamental unit of chromatin. The nucleosomal structure
(1KX5) (Davey et al., 2002) rendered with Pymol. H2A, H2B, H3, and H4 are displayed in red,
blue, orange, and green, respectively. Chains of nucleosomes are condensed with linker histones
into higher order chromatin structures. Figure adapted from a previously published illustration
(Hansen, 2002).
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Much remains to be elucidated regarding the composition of these higher-order chromatin
structures. This is exemplified by the 30 nm fiber, the first level of chromatin compaction. While
the existence of the 30 nm fiber is generally agreed upon, the structural composition of the fiber
remains controversial (Robinson and Rhodes, 2006). Two models have been proposed: a onestart fiber formed from a simple solenoid pattern of nucleosomes (Huynh et al., 2005; Robinson
et al., 2006), and a two-start fiber with interdigitating nucleosomes (Dorigo et al., 2004; Schalch
et al., 2005). It is formally possible that both could co-exist in different environments in vivo.
Further compaction, beyond that of the 30 nm fiber, is even less well understood. This relative
ignorance is not a product of lack of investigation; to the contrary, it truly underscores the
complexity of even the simplest forms of chromatin structure.
From microscopic investigation, chromatin within the interphase nucleus has been
subdivided into two morphological states, heterochromatin and euchromatin. Heterochromatin
consists of densely compacted chromatin that is traditionally considered inaccessible and
therefore transcriptionally inactive. In contrast, euchromatin is more loosely compacted, and
consequently highly accessible and transcriptionally active (Allis et al., 2007). In recent years,
the inaccessibility of heterochromatin has come under scrutiny. While highly condensed and
transcriptionally silenced, heterochromatin is not inaccessible. In fact, proteins required for the
maintenance of condensed chromatin can freely diffuse into and out of heterochromatic areas
(Phair et al., 2004). A heightened understanding of higher-order chromatin structures will be
critical to the understanding of epigenetic mechanisms.
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1.2. Epigenetic phenomena
The field of epigenetics formed around a series of phenotypic phenomena observed in the
absence of genotypic changes, beginning as early as 1930 with the first report of PEV (Muller,
1930). This phenomenon was not restricted to phenotypes involving eye color; rather, it was a
general property of the relative location of any gene within the linear sequence of chromosomes
(Hannah, 1951). Similar phenotypic changes were reported in maize, caused by the movement of
transposable elements. These segments of DNA have the intrinsic ability to jump between
different loci within the genome, causing heritable, but often reversible changes to the expression
of neighboring genes (McClintock, 1950).
Inheritance of sex chromosomes presents another epigenetic quandary. While females
inherit two X chromosomes, one from each parent, males only inherit a maternal X chromosome.
The X chromosome contains many genes required for sex determination, but it also carries many
housekeeping genes that if unregulated, could have disastrous consequences for a cell (Allis et
al., 2007). Therefore, an equalization of the expression of genes residing in the X chromosome
between males and females, despite a different copy number, is required – a process called
dosage compensation. Dosage compensation necessitates two functions: 1) the ability to count X
chromosomes, and 2) the ability to adjust the level of expression accordingly. Surprisingly, three
different mechanisms of dosage compensation have been observed in different model organisms:
two-fold up regulation of X-linked genes in the male worm, two-fold suppression of X-linked
genes in the female fly, and random inactivation of a single X chromosome in the female
mammal (Chow and Heard, 2009; Ercan and Lieb, 2009; Gelbart and Kuroda, 2009).
Importantly, the mechanisms are reversible, so that following reproduction, the correct
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compensation can be applied anew to the next generation, based on the genotype of the progeny
(Chow and Heard, 2009).
Contrary to genes on sex chromosomes, most genes located on autosomal chromosomes
are expressed equally, regardless of their parental origins. However, the expression of a small
subset of genes is restricted to either the maternal- or paternal-inherited gene in both males and
females, through a process call imprinting (Allis et al., 2007). One of the earliest observations of
imprinting involved mice with a genetic deletion on chromosome 17 resulting in a “hairpin” tail.
Progeny inheriting the deletion were viable only when the deletion was inherited from the father
and died during embryogenesis when the deletion was inherited from the mother (Johnson,
1974). This led to the suggestion that the deleted region of chromosome 17 may be active only
on the maternally inherited chromosome (McClaren, 1979). While affecting a small fraction of
the genome, imprinting is of great consequence to human medical genetics as a number of
disorders are inherited through imprinted genes, such as Prader Willi and Angelman syndromes
(Allis et al., 2007).
Perhaps much of the attraction of epigenetics arises from the mysteries of development of
multi-cellular organisms. Through exponential rounds of division without changes to the DNA
sequence itself, how can one cell lead to the formation of a complex organism, complete with
organ systems, and nearly countless cell morphologies and functions? Recent research in
epigenetics has focused on elucidating the mechanisms underlying these and other related
phenomena. Not surprisingly, an overlapping set of fundamental molecular mechanisms have
been discovered that form the foundation for choreographing the complex expression of the
genome.
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1.3. Epigenetic mechanisms
Most epigenetic phenomena result from a complex interplay between a small set of
molecular mechanisms, including post-translational modification of histones, substitution of
canonical histones for sequence variants, nucleosomal remodeling, DNA methylation, and
siRNA-mediated transcriptional silencing (Allis et al., 2007). These individual mechanisms act
in concert to control gene expression, with each mechanism contributing to the initiation and/or
maintenance of the epigenetic signal. One of the oldest epigenetic molecular mechanisms, found
in organisms ranging from yeast to vertebrates, is the post-translational modification (PTM) of
histones (Allis et al., 2007; Kouzarides, 2007). PTMs are chemical modifications to proteins
subsequent to ribosomal synthesis that increase the chemical complexity afforded by the standard
20 amino acids (Walsh, 2005). As most PTMs are reversible, they allow transient regulation of
protein activity and are used to control complex biochemical systems. Histones harbor an
extraordinary density of PTMs, especially within their N-terminal tails, including lysine and
arginine methylation, lysine acetylation, serine and threonine phosphorylation, and lysine
ubiquitylation and sumoylation (Allis et al., 2007; Kouzarides, 2007). Functions of specific
histone PTMs will be discussed in detail in the following sections.
In addition to PTM of histones, the chemical composition of chromatin can be reversibly
controlled through the incorporation of histone variant proteins (Allis et al., 2007). These
proteins are sequence variants of the canonical histone sequences that can replace their
respective core histones within the nucleosome. Histone variants can occupy specific locations
within the linear sequence of chromosomes, demarcate specific regions of active and inactive
chromatin, and signal in diverse chromatin-templated processes (Allis et al., 2007). For example,
H3.3 and H2A.Z are associated with actively transcribed genes, localized to the open-reading

7

frames and promoters, respectively, suggesting a role in transcriptional regulation (Henikoff and
Ahmad, 2005; Kamakaka and Biggins, 2005); conversely, macroH2A is found in the inactive X
chromosome of mammals, possibly playing a role in dosage compensation (Costanzi and
Pehrson, 1998).
Collectively, histone variants present chemical changes that can potentially be interpreted
similarly to histone PTMs. In fact, incorporation of variants has been proposed as a mechanism
for erasing a record of histone PTMs (Schwartz and Ahmad, 2005). Furthermore, histone
variants harbor a set of PTMs that are partially distinct from those found in canonical histones
(Allis et al., 2007). This is exemplified by the phosphorylation of H2A.X coincident with DNA
double strand breaks (Thambirajah et al., 2009).
The role of incorporating histone variants into chromatin falls to nucleosomal remodeling
complexes (Clapier and Cairns, 2009). These molecular machines can assemble and disassemble
nucleosomes, and reposition nucleosomes translationally along DNA. As the nucleosome is the
first barrier to DNA for many DNA binding proteins, nucleosomal composition and positioning
is relevant to almost all chromatin-templated activities. This is exemplified in transcriptional
activation, where significant nucleosomal ejection and sliding occurs surrounding the
transcription start site, the promoter, and throughout the coding region (Clapier and Cairns,
2009), allowing the polymerase complex to assemble and proceed through a gene. The function
of many chromatin remodelers is likely to be integrally linked to specific patterns of histone
PTMs. This is reflected in the prevalence of modification-specific histone binding modules
within remodeling complexes (Clapier and Cairns, 2009).
DNA methylation also plays an integral role in many epigenetic phenomena. Position 5
of the cytidine pyrimidine ring is methylated by dedicated DNA methyltransferases. Generally,
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DNA methylation is found in CpG rich regions of repeating elements and CpG islands in
promoters, leading to silencing in both cases (Allis et al., 2007). Two types of DNA
methyltransferases are required for placement and inheritance of methylation patterns. De novo
DNA methyltransferases modify unmethylated loci within the genome, while maintenance DNA
methyltransferases preferentially act on hemimethylated loci, allowing for inheritance of the
mark following replication (Bestor and Ingram, 1983; Okano et al., 1999). Asymmetric
methylation of maternally and paternally inherited genes assists in the establishment of
imprinting (Allis et al., 2007).
Methylation of DNA can regulate the binding of DNA interacting proteins both positively
and negatively. Certain transcription factors are unable to interact with methylated promoters,
thereby passively repressing expression of methylated genes (Watt and Molloy, 1988).
Conversely, a family of proteins harboring methyl CpG binding domains (MBDs) interact with
methylated DNA, often in a sequence-specific manner, to actively repress transcription (Allis et
al., 2007). As described for remodeling complexes, DNA methyltransferases rely heavily on
histone PTMs. In mammals, deletion of methyltransferases establishing either H3K9me or
K27me disrupts DNA methylation patterns (Lehnertz et al., 2003; Vire et al., 2006).
Furthermore, many histone remodeling complexes, including ATRX, assist in maintaining
appropriate DNA methylation patterns (Gibbons et al., 2000).
Recently, small non-coding RNAs have been implicated in the maintenance of silenced
chromatin. These non-coding RNAs are processed into 21-27 bp small interfering RNAs
(siRNAs) by Dicer and can mediate both post-transcriptional and transcriptional gene silencing
(TGS) (Allis et al., 2007). siRNA-mediated TGS employs the RNA-Induced Transcriptional
Silencing (RITS) complex. The RITS complex, through complementary interaction with a
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nascent transcript (Buhler et al., 2006), or possibly through complementarity with the genomic
DNA itself, targets repressive complexes to genomic loci to initiate the formation of
heterochromatin. This process is best understood in S. pombe, where the RITS complex recruits
H3K9 methyltransferase, Clr4, and HP1 homolog, Swi6, which binds H3K9me, and so facilitates
the spread of heterochromatin (Hall et al., 2002; Volpe et al., 2002). In humans, siRNA-mediated
TGS acts cooperatively with histone PTMs and DNA methylation to establish dosage
compensation and gene imprinting (Allis et al., 2007).
These epigenetic mechanisms alter the structure of chromatin through nucleosomal
positioning and control of chromatin condensation, and fine-tune the recruitment of chromatinassociated proteins. These combined effects allow the control of gene expression programs in
embryogenesis and cell fate determination, and when disrupted, can result in the pathogenesis of
many disease states.

1.4. Post-translational modification of histones
At least nine distinct types of histone PTMs have been observed. Certain types have been
well characterized, such as acetylation, methylation of lysines and arginines, and
phosphorylation, while current understanding of other types, including ubiquitylation,
sumoylation, ADP ribosylation, deimination, proline isomerization, and proteolysis is incomplete
(Duncan et al., 2008; Kouzarides, 2007). While acetylation is synonymous with transcriptionally
active chromatin, other modifications, including methylation (Martin and Zhang, 2005) and
ubiquitylation (Shilatifard, 2006) correlate with active and repressed chromatin in a positionspecific manner. In addition to transcriptional regulation, histone PTMs function in diverse
processes, including DNA replication, DNA repair, mitosis, and apoptosis (Allis et al., 2007).
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Although the existence of histone PTMs has been established since the late 1960s
(Allfrey et al., 1964), the mid-1990s brought the discovery of the first enzymes involved in the
modification of histones. Isolation of a histone lysine acetyltransferase (HAT), Gcn5, and a
histone lysine deacetylase (HDAC), Rpd3p, set the stage for reversible regulation of histone
PTMs (Brownell et al., 1996; Taunton et al., 1996). Over the last decade, astonishing progress
has been made in the identification and characterization of the enzymes that establish and reverse
the vast array of known histone modifications (Kouzarides, 2007).
What is most compelling regarding histone PTMs is their sheer density. More than 60
amino acid side chains have been shown to carry PTMs, representing over two-thirds of the
modifiable positions in the nucleosome (Kouzarides, 2007; Taverna et al., 2007). However, this
number is an underestimate of the combinatorial potential of histone PTMs because some lysines
can be modified by either methylation or acetylation. Furthermore, lysine methylation exists in
three distinct forms: mono-, di-, and trimethylation; arginine methylation is also present is three
forms: mono-, asymmetric di-, and symmetric dimethylation. In some cases each methylation
state is thought to have a distinct function (Martin and Zhang, 2005), and in other cases the
different states seem to be redundant (Frederiks et al., 2008). Despite this extraordinary
combinatorial diversity, a smaller subset of the sum of possible PTM combinations may exist
and be functionally meaningful in vivo. Many gene promoters in a pool of CD4+ T cells show
evidence of a common set of 17 acetylations and methylations (Wang et al., 2008). Whether
these modifications reside in a nucleosome simultaneously is yet to be verified. However, it
underscores the complexity and combinatorial power of histone PTMs, as well as the tendency
for certain patterns to arise, parallel to genomic functions.
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Histone PTMs, often in a site-specific context, facilitate chromatin-templated processes
through three proposed mechanisms: 1) histone PTMs can alter charge density, thereby assisting
or impeding intra- and internucleosomal contacts and changing chromatin accessibility as a
result; 2) histone PTMs can recruit position- and modification-specific binding modules and any
associated activities; and, 3) conversely, histone PTMs can prevent the binding of chromatin
associated proteins, excluding any associated activities (Figure 1.2) (Allis et al., 2007). Examples
of each of the three mechanistic roles of histone PTMs will be discussed below.
Chromatin is a highly charged polymer. As such, its electrostatic surface plays a decisive
role in its conformational state and oligomeric potential. PTMs, including acetylation and
phosphorylation, alter intrinsic electrostatic properties of amino acid side chains and thus, have
the potential to tune the conformational state of chromatin (Figure 1.2, top panel). A number of
different lysines on each of the core histones are acetylated, mostly residing within their Nterminal tails (Allis et al., 2007). Hyperacetylation of histone tails controls chromatin
conformation on multiple levels, weakening interactions between histone tails and nucleosomal
DNA, decreasing compaction of the 30 nm fiber, and reducing oligomerization of nucleosomal
arrays (Wolffe and Hayes, 1999). Furthermore, the acetylation of H4K16 alone precludes the
formation of 30 nm fibers in vitro (Robinson et al., 2008; Shogren-Knaak et al., 2006).
Ubiquitylation has also been proposed to prevent higher order compaction of chromatin
structures (Henry and Berger, 2002; Sun and Allis, 2002). However, this is not due to charge
neutralization; rather, it has been speculated that given its sheer size (76 amino acids compared
to 102-135 amino acids for each of the histones), ubiquitin may act as a wedge between adjacent
nucleosomes, preventing chromatin condensation. Local control of chromatin conformation by
asd
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Figure 1.2. Mechanisms of action of histone PTMs. Histone PTMs can function through three
distinct mechanisms: 1) direct conformational changes to nucleosomes and chromatin; 2)
recruitment of effectors; and 3) exclusion of effectors.
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PTM of histones through electrostatic or steric mechanisms presents a mechanism for regulating
access of specific genomic regions to effectors of chromatin-templated processes.
Histone PTMs can also regulate chromatin indirectly through the recruitment of positionand modification-specific binding modules (Figure 1.2, middle panel). Over the past decade, a
vast set of these modules have been reported that can act as intermediaries between
modifications and downstream events (Taverna et al., 2007). Examples include bromodomains,
the Royal superfamily of domains – collectively comprised of chromodomains, tudor domains,
and MBT repeats – and 14-3-3 domains, which recognize acetyllysines, methyllysines, and
phosphoserines, respectively (Dhalluin et al., 1999; Macdonald et al., 2005; Ruthenburg et al.,
2007a; Zeng and Zhou, 2002). Histone PTMs can be interpreted and translated into a diverse set
of biological responses by linking specific modules with an array of effectors, including
transcriptional coactivators and corepressors, chromatin remodelers, and histone modifying
enzymes (Ruthenburg et al., 2007b).
The modular nature of interpretation of histone PTMs permits the combinatorial
recognition of multiple PTMs, potentially within one histone tail, on separate histones within a
nucleosome, or in neighboring nucleosomes (Ruthenburg et al., 2007b). In the first example of
cooperative recognition of histone PTMs, the tandem bromodomains of TFIID were shown to
have enhanced affinity for doubly acetylated H4 peptides over either singly acetylated species,
suggesting bivalent recognition within a single histone tail (Jacobson et al., 2000). Given the
prevalence of multiple PTM recognition modules contained within single polypeptides or within
complexes of chromatin-associated proteins, this is likely to be a universal strategy for the
interpretation of multiple histone PTMs (Ruthenburg et al., 2007b).
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Histone PTMs can also function through the exclusion of effectors (Figure 1.2, bottom
panel). This is best exemplified by the observation of binary switches between adjacent
modifications. For example, the phosphorylation of H3S10 prevents the binding of HP1 to
methylated H3K9, consequently disrupting heterochromatin formation (Fischle et al., 2005;
Hirota et al., 2005). A similar switch exists in H2B in yeast, where deacetylation of K11 is
required for phosphorylation of S10 during apoptotic chromatin condensation (Ahn et al., 2006).
The diversity and scope of histone PTMs has led to the proposal of a histone code,
through which combinatorial site-specific PTMs provide the blueprint for choreographing
complex genome-templated processes (Strahl and Allis, 2000). Alternatively, the large set of
histone PTMs may be more reminiscent of cytosolic PTM-regulated signaling cascades of
cellular metabolism (Allis et al., 2007). The dynamic and complex nature of histone PTMs
compared to the stable, four-letter genetic code, makes the histone code hypothesis difficult to
validate – studying histone PTMs is more like interpreting a conversation than translating a
book. However, the position- and modification-specific recruitment of binding modules, the
presence of binary PTM-based switches, and the conservation of complex PTM patterns at
specific functional loci lend credibility to the histone code hypothesis. Extraordinary progress
has been made in the identification of novel histone PTMs, the isolation of enzymatic activities
responsible for their deposition and removal, and in deciphering the mechanisms underlying their
physiologic functions. Yet, much remains to be discovered to broaden our understanding of
histone PTMs and their epigenetic roles in development and disease.
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1.4.1. Ubiquitylation of histones
Monoubiquitylation of proteins was discovered in the context of H2A (Goldknopf
and Busch, 1977; Hunt and Dayhoff, 1977). Soon after, monoubiquitylation of H2B was
established (West and Bonner, 1980). Unlike small PTMs, including acetylation, methylation,
and phosphorylation, ubiquitylation results from the acylation of a lysine side chain with the 76
amino acid protein ubiquitin. The C-terminal glycine (G76) of ubiquitin is attached to the ε-NH2
of a lysine through an amide bond, forming a branched isopeptide linkage (Hershko et al., 2000).
Due to the size of ubiquitin relative to small chemical PTMs, ubiquitylation is considered an
information-rich modification (Walsh, 2005).
Ubiquitin is expressed as a head-to-tail repeat of five ubiquitin sequences (Figure 1.3).
Ubiquitin monomers can be mobilized from the repeats through the action of deubiquitylating
enzymes (DUBs) and ubiquitin C-terminal hydrolases (UCHs) (Walsh, 2005). The ubiquitin
monomers are then activated and transferred to substrates through the concerted effort of
ubiquitin activating enzymes (E1s), ubiquitin-conjugating enzymes (E2s), and ubiquitin protein
ligases (E3s) (Hershko et al., 2000; Pickart, 2001). E1 activates the C-terminus of ubiquitin as an
ubiquityl-S-E1 thioester through an ubiquityl-AMP intermediate. The ubiquityl moiety is then
transferred from the cysteine side chain of E1 to a cysteine side chain of a specific E2, forming
an ubiquityl-S-E2 thioester. Finally, often cooperatively with an E3, the ubiquityl moiety is
conjugated to the lysine side chain of a target protein. Most of the substrate specificity of the
ubiquitylation machinery is encoded within E3-substrate interactions. Ubiquitin can be removed
from lysine side chains by DUBs and UCHs, allowing for reversible signaling, as well as the
recycling of ubiquitin monomers (Walsh, 2005).
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Figure 1.3. The ubiquitin cycle. Ubiquitin is attached to proteins through the concerted action
of E1, E2, and E3 ubiquitin conjugating enzymes. Ubiquitin is recycled through the actions of
DUBs and UCHs. Monoubiquitylation functions in cell signaling, while polyubiquitylation
targets proteins for proteasomal degradation.
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Early investigation of ubiquitin elucidated the role of polyubiquitylation in proteolytic
degradation of proteins (Hershko et al., 2000). Polyubiquitin chains are linked through isopeptide
bonds between ubiquitin lysines and successive ubiquityl-α-carboxylic acids; these chains can be
built through K6, K11, K27, K29, K33, K48, and K63 – each linkage correlated with divergent
functions (Xu et al., 2009). For proteasomal targeting, a protein must carry a minimum of four
K48-linked ubiquitins (Walsh, 2005). While polyubiquitylation typically leads to proteasomal
destruction of target proteins, recent investigation shows that monoubiquitylation signals in nonproteasomal pathways, including receptor internalization and vesicular trafficking (Katzmann et
al., 2002; Raiborg et al., 2003), gene regulation (Shilatifard, 2006), and DNA damage repair
(Huang and D'Andrea, 2006).
Most ubiquitin-based signaling pathways employ specific ubiquitin binding motifs. In
vivo, ubiquitin is recognized by more than sixteen families of ubiquitin binding motifs (Hurley et
al., 2006). These motifs are primarily α-helical, from the single α-helix of the ubiquitin
interacting motif (UIM) to the small helix bundle of the ubiquitin associated (UBA) domain.
Although interaction surfaces of ubiquitin binding motifs vary widely, most center on a
hydrophobic patch of ubiquitin’s surface including I44 (Hurley et al., 2006). Other ubiquitin
surfaces involved in ubiquitin signaling include the C-terminal Gly-Gly region and a charged
patch including D58 (Hurley et al., 2006).
Monoubiquitylated forms of H2A (uH2A) and H2B (uH2B) most often perform opposite
functions in gene regulation. H2A is ubiquitylated by the polycomb repressor complex 1 (PRC1)
and is correlated with methylation of H3K27, silencing of homeotic genes, and X inactivation
(Shilatifard, 2006). In contrast, uH2B is implicated in transcriptional elongation and co-localizes
with active histone PTMs, including methylated H3K4 (Weake and Workman, 2008). uH2B is
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also critical to expression of homeotic genes, suggesting that an interplay between ubiquitylation
of H2A and H2B in gene expression programs responsible for developmental patterning. In
addition to roles in regulation of gene expression, uH2A and uH2B signal in DNA damage repair
pathways (Game and Chernikova, 2009; Huang and D'Andrea, 2006). The function of uH2B in
these processes is detailed in the following sections.

1.4.2. Ubiquitylation of H2B
H2B is ubiquitylated on K120 in vertebrates (Thorne et al., 1987), corresponding to K123
in S. cerevisiae (Robzyk et al., 2000) and K119 in S. pombe (Tanny et al., 2007). In higher
organisms, uH2B represents 1% of the total cellular H2B (West and Bonner, 1980); this number
may reach 10% in S. cerevisiae (Robzyk et al., 2000). The E2 and E3 enzymes responsible for
H2B ubiquitylation were first discovered in budding yeast as Rad6 and Bre1, respectively
(Hwang et al., 2003; Robzyk et al., 2000; Wood et al., 2003a). Orthologs of yeast Rad6, RAD6A
and RAD6B, and yeast Bre1, BRE1A and BRE1B (RNF20/40), can efficiently ubiquitylate
H2BK120 in human cells (Kim et al., 2009; Kim et al., 2005; Zhu et al., 2005). BRE1A and
BRE1B interact to form a complex, which in turn, interacts with RAD6A or RAD6B. RNAimediated knockdown of either BRE1A or BRE1B, or RAD6A drastically reduces uH2B in
human cells (Kim et al., 2009; Kim et al., 2005; Zhu et al., 2005). RAD6B knockdown has only
a minimal effect on uH2B accumulation, suggesting a dominant role for RAD6A in vivo (Kim et
al., 2009). Rad6, in concert with E3s other than Bre1, also ubiquitylates other proteins in DNA
damage and protein degradation pathways (Osley, 2006).
In addition to RAD6A/B, other E2s have been implicated in ubiquitylation of H2BK120,
including UbcH6 (Zhu et al., 2005), though their physiological roles are controversial (Kim et
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al., 2009). Additionally, Mdm2 and BRCA1, both E3 ubiquitin ligases, can ubiquitylate H2B in
vitro, but the in vivo relevance and site-specificity remain unclear (Chen et al., 2002; Mallery et
al., 2002; Minsky and Oren, 2004; Xia et al., 2003).
In S. cerevisiae, ubiquitin is removed from H2B by two DUBs, Ubp8 and Ubp10 (Daniel
et al., 2004; Emre et al., 2005; Gardner et al., 2005; Henry et al., 2003). Ubp8 is a component of
the SAGA complex containing HAT, Gcn5 (Daniel et al., 2004; Henry et al., 2003). While Ubp8
is not necessary for SAGA function, two SAGA components, Sus1 and Sgf1, are required for
association of Ubp8 with SAGA and the resultant removal of ubiquitin from H2B (Henry et al.,
2003; Kohler et al., 2006). Recently, the human ortholog of Ubp8, ubiquitin specific protease 22
(USP22), was reported to be a part of the human SAGA-like complex, STAGA (Zhang et al.,
2008; Zhao et al., 2008). USP22 can remove ubiquitin from H2B and its incorporation into the
STAGA complex, necessitates human orthologs of Sgf1 and Sus1, ATXN7L3 and ENY2,
respectively (Zhao et al., 2008). In addition to Ubp8, Ubp10 carries out the deubiquitylation of
H2B in S. cerevisiae (Emre et al., 2005; Gardner et al., 2005). Ubp10 associates with Sir4 and is
implicated in telomeric silencing. Human DUBs, USP7 and USP3 may also deubiquitylate H2B,
but their physiologic roles are currently unclear (Nicassio et al., 2007; van der Knaap et al.,
2005).
Ubiquitylation and deubiquitylation of H2B has been correlated with many chromatin
templated processes, including transcriptional activation and elongation, trans-histone
methylation of H3, and DNA damage repair (Figure 1.4) (Game and Chernikova, 2009; Weake
and Workman, 2008). The role of uH2B in these processes will be discussed in detail below.
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Figure 1.4. The role of uH2B in transcription and H3 methylation. 1. Rad6 and Bre1 are
recruited during transcription initiation by Bre1-activator interactions. 2. A cycle of H2B
ubiquitylation is correlated with transcriptional elongation. The Pol II CTD is phosphorylated by
Kin28 and Ctk. The PAF and Bur1/Bur2 complexes mediate the movement of ubiquitin ligase
activities of Rad6 and Bre1 with this elongating form of Pol II through the open reading frame of
a gene. The resultant uH2B formation is shown behind the elongating polymerase for clarity, but
this spatial localization is unknown. Remodeling complex FACT may participate in the
disassembly and reassembly of nucleosomes as Pol II processes through the chromatin template.
DUB activity of Ubp8 in the SAGA complex subsequently removes ubiquitin from H2B. 3.
uH2B is required for efficient methylation of H3K4 and K79 by Set1 and Dot1, respectively. In
both cases Cps35 and proteasomal ATPases may bridge uH2B and methylation. Cps35
ubiquitylation is also implicated in H3K4 methylation.
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1.4.2.1 uH2B and transcription
During transcriptional activation, Pol II is recruited to promoters of genes and
transcription is initiated by cooperative functions of activators and coactivators. Subsequent
promoter clearance allows Pol II to exit the promoter region and move into the open reading
frame of the gene. Transcription elongation assisted by elongation factors continues until the
nascent mRNA is complete and transcription is terminated. Considerable evidence suggests a
role for the ubiquitylation cycle of H2B in transcriptional elongation (Laribee et al., 2007;
Weake and Workman, 2008). Mutations affecting ubiquitylation of H2B in S. cerevisiae and S.
pombe decrease accumulation of transcripts (Tanny et al., 2007; Xiao et al., 2005). In S.
cerevisiae, Rad6 associates with the elongating form of Pol II, which is phosphorylated at Ser2
and Ser5 in its C-terminal domain (CTD) (Figure 1.4, middle panel) (Xiao et al., 2005).
Interestingly, deletion of Kin28, responsible for phosphorylation of Ser5 in the Pol II CTD,
abolishes ubiquitylation of H2B, while deletion of Ctk1, responsible for phosphorylation of Ser2
in the Pol II CTD, has no effect on H2B ubiquitylation levels (Xiao et al., 2005).
The interaction of Rad6 and elongating Pol II is mediated through Bre1 and the Pol II
associated factor (PAF) complex. Bre1 in yeast and humans is recruited to promoters through
interactions with activators, including p53 and Gal4 (Figure 1.4, top panel) (Kao et al., 2004;
Kim et al., 2005; Wood et al., 2003a). This recruitment is independent of Rad6 and, in turn, is
required for Rad6 localization to promoter regions (Kao et al., 2004; Wood et al., 2003a; Wood
et al., 2003b). However, Bre1 and Rad6 recruitment to promoters is insufficient for H2B
ubiquitylation, which requires additional factors, most notably the PAF complex and cyclindependent kinase complex, Bur1/Bur2 (Figure 1.4, middle panel) (Kim and Roeder, 2009;
Laribee et al., 2005; Ng et al., 2003b; Wood et al., 2003b; Wood et al., 2005; Xiao et al., 2005).
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Mutations in two components of the PAF complex, Paf1 and Rtf1, disrupt H2B ubiquitylation
without altering Rad6 recruitment to promoters (Ng et al., 2003b; Wood et al., 2003b; Xiao et al.,
2005). While properly recruited to the promoter, Rad6 fails to follow Pol II into the open reading
frame in rtf1Δ cells (Xiao et al., 2005). This suggests that the ubiquitylation machinery is
recruited to the promoter through Bre1-activator interactions, and then it is handed off to PAF to
follow Pol II into the open reading frame. The Bur1/Bur2 complex is not only required for
recruitment of the PAF complex, but also phosphorylates Ser120 of Rad6 (Figure 1.4, middle
panel) (Laribee et al., 2005; Wood et al., 2005). Similar phosphorylation of human RAD6A by
human cyclin-dependent kinase 2 (CDK2) enhances H2B ubiquitylation in vitro (Sarcevic et al.,
2002).
Coincident with Pol II, the PAF complex, Rad6, and uH2B are found throughout the
coding region of active genes (Kao et al., 2004; Minsky et al., 2008; Xiao et al., 2005).
Interestingly, the presence of Rad6 in the coding regions of activated genes is transient compared
to Pol II (Kao et al., 2004; Xiao et al., 2005). Thus, Rad6-mediated ubiquitylation of H2B may
be involved in pioneering transcription of a newly activated gene that brings about stable
changes in the chromatin template allowing subsequent rounds of transcription without Rad6.
Similarly to H2B ubiquitylation, H2B deubiquitylation is required for optimal transcriptional
efficiency. Reminiscent of Rad6, Ubp8 associates with elongating Pol II in the open reading
frame of SAGA-regulated genes (Figure 1.4, middle panel), which have decreased expression in
ubp8Δ strains (Daniel et al., 2004; Henry et al., 2003; Mutiu et al., 2007). Additionally, Ubp8 is
a prerequisite for Ctk1-mediated phosphorylation of Ser2 of the Pol II CTD (Wyce et al., 2007).
A double knockout of Ubp8 and Bre1 reestablishes Ser2 phosphorylation, suggesting that
ubiquitylation of H2B blocks Ctk1 recruitment. Supporting this notion, Ctk1 associates with
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H2A and H2B but shows no affinity for uH2B (Wyce et al., 2007). This evokes a model in which
a cycle of ubiquitylation and deubiquitylation coordinated with Pol II CTD phosphorylation is
required during transcriptional elongation of certain genes (Weake and Workman, 2008).
However, minimal evidence for this model has been reported.
While much is known about how ubiquitylation of H2B is coordinated with transcription
elongation, far less is understood regarding any mechanistic role of uH2B in the process.
Ubiquitylation of H2B is required for efficient methylation of H3K4 and H3K79 in an
evolutionarily conserved pathway (Figure 1.4, bottom panel) (Briggs et al., 2002; Kim et al.,
2005; Ng et al., 2002b; van Leeuwen et al., 2002; Zhu et al., 2005). It is plausible that these
methylation events could translate ubiquitylation of H2B into transcriptional activity through the
recruitment of chromatin remodelers or other elongation factors. However, evidence suggests
that the impact of H2B ubiquitylation on transcriptional efficiency is independent of H3K4 and
K79 methylation (Fleming et al., 2008; Shukla and Bhaumik, 2007; Tanny et al., 2007). A
second model has been proposed to explain methylation-independent functions of uH2B,
implicating chromatin remodeling and assembly. uH2B may stimulate the activity of a chromatin
remodeling complex, “facilitates chromatin transcription” or FACT, thus easing the nucleosomal
barrier to transcription (Figure 1.4, middle panel) (Laribee et al., 2007). FACT is proposed to
remove an H2A/H2B dimer from a nucleosome during transcription and has also been implicated
in nucleosome reassembly behind elongating Pol II (Fleming et al., 2008; Kaplan et al., 2003;
Mason and Struhl, 2003; Reinberg and Sims, 2006). While FACT permits low levels of
transcription of a chromatinized template in vitro, transcriptional efficiency is greatly enhanced
by the addition of PAF, UbcH6, and BRE1A and BRE1B (Pavri et al., 2006). Unfortunately,
although the chromatin template was ubiquitylated in this work, H2B was never verified as the
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substrate for ubiquitylation. As a result of the contentious role of UbcH6 in H2B ubiquitylation,
this conclusion remains controversial. While much has been discovered regarding the
requirements for ubiquitylation of H2B, future work will be required to elucidate the mechanism
linking the H2B ubiquitylation cycle to efficient transcription elongation.

1.4.2.2. uH2B and methylation of histone H3
Soon after its discovery in S. cerevisiae, uH2B was demonstrated to be required for
efficient methylation of H3K4 and H3K79, establishing a trans-histone regulatory pathway
(Figure 1.4, bottom panel) (Briggs et al., 2002; Dover et al., 2002; Ng et al., 2002b; Sun and
Allis, 2002). Further investigation revealed that uH2B is required for di- and trimethylation of
these positions, while elimination of H2B ubiquitylation has no effect on monomethylation
(Shahbazian et al., 2005). Similar observations have been reported in human cell lines.
Knockdown of RAD6A, BRE1A, or BRE1B results in decreased di- and trimethylation H3K4, as
well as decreased dimethylation H3K79, to a degree that correlates well with reduction of uH2B
(Kim et al., 2009; Kim et al., 2005). Monomethylation of both positions is unaffected.
Overexpression of BRE1A results in increased trimethylation and dimethylation of H3K4 and
K79, respectively; however, contradicting results have been observed regarding the levels of
H3K4 mono- and dimethylation (Kim et al., 2005; Zhu et al., 2005).
It would be expected that disruption of H2B deubiquitylation machinery would have an
effect similar to overexpression of ubiquitylation machinery. Indeed, promoter-specific analysis
reveals an increase in H3K4 trimethylation in ubp8Δ strains compared to wild-type background
following gene induction, with negligible changes to mono- and dimethylation (Henry et al.,
2003). Surprisingly, in a separate study deletion of ubp8 resulted in minimal decreases in global
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H3K4 di- and trimethylation, simultaneous with a drastic increase in monomethylation (Daniel et
al., 2004). This apparent discrepancy is unresolved.
The mechanistic role of uH2B in stimulating methylation is unclear. It has been proposed
that uH2B may induce H3 methylation directly, either by altering chromatin structure and
therefore nucleosomal accessibility, or through the recruitment of enzymatic function (Henry and
Berger, 2002; Sun and Allis, 2002). However, the possibility that one or more additional factors
may be required to translate the effect of uH2B into heightened methyltransferase activity is
equally likely. For example, proteasomal ATPases and Cps35, a component of the Set1 H3K4
methyltransferase complex, have been implicated in bridging uH2B and H3 methylation (Figure
1.4, bottom panel) (Ezhkova and Tansey, 2004; Lee et al., 2007). Additionally, it has been
suggested that Cps35 is itself ubiquitylated, leading to efficient methylation of H3K4 (VitalianoPrunier et al., 2008). These proposed mechanisms are not mutually exclusive and further
investigation will elucidate the possible role of each in this trans-histone biochemical network.

1.4.3. Methylation of histone H3K4
In organisms ranging from yeast to humans, trimethylated H3K4 occupies the 5’ region
of actively transcribed genes, where it correlates with histone acetylation and Pol II occupancy
and is critical to regulation of homeotic genes (Ruthenburg et al., 2007a). Functions of monoand dimethylated H3K4 are less clear and may vary across organisms and even in different cell
types within organisms (Ruthenburg et al., 2007a). Set1 is the sole H3K4 methyltransferase in S.
cerevisiae. Increased complexity is found in vertebrates, where up to nine H3K4
methyltransferases have been reported, most included in the conserved MLL family (Ruthenburg
et al., 2007a). While each MLL family methyltransferase is specific for H3K4, they seem to
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occupy non-redundant niches (Glaser et al., 2006; Lee et al., 2006; Yu et al., 1995). Each MLL
methyltransferase exists in a large multi-subunit complex, and while the common core subunits
are conserved, other components are unique and may hold clues to the regulated actions of
individual methyltransferases (Dou et al., 2006).

1.4.4. Methylation of histone H3K79
Methylation of H3K79 is implicated in maintenance of telomeric silencing, DNA damage
repair pathways, and in the pathogenesis of human disease (van Leeuwen et al., 2002). H3K79
exists in mono-, di-, and trimethylated states in yeast and mono- and dimethylated states in
humans (Garcia et al., 2007) and is closely correlated with transcriptionally active chromatin (Ng
et al., 2003a). While the trimethylated state globally dominates S. cerevisiae chromatin, the
distribution in vertebrates centers around unmodified and monomethylated states (Garcia et al.,
2007). The various levels of methylation function redundantly in telomeric silencing in yeast
(Frederiks et al., 2008), but distinct roles for methylation states in human cells have not been
investigated.
To date, a single H3K79 methyltransferase, disruptor of telomeric silencing-like (Dot1L),
has been reported in humans (Feng et al., 2002), analogous to the lone H3K79 methyltransferase
in yeast, Dot1 (Lacoste et al., 2002; Ng et al., 2002a; van Leeuwen et al., 2002). Unlike most
histone lysine methyltransferases, Dot1 lacks a characteristic Set domain and its catalytic domain
bears resemblance to protein arginine methyltransferases (Dlakic, 2001; Min et al., 2003;
Sawada et al., 2004). While the catalytic domain of Dot1 is evolutionarily conserved, the domain
organization of yeast and human homologs is markedly different, suggesting divergent regulation
or mechanism of action (Figure 1.5) (Sawada et al., 2004). Except for a lysine rich stretch
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Figure 1.5. Comparison of yeast Dot1 and human Dot1L methyltransferases. A) Domain
alignment of Dot1 and Dot1L. Lysine-rich domains implicated in DNA binding are labeled.
MTase = methyltransferase domain. B) Cartoon representation of human Dot1L catalytic domain
(1NW3) (Min et al., 2003). S-adenosylmethionine (SAM) is shown in red. C) Structural
alignment of human Dot1L (green) and yeast Dot1 (blue, 1U2Z) (Sawada et al., 2004) catalytic
domains. SAM bound to the human and yeast methyltransferases is shown in red and orange,
respectively.
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involved in DNA binding (Min et al., 2003; Sawada et al., 2004), the functions of the
evolutionarily distinct domains of Dot1 have not been characterized.

1.4.4.1. Methylation of histone H3K79 and maintenance of silencing
Dot1 was discovered in S. cerevisiae based on its role in telomeric silencing. Both
overexpression and deletion of dot1 results in a weakening of telomeric silencing (Singer et al.,
1998). This seems counterintuitive for a methyltransferase marking active chromatin. Indeed,
methylation of H3K79 functions in telomeric silencing by demarcating active chromatin (van
Leeuwen et al., 2002). Nucleosomes containing methylated H3K79 disallow the binding of Sir
proteins required for telomeric silencing. Thus, overexpression of Dot1 results in spreading of
methylation of H3K79 into telomeric regions, preventing silencing; conversely, deletion of dot1
eliminates H3K79 methylation allowing Sir proteins to bind to active chromatin, effectively
diluting these proteins at telomeres below the threshold concentration required for silencing (Ng
et al., 2003a; Shilatifard, 2006; Yang et al., 2008). This is in part facilitated through competition
between Sir3 binding and Dot1 activity. Both Dot1 and Sir3 recognize a region of the N-terminal
tail of H4 including the basic patch spanning residues 16-20. H4K16Q, a mutation mimicking
acetylation of H4K16, disrupts Sir3 binding, favoring Dot1 activity in in vitro competition
experiments. Additionally, the surface of the nucleosome surrounding H3K79 is critical for
silencing (Park et al., 2002). Sir3 recognizes H3K79 peptides in a methylation dependent
manner, suggesting that Sir3 binding in vivo may be disrupted by Dot1-mediated methylation
(Altaf et al., 2007). The role of Dot1 in silencing is evolutionarily conserved. Dot1L-deficient
mouse embryonic stem cells, exhibit reduced heterochromatic histone PTMs at telomeres and
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centromeres along with elongated telomeres and chromosomal segregation defects (Jones et al.,
2008).

1.4.4.2. Methylation of histone H3K79 and the DNA damage response
To ensure the fidelity of the genome, various pathways have evolved to repair DNA
damage. Two pathways exist for the repair of DNA double strand breaks (DSBs): nonhomologous end-joining (NHEJ) and homologous recombination repair (HRR) (Aylon and
Kupiec, 2004). HRR employs homologous DNA sequences to reconstruct DSB junctions and is
the primary DSB repair mechanism in S. cerevisiae. Quality control measures, or cell-cycle
checkpoints, exist throughout the replicative cycle of the cell and are activated when DNA
damage is recognized, to prevent further cell-cycle progression until the integrity of the genome
is restored (Wahl and Carr, 2001).
The trans-histone pathway linking Rad6/Bre1-mediated ubiquitylation of H2B and Dot1mediated methylation of H3K79 is intimately linked with cell-cycle checkpoint control and DNA
damage repair in S. cerevisiae (Game and Chernikova, 2009). Decreased survival following
ionizing radiation (IR) -induced DSBs is observed in dot1Δ strains (Game et al., 2005). This
mutation is epistatic with bre1Δ and H3K79 mutations, implicating the uH2B-H3K79me axis in
DSB repair (Game et al., 2005; Game et al., 2006). This sensitivity is due to defective HRR, as
dot1Δ on the background of rad50Δ or rad51Δ, both deficient in HRR, exhibit no increased
sensitivity to IR over rad50Δ and rad51Δ strains alone (Game et al., 2006). The reported
dysfunction in the HRR pathway likely results from the abrogation of checkpoint control.
dot1Δ strains fail to activate G1 and S-phase cell-cycle checkpoints following ultraviolet- or IRinduced DNA damage as measured by activation of Rad53, a checkpoint regulator of all cell-
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cycle stages in S. cerevisiae (Giannattasio et al., 2005; Wysocki et al., 2005). Similar defects are
observed in bre1Δ strains, and in strains with mutations of H3K79 or H2BK123 (Giannattasio et
al., 2005; Wysocki et al., 2005).
The discovery of H3K79me-specific binding modules in checkpoint control pathways
presented a mechanistic role for Dot1 in HRR (Huyen et al., 2004). Mutations within the tandem
tudor domain of 53BP1, or its S. cerevisiae ortholog, Rad9, disrupt interaction with H3K79me in
vitro and prevent the formation of 53BP1/Rad9 foci at DSBs in vivo (Grenon et al., 2007; Huyen
et al., 2004). Knockdown of Dot1L also abolishes the establishment of 53BP1 foci and the
resultant cell-cycle delay and initiation of HRR (Huyen et al., 2004). No difference is observed
in either G2 IR-sensitivity or G1 checkpoint failure between Rad9 Tudor domain mutants and
dot1Δ strains, verifying its significance in yeast (Grenon et al., 2007). Recent conflicting
evidence implicates methylation of H4K20, instead of H3K79, in 53BP1 binding, bringing this
model into question in mammals (Botuyan et al., 2006).

1.4.4.3. Methylation of histone H3K79 and human disease
Methylation of H3K79 is pathogenically linked with a subset of human leukemias, MLLrearranged leukemias. MLL-rearranged leukemias result from translocations, fusing regions of
the H3K4 methyltransferase, MLL, which typically lack the catalytic Set domain, to greater than
50 fusion partners and can present as acute lymphoblastic leukemia (ALL), acute myeloid
leukemia (AML), or mixed lineage leukemia (MLL). These fusions are present in roughly 10%
of all human leukemias and in excess of 70% of infant leukemias, and carry poor prognoses
compared to non MLL-rearranged leukemias, underscoring their importance to human disease
(Krivtsov and Armstrong, 2007). Of the myriad of fusion partners, greater than 80% of
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pathogenic MLL fusions occur with a small subset, including elongation factors, AF4, AF10,
AF9, AF6, ENL, and ELL (Krivtsov and Armstrong, 2007).
Model leukemogenic systems induced by MLL fusions have unequivocally demonstrated
a role for aberrant Dot1L-mediated H3K79 methylation in the majority of cases. AF4 and AF10
interact with Dot1L, allowing the recruitment of Dot1L activity to genomic loci targeted by the
associated MLL fusions (Bitoun et al., 2007; Okada et al., 2005). This recruitment alone is
leukemogenic, as MLL-Dot1L fusions can transform cell lines (Okada et al., 2005). Genomewide expression analysis and chromatin immunoprecipitation (ChIP) reveal aberrant expression
of developmentally regulated genes, including genes involved in hematopoesis and self-renewal,
and associated regions of H3K79 methylation in MLL-AF4 and AF10 models (Guenther et al.,
2008; Krivtsov et al., 2008). These patterns correlate with observations in gene expression and
H3K79 methylation in MLL-rearranged leukemic patients. In fact, H3K79 methylation patterns
alone can distinguish MLL-rearranged from non MLL-rearranged leukemia (Krivtsov et al.,
2008). Furthermore, overexpression of a catalytically inactive mutant of Dot1L or RNAi
knockdown of Dot1L abolish oncogenicity of MLL-AF10 fusion cell lines (Okada et al., 2005;
Zhang et al., 2006); similarly, knockdown of Dot1L reduces H3K79 methylation and aberrant
transcription of developmentally regulated genes in MLL-AF4 cell lines (Krivtsov et al., 2008).
This invokes the possibility of exploiting Dot1L as a much needed therapeutic target in MLLrearranged leukemia.

1.5. Semisynthetic strategies to generate post-translationally modified histones
The last fifteen years has brought somewhat of an enlightenment period in the
investigation of histone PTMs. Many new types of histone PTMs have been discovered.
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Advances in antibody- and mass spectrometry-based technologies have unearthed nearly
countless modification sites. Clever biochemistry guided by homology searches, only possible in
the post-genomic era, have led to the isolation of the proteins responsible for establishing,
erasing, and interpreting many of these histone PTMs in a wide range of organisms.
Furthermore, ChIP protocols, coupled with microarray technology (ChIP-chip) or massively
parallel sequencing (ChIP-seq) have been used to map the genome-wide localization of these
histone PTMs and chromatin associated proteins at the resolution of a single nucleosome. The
breadth of knowledge gained has been extraordinary, the correlative potential between structure
and function, compelling; yet, as the dust settles, it is clear that the mechanisms of action through
which histone PTMs function in many chromatin-templated processes are vague, indirect, or
completely obscure. This naiveté stems from the difficulty in isolating the actions of single
components within complex multi-component systems, often equipped with redundant and
compensatory mechanisms. In order to interrogate the mechanisms of PTMs in these processes,
it is necessary to develop defined biochemical models in vitro. A few exceptions aside, a wide
chasm exists between current ability for bottom-up reconstitution and top-down observation of
these chromatin-templated processes. Advancing our understanding of epigenetics will require
the narrowing of this gap.
Dissecting the functions of histone PTMs in chromatin-templated processes necessitates
the preparation of homogeneously modified histones. This allows the roles of modifications to be
isolated from distinct functions associated with the enzymes responsible for establishing the
modifications. This can be accomplished enzymatically; however, the relative promiscuity of
many histone modifying enzymes in vitro and challenges associated with separating modified
from unmodified histones, detracts from this strategy. Recently, three semisynthetic protein
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chemistry technologies have been employed to generate modified histones, ensuring chemical
homogeneity and bypassing the use of complex enzymatic machinery. These technologies,
expressed protein ligation, ribosomal incorporation of unnatural amino acids, and alkylated
methyllysine analogs, and their applications to histones will be explored in the following
sections.

1.5.1. Expressed protein ligation and applications to modified histones
Native chemical ligation (NCL) enables the regioselective ligation of two polypeptides
when one contains an N-terminal cysteine and the other, a C-terminal thioester, forming a native
amide bond at the junction (Dawson et al., 1994). As robust methodologies exist for the
generation of C-terminal thioesters and N-terminal cysteines in both recombinant proteins and
synthetic peptides, NCL can be extended to the ligation of recombinant proteins with synthetic
peptides in an application known as expressed protein ligation (EPL) (Figure 1.6) (Muralidharan
and Muir, 2006). The power of EPL lies in the ability to apply the vast toolkit of peptide
chemistry to proteins otherwise too large to be accessible synthetically, using modern solidphase methodologies. EPL has been applied to structure-function analysis in a diverse set of
proteins through the site-specific introduction of post-translational modifications, unnatural
amino acids, optical probes, and isotopic labels (Flavell and Muir, 2009; Muralidharan and Muir,
2006; Pellois and Muir, 2006). Due to the length limitations of solid phase peptide synthesis
(SPPS), the N- and C-terminal regions of proteins are most accessible to EPL. Chemical access
to internal regions of large proteins by EPL requires sequential ligation of a minimum of three
fragments.
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Figure 1.6. Expressed protein ligation. EPL allows the ligation of two polypeptides of
synthetic and recombinant origins, when one contains a C-terminal thioester, and the other, an Nterminal cysteine. Protein C-terminal thioesters can be generated through thiolysis of
recombinant intein fusion proteins. Protein N-terminal cysteines can be revealed following
proteolysis of leader sequences (LS). Peptides bearing C-terminal thioesters or N-terminal
cysteines can be prepare using SPPS.
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Not surprisingly, the generation of post-translationally modified histones is an attractive
application of EPL, owing to the density of PTMs located within histone N-terminal tails. H2B,
H3, and H4 have been prepared bearing acetylations, lysine and arginine methylations, and
phosphorylations within their N-terminal tails (Chiang et al., 2009; Ferreira et al., 2007; He et
al., 2003; Li and Shogren-Knaak, 2008; Li and Shogren-Knaak, 2009; Shogren-Knaak et al.,
2003; Shogren-Knaak and Peterson, 2004). Additionally, acetylations have been introduced near
the C-terminus of H3 (Manohar et al., 2009). Combinations of these PTMs can be easily
introduced simultaneously into a single histone N- or C-terminal tail using EPL. To date,
semisynthetic histones generated by EPL have been used to gain insight into a direct role for
H4K16 acetylation in chromatin conformation (Shogren-Knaak et al., 2006), to reveal
cooperativity in SAGA-mediated acetylation of histones within nucleosomes and in nucleosomal
arrays (Li and Shogren-Knaak, 2008; Li and Shogren-Knaak, 2009), and to dissect the effect of
acetylation of histones on activity of chromatin remodeling complexes (Ferreira et al., 2007).

1.5.2. Ribosomal methodologies for the incorporation of PTMs into histones.
Nonsense suppression mutagenesis allows for ribosomal synthesis of polypeptides
containing unnatural amino acids (Wang et al., 2006). Typically, an amber nonsense tRNA is
hijacked to code for an unnatural amino acid. This amber tRNA can be charged with an
unnatural amino acid in vitro, or an orthogonal tRNA/tRNA synthetase pair can be evolved to
charge the tRNA in vivo (Dougherty, 2000; Wang et al., 2006). Recently, a bacterial pyrrolysyl
tRNA synthetase/amber tRNA pair was evolved to incorporate acetyllysine into myoglobin
(Neumann et al., 2008). Unlike EPL, nonsense suppression mutagenesis is not limited to terminal
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protein sequences. Research is underway to adapt this technology to the generation of acetylated
histones.
In vitro genetic reprogramming has also been exploited for the ribosomal synthesis of
histone peptides bearing acetyl- and methyllysines (Kang et al., 2008). In this work, codons from
unused amino acids were reassigned to acetyl-, mono-, di-, and trimethylated lysines. A
ribozyme-based tRNA acylating catalyst, dinitro-flexizyme (Murakami et al., 2006), was used to
charge the corresponding reassigned tRNAs. mRNAs containing reassigned codons were
translated in vitro using a system lacking the unused amino acids, allowing the generation of
modified histone peptides. The extension of this technology to full-length histone proteins, where
this application will be more limited due to fewer unused codons, has not been reported.
Presumably, cysteine and tryptophan, which are either absent or found in low abundance in
canonical histone sequences, can be hijacked for the generation of full-length modified histones.

1.5.3. Methyllysine analogs and applications to modified histones
Recently, the unique nucleophilic properties of cysteine were exploited to incorporate
methyllysine analogs (MLAs) into histones in a site-specific fashion (Simon et al., 2007). Under
stringent pH control, the thiol of a cysteine side chain can be directly targeted in an alkylation
reaction, leaving all other nucleophiles within a protein untouched. In this fashion, a cysteine can
be alkylated with an electrophilic ethylamine, to generate aminoethylcysteine (Kenyon and
Bruice, 1977). Aminoethylcysteine is structurally similar to lysine, replacing the γ-methylene of
lysine with a sulfide. This substitution has minor consequences on the structural and chemical
properties of lysine, lengthening the side chain by 0.28 Å and decreasing the pKa of the ε-NH2
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group by 1.1 (Gloss and Kirsch, 1995). By replacing the electrophile with the corresponding
mono-, di-, and trimethylated amines, cysteines can be converted to MLAs (Simon et al., 2007).
Only one or two cysteines exists in the canonical core histone proteins. These cysteines in
the histone fold of H3 can be mutated to an alanine without significant effects on nucleosomal
reconstitution or chromatin function. Thus, orthogonal cysteines can be genetically incorporated
into recombinant histones in a site-specific manner. These cysteines can be alkylated to generate
histones bearing MLAs. Using this approach, MLAs have been introduced in the globular
domains of histones with similar ease as N-terminal tails (Simon et al., 2007). Despite minor
chemical changes compared to native methylated counterparts, histones bearing MLAs are
recognized by site- and modification-specific antibodies and binding modules, and can function
in enzymatic assays. However, in some cases, slightly decreased performance is observed
compared to natively modified histones (Simon et al., 2007). To date, MLAs have been used to
determine methylation-state preferences of lysine demethylases (Lee et al., 2009; Lin et al.,
2008), to examine histone PTM crosstalk (Hung et al., 2009; Li et al., 2009), and to investigate
structural perturbation of nucleosomes and nucleosome arrays carrying lysine methylations (Lu
et al., 2008). This strategy has yet to be successfully applied to the installment of other types of
histone PTMs.
A similar approach has been reported for the incorporation of acetyl- and methyllysine
analogs into histones (Guo et al., 2008). In this case, nonsense suppression mutagenesis was used
to encode phenylselenocysteine, which was subsequently eliminated to form dehydroalanine.
Michael addition of N-acetylated or N-methylated cysteamine yields the corresponding acetyl- or
methyllysine analog. However, Michael addition with dehydroalanine results in racemization of
the α-carbon, greatly limiting the use of this technology for biochemical applications.
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1.6. Summary
Complex epigenetic phenomena are choreographed through the cooperative actions of a
small subset of molecular mechanisms, including histone PTMs, histone variants, chromatin
remodeling, DNA methylation, and siRNA-mediated TGS. Histone PTMs densely populate
chromatin and influence its function through three mechanisms: 1) intra- and internucleosomal
conformational changes; 2) site- and modification-specific recruitment of effectors; and 3)
exclusion of effectors. One such modification, uH2B, is correlated with diverse processes
including transcriptional elongation, trans-histone biochemical pathways, and the response to
DNA DSBs.
Full elucidation of the role of uH2B and other histone PTMs requires their isolation from
complex cellular processes. Robust semisynthetic methodologies have been reported for the
incorporation of PTMs into histones to isolate their functions in vitro. Early mechanistic studies
using semisynthetically modified histones have revealed the power of these technologies. A
combination of semisynthetic protein chemistry to create engineered chromatin substrates, and
their subsequent biochemical analysis, will play an important role in the hypothesis-driven
dissection of the mechanisms underlying histone PTMs and their potential function in a histone
code.
The goals of this thesis are two-fold: 1) to develop EPL-based technology for the sitespecific ubiquitylation H2B; and 2) to interrogate the role of uH2B in Dot1L-mediated
methylation of H3K79. In chapter 2, a generalizable strategy for the ubiquitylation of peptides
using a photolytically removable ligation auxiliary is presented. This strategy is then extended to
generate full-length uH2B. In chapter 3, a direct stimulation of intranucleosomal Dot1Lmediated methylation of H3K79 by uH2B is established using semisynthetic uH2B. In chapter 4,
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a highly optimized semisynthesis of uH2B bearing a single G76A ubiquitin point mutation is
presented. Semisynthetic u(G76A)H2B is indistinguishable from uH2B by Dot1L, allowing the
detailed kinetic and structure activity relationship analyses presented in chapter 5.
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Chapter 2: Semisynthesis of native ubiquitylated H2B1
The ability to generate homogeneously ubiquitylated H2B is paramount to understanding
its functions in transcriptional elongation, methylation of H3K4 and K79, and DNA damage
repair. Two biological solutions exist to accomplish this: 1) purification from endogenous
sources (Figure 2.1, top panel), and 2) in vitro modification using purified enzymes (Figure 2.1,
middle panel). Because of its natural abundance uH2B can be purified directly from cells
(Davies and Lindsey, 1994; West and Bonner, 1980). However, heterogeneity due to the
coexistence of other PTMs complicates biochemical analysis. Additionally, RAD6A or UbcH6
can be combined with BRE1A/B to ubiquitylate H2B in vitro, though yields are limiting (Kim et
al., 2009; Zhu et al., 2005). Therefore, we decided to employ EPL to regioselectively
ubiquitylate H2B, thus bypassing the requirement for the complex cellular ubiquitylation
machinery and ensuring chemical homogeneity (Figure 2.1, bottom panel).
While robust methodologies exist for the installment of small PTMs into proteins using
EPL, including phosphorylations (Flavell et al., 2002; Muir et al., 1998; Wu et al., 2001),
acetylations (He et al., 2003; Shogren-Knaak and Peterson, 2004), methylations (He et al., 2003;
Shogren-Knaak and Peterson, 2004), lipidations (Alexandrov et al., 2002; Pylypenko et al., 2006;
Rak et al., 2003), and glycosylations (Macmillan and Bertozzi, 2000; Macmillan and Bertozzi,
2004; Tolbert and Wong, 2000), all rely on the incorporation of pre-modified amino acid
building blocks into a synthetic peptide or modest chemical derivatization of a protected peptide.
The application of these strategies to ubiquitylation is not feasible. The total chemical synthesis
of ubiquitin has been achieved using both stepwise solid phase peptide synthesis (SPPS)

1

The work in this chapter was performed as part of a close collaboration with Dr. Champak
Chatterjee in the Laboratory of Synthetic Protein Chemistry at the Rockefeller University.
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Figure 2.1. Biological and chemical approaches to the preparation of uH2B. Two biological
approaches exist for the preparation of uH2B: 1) purification from endogenous sources (top
panel), and 2) in vitro enzymatic ubiquitylation (middle panel). The former is complicated by copurification of other PTMs, while the latter only leads to modest yields. We decided to develop a
chemical approach for the generation of uH2B (bottom panel).

42

(Ramage et al., 1994) and NCL (Bang et al., 2005). This has allowed conjugation of ubiquitin to
the ε-NH2 of a single lysine residue through an isopeptide bond (Layfield et al., 1999). However,
extension of these approaches to the site-specific ubiquitylation of peptides and proteins is
nontrivial. In thinking about this problem, we were influenced by the elegant semisynthesis of
ubiquitin analogs containing C-terminal electrophiles (Borodovsky et al., 2002). This is
accomplished through the direct aminolysis of recombinant ubiquitin-α-thioesters generated by
thiolysis of the corresponding ubiquitin-intein fusions. We wondered whether a similar approach
could be exploited for the site-specific ubiquitylation of a lysine in a peptide or protein using
EPL. Due to the absence of native cysteines in ubiquitin, such a scheme requires the use of a
traceless ligation strategy to retain the native isopeptide linkage. In principle, use of a ligation
auxiliary provides a solution to this problem. Several thiol-bearing auxiliaries have been reported
that can facilitate an EPL reaction, acting as N-terminal cysteine surrogates, and following
ligation can be removed under acidic (Low et al., 2001) or photolytic conditions (Kawakami and
Aimoto, 2003). However, their general applicability suffers from the common requirement for a
sterically undemanding ligation site (Hackenberger and Schwarzer, 2008; Marinzi et al., 2001;
Marinzi et al., 2004; Offer et al., 2002). The two C-terminal residues of ubiquitin are Gly-Gly,
which constitutes an ideal junction for an auxiliary-mediated ligation. Thus, an ubiquitin-αthioester lacking the C-terminal glycine could be ligated to a peptide containing a ligation
auxiliary linked to a lysine side-chain through a glycyl linker (Figure 2.2). Following protein
ligation, the auxiliary could be removed leaving the native sequence surrounding the isopeptide
linkage (Chatterjee et al., 2007). In this chapter, this strategy is used in the semisynthesis of an
ubiquitylated H2B peptide and the full-length native uH2B.
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Figure 2.2. Scheme of auxiliary-mediated peptide ubiquitylation. A) Retrosynthetic scheme
of ligation strategy. A ubiquitylated peptide is generated by ligation of ubiquitin(1-75)-αthioester to a peptide conjugated to a ligation auxiliary through a glycyl linker. A dashed line
represents the retrosynthetic disconnection. B) Synthetic scheme for peptide ubiquitylation.
Auxiliary-mediated NCL reaction proceeds in two steps: (a) trans-thioesterification followed by
(b) an S-to-N acyl shift. In step (c), the ligation auxiliary is removed, leaving the native ubiquitin
sequence.
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2.1. Synthesis of photolytically removable ligation auxiliary
To perform the traceless ligation reaction, we selected a derivative of a previously
reported photolytically cleavable ligation auxiliary, 1 (Kawakami and Aimoto, 2003; Marinzi et
al., 2004; Pellois and Muir, 2005). Compound 1 was synthesized in solution using eight steps
from vanillin, 2 (Figure 2.3) (Chatterjee et al., 2007; Pellois and Muir, 2005). In the first step, the
phenolic-OH of vanillin was alkylated with methyl 4-chlorobutanoate, in the presence of
potassium carbonate and tetrabutyl ammonium iodide in tetrahydrofuran (THF), forming ester 3.
Following extraction, compound 3 was subjected to electrophilic aromatic substitution using
nitric acid, affording nitrated product 4. Compound 4 was purified by extraction and
crystallization. Wittig reaction of 4 with methyltriphenylphosphonium bromide and sodium
hexamethyldisilazide in THF, yielded styrene 5. Compound 5 was isolated following flash
column chromatography. Asymmetric aminohydroxylation of 5 with tert-butylcarbamate,
(DHQ)2PHAL, K2OsO2(OH)4, and tert-butyl hypochlorite in sodium hydroxide, followed by
flash column chromatography, yielded alcohol 6. Regioselectivity of the asymmetric
aminohydroxylation reaction was accomplished using a mixture of n-propanol and water, while
enantioselectivity was established through the use of chiral compound, (DHQ)2PHAL.
K2OsO2(OH)4 functioned as a reaction catalyst (Reddy and Sharpless, 1998). A Mitsunobu
reaction, employing thioacetic acid, triphenylphosphine and

diisopropyl azodicarboxylate

(DIAD) in THF, was used to convert compound 6 into thioester 7 (Rozwadowska, 1997).
Following flash column chromatography, 7 underwent simultaneous saponification and tert-butyl
disulfide formation, in the presence of sodium methoxide and 2-methyl-2-propane thiol in
aqueous sodium hydroxide with constant oxygen bubbling, yielding disulfide 8.
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Figure 2.3. Synthesis of photolytically removable ligation auxiliary, 1. (a)
ClCH2CH2CH2C(O)OCH3, K2CO3, (CH3CH2CH2CH2)4NI, CH3CN; (b) HNO3, AcOH; (c)
Ph3PCH3Br, sodium hexamethyldisilazide, THF; (d) K2OsO2(OH)4, (DHQ)2PHAL, n-prOH, tBu hypochlorite, t-Bu carbamate, NaOH, H2O; (e) AcSH, Ph3P, DIAD, THF; (f) t-BuSH, sodium
methoxide, NaOH, MeOH; (g) CH3NH2, PyBOP, DIEA, DCM; (h) TFA, TIS, H2O.
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Nucleophilicity of the carboxylic acid in 8 during conjugation to peptides necessitated the
elimination of this reactive group. High temperatures required for acid chloride formation with 8
led to decomposition of the compound. Resultantly, compound 8 was treated with methylamine
and PyBOP in the presence of diisopropylethylamine (DIEA) in dichloromethane (DCM) to form
amide 9. Following removal of solvent in vacuo, compound 9 was dissolved in a 95:2.5:2.5
mixture of trifluoroacetic acid (TFA), triisopropylsilane (TIS), and water to effect removal of the
Na-tert-butoxycarbonyl (Boc) protecting group, affording ligation auxiliary, 1. Compound 1 was
purified by process scale reverse-phase high performance liquid chromatography (RP-HPLC)
and its identity was verified by 1H and

13

C nuclear magnetic resonance (NMR) and high-

resolution mass spectrometry (Figure 2.4).

2.2. Site-specific peptide ubiquitylation
As an intermediate step toward the semisynthesis of uH2B, we established a robust
methodology for the site-specific ubiquitylation of a peptide using the C-terminal peptide of H2B
as a model (Figure 2.5) (Chatterjee et al., 2007). To this end, peptidyl resin 10, corresponding to
residues 115-125 of human H2B and containing an A117C mutation, was synthesized by SPPS
using the 9-fluorenylmethoxylcarbonyl (Fmoc) Nα protection strategy. The cysteine was included
to allow further derivatization of the ubiquitylated product. Orthogonal protection of K6 of
peptidyl resin 10, representing K120 in the full-length H2B, with a hydrazine-labile ivDde group,
allowed the regioselective installment of the ligation auxiliary. Following hydrazine treatment to
give peptidyl resin 11, bromoacetic acid was coupled to the ε-NH2 of K6 with
diisopropylcarbodiimide (DIC), affording peptidyl resin 12. Reaction of the ligation auxiliary, 1,
with resin 12 in the presence of DIEA and 1,8-diazobicycloimide (DBU) in N,N-
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Figure 2.4. Characterization of ligation auxiliary 1. A) 1H NMR spectrum of 1. Peaks are
labeled relative to diagram of 1 at right. B) RP-HPLC chromatogram of compound 1. C) ESI-MS
spectrum of compound 1. Peaks at 415 and 862.9 represent photolysis of CH-NH2 bond and
dimeric form of 1, respectively.
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Figure 2.5. Synthesis of auxiliary conjugated peptide and ligation to ubiquitin. (a) 1. 2%
NH2NH2, DMF; 2. BrCH2CO2H, DIC, DMF; (b) auxiliary 1, DIEA, DBU, DMF; (c) TFA, TIS,
anisole, H2O; (d) 300 mM NaPi, 50 mM MESNa, 25 mM TCEP, 3 M guanidinium HCl, pH 7.5;
(e) He-Cd laser 325 nm. PG = protecting group, R = CH3, R’ = CH2CH2CH2C(O)NHCH3, MES
= 2-mercaptoethanesulfonic acid.
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dimethylformamide (DMF) yielded resin 13. Auxiliary-conjugated peptide 14, was purified by
RP-HPLC following simultaneous side chain deprotection and cleavage from the resin using a
92.5:2.5:2.5:2.5 mixture of TFA, TIS, anisole, and water (Figure 2.6).
Peptide 14 was reduced with tris(2-carboxyethyl)phosphine (TCEP) to remove the S-tertbutyl protecting group on the ligation auxiliary. This deprotected peptide was ligated to
ubiquitin(1-75)-α-thioester, 15, generated by thiolysis of the corresponding intein fusion using
mercaptoethanesulfonic acid (MES) (Figure 2.6). The time course of the EPL reaction was
followed by RP-HPLC and was significantly slower than a typical cysteine-mediated EPL
reaction, likely owing from the ligation onto a sterically hindered secondary amine (Figure 2.7).
Resultantly, the reaction was allowed to proceed for 5 days prior to purification of intermediate
product, 16, by RP-HPLC. Removal of the ligation auxiliary was achieved by irradiation with a
He-Cd laser at 325 nm. Three to four pulses of five seconds each led to nearly complete
conversion of 16, to ubiquitylated peptide 17. Progression of the photolysis reaction was
monitored by RP-HPLC - removal of the auxiliary resulted in the diminished absorption of the
ubiquitylated peptide at 350 nm (Figure 2.8). Ubiquitylated peptide 17 was purified by RPHPLC and its identity was confirmed by electrospray ionization mass spectrometry (ESI-MS).
To verify the site-specificity of protein ligation, we subjected protein 17 to an enzymatic
ubiquitin hydrolysis reaction with ubiquitin C-terminal hydrolase L3 (UCH-L3). In addition to
processing linear ubiquitin fusions, UCH-L3 is able to hydrolyze certain isopeptide conjugates of
ubiquitin (Larsen et al., 1998; Misaghi et al., 2005; Tirat et al., 2005). Incubation of ubiquitylated
peptide 17 with UCH-L3 resulted in almost complete conversion to ubiquitin(1-76) and the H2B
asdf
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Figure 2.6. Characterization of peptide 14 and ubiquitin(1-75)-α-thioester, 15. A) RP-HPLC
chromatogram, and B) ESI-MS spectrum of peptide 14. [(M+2H)2+ observed = 859.9 Da.
(M+2H)2+ expected = 859.5 Da.] 1,302.8 represents MS fragmentation of parent ion. C) RPHPLC chromatogram, and D) ESI-MS spectrum of ubiquitin(1-75)-α-thioester, 15. [(M+H)+
observed = 8,632 ± 2 Da (s.d.). (M+H)+ expected = 8,632 Da.] Charge states are labeled.
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Figure 2.7. EPL of peptide 14 and ubiquitin(1-75)-α-thioester, 15. A) Schematic of auxiliarymediated EPL linking ubiquitin(1-75)-α-thioester, 15, with peptide 14. B) Superimposed RPHPLC chromatograms showing accumulation of ligation product 16 at 0, 24, 48, 90 h and 5 days.
An asterisk indicates formation of a mixed disulfide between peptide 14 and MES.
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Figure 2.8. Photolytic removal of ligation auxiliary forming ubiquitylated peptide. A)
Irradiation of protein 16 with a He-Cd laser at 325 nm effected removal of the ligation auxiliary,
yielding ubiquitylated peptide 17. B) RP-HPLC chromatograms of ligation product 16 and crude
photolysis mixture containing ubiquitylated peptide 17. C) Corresponding deconvoluted ESI-MS
spectra of 16 [(M+H)+ observed = 10,120 ± 2 Da (s.d.). (M+H)+ expected = 10,120 Da.] and 17
[(M+H)+ observed = 9,793 ± 4 Da. (M+H)+ expected = 9,793 Da.]
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peptide (Figure 2.9). As these products can only be generated from the expected protein ligation,
this result verifies the site-specificity of our strategy. Additionally, successful ubiquitin
hydrolysis indicates that the ubiquityl moiety in peptide conjugate 17 exhibits a native fold,
validating this semisynthetic approach for the generation of biologically active ubiquitylated
peptides.
In addition to ubiquitin, proteins are modified by various ubiquitin-like modifiers (Ubls),
most notably, small ubiquitin-like modifier (SUMO) (Walsh, 2005). Typically, a single Ubl is
conjugated to a target protein, analogous to protein monoubiquitylation. As most Ubls also
terminate in Gly-Gly sequences, our semisynthetic strategy can be applied to the site-specific
conjugation of Ubls to peptides. To demonstrate this generality, peptide 14 was conjugated with
yeast SUMO ortholog, Smt3 (Figure 2.10). Peptide 14 was ligated to HA-tagged Smt3(2-97)-αthioester, 18, yielding intermediate product 19. Irradiation of protein 19 as described above,
afforded sumoylated peptide 20. Thus, this semisynthesis facilitates the general site-specific
modification of peptides with ubiquitin and Ubls.

2.3. Site-specific ubiquitylation of full-length H2B
Adapting this approach to the production of an ubiquitylated protein, in this case uH2B,
requires the ligation of three polypeptides (Figure 2.11A) (McGinty et al., 2008). As H2B is
devoid of cysteines, much like ubiquitin, this strategy necessitates the incorporation of additional
functionality to facilitate a second traceless EPL reaction. With this in mind, peptide 21 was
synthesized corresponding to residues 117-125 of Xenopus H2B bearing both the ligation
auxiliary, 1, attached to the ε-NH2 of K120, and an A117C mutation (Figure 2.12). Orthogonal
side-chain protection of K120 with the acid-labile 4-methyltritryl (Mtt) protecting group allowed
the ligation auxiliary to be coupled to this amino group as described above. Also critical to the
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Figure 2.9. Ubiquitin hydrolysis with UCH-L3. A) Superimposed RP-HPLC chromatograms
of 17 after incubation at 37 °C for 8 h with (assay) and without (control) UCH-L3. An asterisk
indicates UCH-L3. B) Deconvoluted ESI-MS spectrum of hydrolyzed ubiquitin [(M+H)+
observed = 8,564 ± 3 Da. (M+H)+ expected = 8,566 Da.]
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Figure 2.10. Peptide sumoylation. A) RP-HPLC chromatogram and B) ESI-MS spectrum of
HA-Smt3(2-97)-α-thioester, 18. [(M+H)+ observed = 12,414 ± 3 Da (s.d.). (M+H)+ expected =
12,414 Da.] C) (a) 300 mM NaPi, 50 mM MESNa, 25 mM TCEP, 3 M guanidinium HCl, pH
7.5; (b) He-Cd laser 325 nm. D) Deconvoluted ESI-MS spectrum of ligation product 19.
[(M+H)+ observed = 13,901 ± 5 Da. (M+H)+ expected = 13,900 Da.] E) Deconvoluted ESI-MS
spectrum of photolysis product 20. [(M+H)+ observed = 13,573 ± 4 Da. (M+H)+ expected =
13,573 Da.]
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Figure 2.11. Semisynthesis of ubiquitylated H2B. A) Retrosynthetic analysis of uH2B
synthesis. uH2B was generated via a 3-piece ligation with the following polypeptides: auxiliary
linked synthetic peptide containing residues 117-125 of H2B and bearing an A117C mutation,
H2B-C, 21; recombinant ubiquitin(1-75)-α-thioester 15; and recombinant H2B(1-116)-αthioester, 24. Dashed lines indicate junctions formed by EPL reactions. B) Synthetic scheme for
the ubiquitylation of H2B. (a) EPL was used to ligate peptide 21 to protein 15, forming branched
protein 22. (b) Ligation product 22 was irradiated with 365 nm light, yielding protein 23. (c)
Ligation of protein 23 to protein 24, forming uH2BA117C, 25. (d) Raney nickel desulfurization
of protein 25, forming uH2B, 26. R = CH2CH2CH2C(O)NHCH3; R’ = CH3; R’’ =
CH2CH2SO3H.
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Figure 2.12. Characterization of peptide 21 and H2B(1-116)-α-thioester, 24. A) Structure of
auxiliary conjugated peptide 21. B) RP-HPLC chromatogram and C) ESI-MS spectrum of
peptide 21. Peak at 1,192.9 represents MS fragmentation product. [(M+H)+ observed = 1,606.8
Da. (M+H)+ expected = 1,607.9 Da.] D) RP-HPLC chromatogram and E) ESI-MS spectrum of
H2B(1-116)-α-thioester, 24. Representative charge states are labeled [(M+H)+ observed =
12,991 ± 3 Da (s.d.). (M+H)+ expected = 12,991 Da.] R = CH2CH2CH2C(O)NHCH3; R’ = CH3.
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synthetic design, was transient protection of the N-terminal cysteine in 21, which precluded
unwanted double ligation of ubiquitin. After examining several possibilities, we settled on the
photoremovable S-(o-nitrobenzyl) group for this purpose, as this proved to be completely stable
during the course of the first ligation reaction and was easily removed by photolysis.
In the first step of the synthesis, the disulfide in peptide 21 was reduced with TCEP
followed by ligation to ubiquitin(1-75)-α-thioester, 15, to give ubiquitylated peptide, 22 (Figure
2.13A, panel i and Figure 2.13B). Protein 22 was purified by RP-HPLC and subsequently
irradiated at 365 nm, resulting in efficient removal of both the ligation auxiliary and the cysteine
protecting group to give deprotected branched protein 23 (Figure 2.13A, panel ii, and Figure
2.13C). In this case, irradiation was performed with a collimated light source equipped with an
inline filter, permitting larger scale photolysis reactions. Purified intermediate product, 23, was
then ligated to recombinant H2B(1-116)-α-thioester, 24 (Figure 2.12), to give uH2BA117C, 25
(Figure 2.13A, panel iii and Figure. 2.13D). In the final step, Raney nickel-mediated
desulfurization (Yan and Dawson, 2001) was used to convert the single cysteine residue in
branched protein 25 to the native alanine residue present in uH2B (Figure 2.13A, panel iv, and
Figure 2.13E). Under optimized conditions, this reduction was found to be highly specific for
cysteine desulfurization over methionine, thereby affording native ubiquitylated H2B, 26.
Excessively long incubations with Raney nickel led to a second desulfurization reaction
involving methionine. The overall yield of the semisynthesis (i.e. steps a-d in Figure 2.11B) was
excellent (20%).

59

Figure 2.13. Semisynthesis of uH2B. A) Superimposed RP-HPLC chromatograms of starting
materials, top trace, and products, bottom trace of each pair, for reactions a-d described in Figure
2.11. ESI-MS spectrum of B) ligation product 22 [(M+H)+ observed = 10,008 ± 1 Da (s.d.).
(M+H)+ expected = 10,009 Da.], C) photolysis product 23 [(M+H)+ observed = 9,547 ± 2 Da.
(M+H)+ expected = 9,548 Da.], D) ligation product 25 [(M+H)+ observed = 22,395 ± 3 Da.
(M+H)+ expected = 22,396 Da.], and E) desulfurization product 26 [(M+H)+ observed = 22,366
± 4 Da. (M+H)+ expected = 22,365 Da.]. Representative charge states are labeled.

60

2.4 Summary
The site-specific ubiquitylation and sumoylation of a peptide was accomplished using a
photolytically removable ligation auxiliary. This strategy was extended to the semisynthesis of
native uH2B. To accomplish this, two orthogonal traceless EPL reactions were performed – the
first using the auxiliary, and the second, a cysteine-mediated ligation coupled with a chemical
desulfurization to convert the cysteine to the native alanine. Importantly, these methodologies are
applicable to the conjugation of ubiquitin and Gly-Gly containing Ubls to other histone, as well
as non-histone peptides and proteins. Mechanistic investigations into the dependence of Dot1L
on H2B ubiquitylation using semisynthetic uH2B are presented in the following chapter.
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Chapter 3: uH2B directly stimulates Dot1L-mediated methylation2
Three models have been proposed to explain the dependency of H3K79 methylation on
H2B ubiquitylation (Figure 3.1). Under the first model, ubiquitin, being a large modification
relative to the nucleosome, acts as a wedge between adjacent nucleosomes, thereby favoring a
less condensed chromatin conformation (Henry and Berger, 2002; Sun and Allis, 2002). In so
doing, uH2B increases the accessibility of the nucleosomal surface, including H3K79 to Dot1.
Alternatively, the second model suggests that Dot1 recognizes elements of ubiquitin and the
nucleosome and as such, is selectively recruited to ubiquitylated nucleosomes (Henry and
Berger, 2002). Moreover, because all evidence linking uH2B to H3K79 methylation has been
observed following genetic perturbations in vivo, it is equally possible that one or more
additional factors may be required to translate the effect of uH2B into heightened Dot1
methyltransferase activity. A number of factors have been implicated in carrying out this
function in yeast, including proteasomal ATPases and a component of the Set1 complex, Cps35.
Mutations in two proteasomal ATPases, Rpt4 and Rpt6, disrupt H3K79 methylation in S.
cerevisiae leaving ubiquitylation of H2B intact (Ezhkova and Tansey, 2004). A Dot1-Cps35
interaction has been demonstrated in yeast by co-immunoprecipitation (Lee et al., 2007). Strains
bearing temperature sensitive alleles of Cps35 show decreased trimethylation of H3K79 at
restrictive temperatures. How these factors influence Dot1 activity is unknown. Furthermore, the
role of these factors in H3K79 methylation in higher organisms has not been investigated. In this
chapter, semisynthetic uH2B (Chapter 2) is used to demonstrate a direct stimulation of Dot1Lmediated intranucleosomal methylation of H3K79 (McGinty et al., 2008).

The work in this chapter was performed as part of a close collaboration with Dr. Jaehoon Kim
in the Laboratory of Biochemistry and Molecular Biology at the Rockefeller University.
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Figure 3.1. Proposed mechanisms for uH2B-mediated stimulation of Dot1. Model 1:
ubiquitin acts as a wedge between adjacent nucleosomes, loosening chromatin structure and
increasing accessibility of Dot1 to H3K79. Model 2: Dot1 recognizes ubiquitin within the
context of the nucleosome, allowing recruitment specifically to ubiquitylated nucleosomes.
Model 3: One or more intermediate factors recruited by uH2B facilitates the secondary
recruitment of Dot1.
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3.1. Reconstitution of ubiquitylated octamers and nucleosomes
The interrogation of the role of uH2B in H3K79 methylation minimally requires the
preparation of histone octamers and nucleosomes. A robust methodology exists for the
reconstitution of octamers from individual recombinant histones (Dyer et al., 2004). In fact, the
preparation of histone octamers containing purified uH2B has been reported (Davies and
Lindsey, 1994). Recombinant Xenopus H2A, H2B, H3, H4, and H3K79R were purified from E.
coli inclusion bodies using size-exclusion chromatography followed by process scale RP-HPLC
(Figure 3.2). To form octamers, purified recombinant histones and semisynthetic uH2B, 26, were
dissolved in a buffer containing 7 M guanidinium HCl and combined in equal molar
concentrations. The resultant mixture was dialyzed against a 2 M NaCl solution lacking
chaotropic agents, allowing the spontaneous formation of octamers. Octamers were purified by
size-exclusion chromatography and appropriate constituents were verified by SDSpolyacrylamide gel electrophoresis (SDS-PAGE) (Figure 3.3). No significant difference in the
efficiency of octamer reconstitution was observed when semisynthetic uH2B was substituted for
recombinant H2B.
Nucleosomes can be reconstituted from preformed octamers and DNA by dialysis or
dilution (Dyer et al., 2004; Owen-Hughes et al., 1999). Both affect nucleosome assembly
through step-wise decreases in monovalent salt concentration. Nucleosomes were prepared by
dilution using octamers containing uH2B and/or H3K79R and a PCR amplified DNA fragment
containing 147 bp of the Widom 601 nucleosomal positioning sequence (Figure 3.4A). With
optimized ratios of octamer and DNA, nucleosomes were reconstituted efficiently as evidenced
by a single species observed following native-PAGE (Figure 3.4B and C). Arrays of
nucleosomes and chromatinized plasmids can also be prepared using dialysis or ATP-dependent
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Figure 3.2. Characterization of recombinant histone proteins. ESI-MS spectra of purified
recombinant histones. A) H2A [(M+H)+ observed = 13,949 ± 1 Da (s.d.). (M+H)+ expected =
13,951 Da.], B) H2B [(M+H)+ observed = 13,814 ± 3 Da. (M+H)+ expected = 13,818 Da.], C)
H3 [(M+H)+ observed = 15,270 ± 1 Da. (M+H)+ expected = 15,272 Da.], D) H4 [(M+H)+
observed = 11,236 ± 1 Da. (M+H)+ expected = 11,237 Da.], and E) H3K79R [(M+H)+ observed
= 15,300 ± 3 Da. (M+H)+ expected = 15,300 Da.].
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Figure 3.3. Reconstitution of octamers containing uH2B. Size exclusion chromatograms of
octamers containing A) H2B or B) uH2B. Octamer peaks are labeled. C) Analysis of octamers
containing uH2B and/or H3K79R by 15% SDS-PAGE and Coomassie staining.
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Figure 3.4. Formation of nucleosomes and chromatinized plasmids with uH2B. A) 147 bp
Widom 601 positioning sequence used in nucleosome formations. B) Representative
optimization of octamer:DNA ratios for nucleosome formation. Nucleosomes analyzed by 5%
native-PAGE followed by ethidium bromide staining are shown. C) Ethidium bromide stained
5% gel of nucleosomes reconstituted with uH2B and/or H3K79R. D) Schematic of plasmid
chromatinization with ATP dependent remodelers, ACF and NAP1. E) Micrococcal nuclease
digestion of plasmids chromatinized with octamers containing H2B or uH2B. An agarose gel of
the digestion products stained with ethidium bromide is shown. Diagram in panel D adapted
from a previously published figure (An and Roeder, 2004).
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chromatin assembly factors. Using the latter strategy, a plasmid was chromatinized with
octamers containing either recombinant H2B or semisynthetic uH2B (Figure 3.4D). Micrococcal
nuclease digestion of the resultant plasmids verified chromatin formation (Figure 3.4E).

3.2. uH2B directly stimulates Dot1L-mediated methylation
With modified nucleosomes in hand, we next turned our attention to exploring the effect
of uH2B on Dot1L methyltransferase activity. Full-length human FLAG-Dot1L (herein referred
to as Dot1L) was isolated from an insect cell overexpression system using M2 agarose (Figure
3.5A). Dot1L was able to methylate unmodified histone octamers in an assay containing 3H Sadenosyl methionine (SAM). However, no activity was observed on H3 alone, (H3/H4)2
tetramers, or on mononucleosomes and chromatinized plasmids assembled with recombinant
unmodified histones (Figure 3.5B and Figure 3.6B). This suggests that the presence of
nucleosomal DNA represses the activity of Dot1L in vitro. This is in stark contrast to yeast
methyltransferase, Dot1, which exhibits greater activity on recombinant nucleosomes than
octamers (Sawada et al., 2004). We predicted that ubiquitylation of H2B would stimulate Dot1L
methyltransferase activity in the context of nucleosomes. To test this hypothesis, a 3H SAM
methyltransferase assay was performed using Dot1L and chemically defined nucleosomes.
Robust methyltransferase activity was observed on mononucleosomes containing uH2B, whereas
no radioactivity was detected on unmodified mononucleosomes (Figure 3.6A). This activity was
specific for H3K79 as Dot1L was incapable of methylating nucleosomes containing both uH2B
and an H3K79R mutant. Importantly, the level of methyltransferase activity observed on
ubiquitylated mononucleosomes was far greater than that observed on unmodified histone
octamers (Figure 3.6C). Dot1L also methylated a chromatinized plasmid containing uH2B
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Figure 3.5. Activity of Dot1L on unmodified substrates. A) Coomassie stained SDS-PAGE
gel of purified FLAG-tagged Dot1L. B) 3H SAM methyltransferase assay with Dot1L and
indicated substrates separated by SDS-PAGE and stained with Coomassie (bottom panels) prior
to probing for 3H methyl incorporation by fluorography (top panels).
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Figure 3.6. Effects of uH2B on Dot1L-mediated methylation. A) Dot1L methyltransferase
assay using chemically defined nucleosomes. Assays performed on mononucleosomes with 3H
SAM and Dot1L were separated on a native 5% gel and stained with ethidium bromide (middle
panel) prior to probing for 3H methyl incorporation by fluorography (top panel). Quantification
was performed by liquid scintillation counting (bottom panel). B) 3H SAM methyltransferase
assay using indicated chromatinized plasmids. Assay samples were separated by 15% SDSPAGE and fluorography was performed. Arrow marks H3. An asterisk indicates an H3
proteolytic product. C) 3H SAM assay with indicated substrates separated by 15% SDS-PAGE
and stained with Coomassie (top panel). Quantification was performed by liquid scintillation
counting (bottom panel). Error bars indicate s.e.m. (n = 4-7).
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(Figure 3.6B). These results establish a direct biochemical connection between ubiquitylated
H2B and H3K79 methylation by Dot1L.
Although H3K79 and H2BK120 reside in separate polypeptides, their side-chains are
located in close proximity (~31 Å) to one another on the face of the nucleosome (Luger et al.,
1997a), posing a structural basis for a crosstalk pathway (Figure 3.7A). Indeed, docking of the
structure of the catalytic domain of Dot1L onto the mononucleosome structure, positions the
catalytic domain adjacent to the site of H2B ubiquitylation (Min et al., 2003). Therefore, a GST
fusion of the catalytic domain of Dot1L, containing residues 1-416 (herein referred to as
Dot1Lcat), was purified from an E. coli expression system in order to interrogate its role in uH2Bdependent H3 methylation (Figure 3.7B). Similar to our observations with Dot1L, a significant
enhancement in activity of Dot1Lcat was measured on mononucleosomes containing uH2B, when
compared to unmodified mononucleosomes (Figure 3.7C). However, unlike the full-length
enzyme, Dot1Lcat also exhibited some, albeit minimal, methyltransferase activity on unmodified
mononucleosomes.
H2B ubiquitylation has been correlated with increased levels of di- and trimethylation of
H3 K79 in humans (Kim et al., 2005; Zhu et al., 2005) and yeast (Shahbazian et al., 2005),
respectively. Therefore, we examined the degree of methylation occurring in our assays. In-gel
trypsin digestion of H3, followed by MALDI-mass spectrometry showed some monomethylation
and no di- and trimethylation of unmodified mononucleosomes, in assays performed with either
Dot1L or the catalytic domain alone (Figure 3.8A and B, top panels). However, robust monoand dimethylation of nucleosomes containing uH2B was observed in both cases (Figure 3.8A
and B, bottom panels). No evidence of trimethylation was observed is our assays, which is
asdfdsa
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Figure 3.7. Effects of uH2B on Dot1Lcat activity. A) Surface rendering of nucleosome (1KX5)
(Davey et al., 2002). H2B and H3 shown in blue and red, respectively. H2BK120 and H3K79 are
colored yellow and labeled. B) Coomassie stained 15% SDS-PAGE gel of purified Dot1Lcat. C)
Dot1Lcat methyltransferase assay using chemically defined nucleosomes. Assays performed on
mononucleosomes with 3H SAM and Dot1Lcat were separated on a native 5% gel and stained
with ethidium bromide (middle panel) prior to probing for 3H methyl incorporation by
fluorography (top panel). Quantification was performed by liquid scintillation counting (bottom
panel). Error bars indicate s.e.m. (n = 4-7).
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Figure 3.8. Characterization of degree of methylation using mass spectrometry. In gel
trypsin digestion of H3 from methyltransferase assays using A) Dot1L or B) Dot1Lcat followed
by MALDI-mass spectrometry. Ion intensities of methylated peptides (residues 73-83) are scaled
relative to an internal standard. Assays were performed using unmodified nucleosomes (top
panels) and nucleosomes containing uH2B (bottom panels).
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consistent with mass spectrometry analysis of H3K79 methylation in human cell lines (Garcia et
al., 2007).

3.3. uH2B-H3K79me crosstalk is strictly intranucleosomal
We have demonstrated that uH2B is required for effective methylation of
mononucleosomes by Dot1L. However, in vivo levels of H3K79 methylation vastly exceed those
of H2B ubiquitylation (Garcia et al., 2007; West and Bonner, 1980). This raises the question: can
uH2B enhance Dot1L-mediated methylation in an internucleosomal fashion? To address this
possibility, a strategy for the creation of asymmetric dinucleosomes was adopted (Zheng and
Hayes, 2003). Dinucleosomes with asymmetric incorporation of uH2B and H3K79R were
produced by ligating uniquely assembled 5’ and 3’ mononucleosomes with complementary DNA
overhangs (Figure 3.9A). The use of non-palindromic complementary overhangs, resulted in
only the desired heterodinucleosome products being formed (Figure 3.9B). Unmodified, wildtype nucleosomes ligated to nucleosomes containing uH2B and H3K79R showed no increased
Dot1L-mediated methylation when compared to unmodified, wild-type nucleosomes ligated to
nucleosomes bearing H3K79R alone (Figure 3.9C, lanes 2 and 3). However, Dot1L was capable
of methylating dinucleosomes, as evidenced by methylation of nucleosomes containing uH2B
ligated to nucleosomes containing uH2B and H3K79R (Figure 3.9C, lane 4). It could be
demonstrated that no significant histone shuffling was occurring during these assays because an
unligated mixture of nucleosomes containing both uH2B and H3K79R and unmodified, wildtype nucleosomes showed no methylation above that observed with dinucleosomes containing
only H3K79R (Figure 3.9C, lanes 1 and 5). These results strongly suggest that efficient
adfsdfsdss
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Figure 3.9. Methyltransferase assays on dinucleosomes using Dot1L. A) 5’ and 3’
mononucleosomes (MN) were reconstituted separately using DNA containing complementary
overhangs. Assembly of 5’ and 3’ nucleosomes with different histones, followed by ligation,
resulted in asymmetric dinucleosome (DN) formation. B) Ligations of unmodified nucleosomes
reconstituted with indicated DNA fragments were separated on a 5% native gel and stained with
ethidium bromide. C) 3H SAM methyltransferase assays performed with Dot1L and
dinucleosomes were separated on a 5% native gel and stained with ethidium bromide (middle
panel) prior to 3H methyl detection by fluorography (top panel). Liquid scintillation counting
was used to quantify 3H methyl incorporation (bottom panel). Nucleosomes are indicated in table
at right. Error bars indicate s.e.m. (n = 8).
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methylation of H3K79 requires the presence of uH2B in the same nucleosome. Therefore, we
propose that the majority of H3K79 methylated nucleosomes in vivo, are likely to have at one
time carried uH2B, which has since been removed by deubiquitylating enzymes or histone
replacement.

3.4. Dot1L-nucleosome interaction is independent of ubiquitylation
The simplest explanation that accounts for the intranucleosomal stimulatory effect of
uH2B on Dot1L-mediated methylation is that uH2B recruits Dot1L to nucleosomes. However,
the presence of a large excess of free ubiquitin had only a modest effect on the extent of Dot1Lmediated H3K79 methylation in uH2B containing nucleosomes (Figure 3.10A). The catalytic
domain of Dot1L has previously been demonstrated to bind to unmodified nucleosomes in
electrophoretic mobility shift assays (Min et al., 2003). We observed no significant difference in
the recruitment of Dot1Lcat to mononucleosomes as a function of ubiquitylation, based on gelshift analysis, and only a modest difference in gel-shift competition assays, over a broad range of
concentrations (Figure 3.10B and C). This establishes that Dot1Lcat is able to bind to both
ubiquitylated and unmodified nucleosomes during methyltransferase assays, even though
efficient methyltransferase activity is only observed on ubiquitylated nucleosomes. Thus, it is
likely that uH2B, possibly through an allosteric mechanism, allows Dot1L to bind nucleosomes
in a catalytically competent manner. Additional investigations, perhaps involving structural
analysis, will be necessary to shed further light on this phenomenon.
as

76

Figure 3.10. Ubiquitin competition and electrophoretic mobility shift assays. A) 3H SAM
methyltransferase assay performed with mononucleosomes and Dot1L. 10 µM and 1 mM
ubiquitin were added as indicated. Assay samples were separated on a 5% gel and stained with
ethidium bromide (bottom panel of each pair) prior to fluorography, (top panel). Liquid
scintillation counting was used to quantify methyltransferase activity in the presence and absence
of 1 mM ubiquitin. Error bars indicate s.e.m. An asterisk indicates p < 0.05 using a two-tailed
unpaired Student’s t-test. (t-score = 2.28; 10 degrees of freedom; n = 6) B) Electrophoreticmobility shift assay performed with Dot1Lcat and indicated nucleosomes. Nucleosomes were
incubated with increasing amounts of Dot1Lcat, separated by 5% native-PAGE, and stained with
ethidium bromide (bottom panel) and a Western blot was performed against Dot1Lcat using an αGST antibody (top panel). C) Indicated 32P-labelled nucleosomes (an asterisk denotes
radiolabelling) were combined with 5 equivalents of Dot1Lcat and increasing quantities of cold
H3K79R nucleosomes to compete the gel-shift of radiolabelled nucleosomes. Samples were
separated on a 5% native gel and analyzed by phosphorimaging. H3K79R was used in these
assays to eliminate potential affinity differences introduced by disproportionate methylation. eq.
= molar equivalent
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3.5. Summary
In this chapter, semisynthetic uH2B was reconstituted into octamers and nucleosomes
with recombinant histones and 147 bp of a strong nucleosomal positioning sequence. At the level
of the nucleosome, uH2B directly stimulates Dot1L-mediated methylation of H3K79. Although
this does not rule out a role for uH2B in higher order chromatin structure (Figure 3.1, model 1),
another mechanism must be responsible for the observations in this chapter. Moreover, while
other factors may further enhance Dot1L activity (Figure 3.1, model 3), they are not necessary
for uH2B-mediated stimulation of Dot1L. This stimulation is facilitated through the catalytic
domain of Dot1L, leading to increases in both mono- and dimethylation of H3K79. Asymmetric
nucleosome ligations demonstrated that the stimulatory role of uH2B is purely intranucleosomal,
as the effect is not transferred to an adjacent nucleosome. Finally, two lines of evidence
invalidate an uH2B-mediated, Dot1L recruitment model (Figure 3.1, model 2): 1) ubiquitin
added in trans fails to diminish Dot1L activity on uH2B containing nucleosomes, and 2)
Dot1Lcat binds nucleosomes independently of the ubiquitylation state of H2B. Rather, it seems
more likely that ubiquitylation of H2B may lead to an allosteric change in the nucleosome or
Dot1L, either increasing the accessibility of H3K79 to Dot1L or the intrinsic catalytic activity of
Dot1L itself (Figure 3.11).
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Figure 3.11. Updated models of uH2B-mediated stimulation of Dot1. Dot1 interacts with the
nucleosome regardless of its ubiquitylation state. Model 4: Following H2B ubiquitylation, Dot1
is allosterically activated. Model 5: H2B ubiquitylation causes a conformational change in the
nucleosome, which allows Dot1 access to H3K79.
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Chapter 4: Highly optimized semisynthesis of u(G76A)H2B3
In chapter 2, the semisynthesis of native uH2B was described using two orthogonal EPL
reactions, ensuring chemical homogeneity and bypassing the cellular ubiquitylation machinery.
Due to the absence of cysteines in uH2B, maintaining the native sequence necessitates the
combination of three polypeptides using two traceless protein ligation strategies: one employing
a photolytically removable ligation auxiliary and the other, a chemical desulfurization (Figure
2.11). In chapter 3, semisynthetic uH2B was used to demonstrate a direct stimulation of Dot1Lmediated intranucleosomal methylation of H3K79. Surprisingly, the stimulatory effect of uH2B
is not a result of recruitment of Dot1L to the nucleosomal surface, as Dot1L is able to bind to
nucleosomes in the absence of ubiquitylation, suggesting that uH2B may stimulate Dot1L
activity through allosteric regulation of Dot1L or the nucleosome itself. However, detailed
biochemical studies were precluded by limitations in scalability of the native semisynthetic
strategy. In this chapter, a highly optimized semisynthesis of uH2B bearing the single G76A
point mutation at the C-terminus of ubiquitin is described, allowing the rapid preparation of tens
of milligrams of ubiquitylated protein. Nucleosomes containing u(G76A)H2B were
indistinguishable by Dot1L from those containing uH2B, permitting both a comprehensive
kinetic analysis of the role of uH2B in H3K79 methylation and the first structure activity
relationship investigation of this complex system, which will be presented in chapter 5.

The work in this chapter was performed as part of a close collaboration with Dr. Maja Köhn
during a sabbatical in the Laboratory of Synthetic Protein Chemistry at the Rockefeller
University.
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4.1. Semisynthesis of u(G76A)H2B
We sought to design a new uH2B semisynthesis, optimizing for efficiency and
scalability, while minimizing changes to the native sequence. Central to the inefficiency and low
yield of the uH2B semisynthesis is the use of a photolytically removable ligation auxiliary
(Figure 4.1). Firstly, the preparation of the auxiliary requires a complex eight-step solution phase
synthesis (Figure 2.3), ultimately limiting the quantity that can be incorporated into a peptide to
be used in EPL (Chatterjee et al., 2007; Marinzi et al., 2004; Pellois and Muir, 2005).
Furthermore, the auxiliary-mediated ligation reaction requires a minimum of five days to reach
60% completion, due to the sterically hindered ligation onto a disubstituted amine (Chatterjee et
al., 2007; McGinty et al., 2008). Finally, photolytic removal of the ligation auxiliary,
concomitant with the cysteine-protecting group, is poorly scalable and cannot be performed in
parallel without multiple irradiation sources. We reasoned that a traditional cysteine-mediated
ligation could be substituted for the auxiliary-mediated ligation to attach ubiquitin to an H2B Cterminal peptide, thus alleviating the costly constraints imposed by the ligation auxiliary (Figure
4.1, blue). Further replacement of the photolytically removable S-(o-nitrobenzyl) cysteineprotecting group in 21 with a chemically labile group would eliminate the need for an irradiation
step entirely (Figure 4.1, green). Following orthogonal ligation to the N-terminal sequence of
H2B, the ligation site cysteines could be reduced to alanines, leaving a G76A substitution at the
C-terminus of ubiquitin as the single sacrifice of the optimized semisynthetic strategy (Figure
4.1, yellow).
To this end, peptide 27 corresponding to residues 117-125 of H2B, bearing an A117C
substitution, was synthesized (Figure 4.2). Orthogonal side-chain protection of K120 allowed the
selective installment of a cysteine through an isopeptide bond with the ε-NH2 of K120. This
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Figure 4.1. New semisynthetic strategy for generation of ubiquitylated H2B. Retrosynthetic
comparison of uH2B (top) and u(G76A)H2B (bottom) syntheses. Both were generated via a 3piece ligation strategy with the following polypeptides: synthetic peptide containing residues
117-125 of H2B and bearing an A117C mutation, H2B-C, 21 and 27; recombinant ubiquitin(175)-α-thioester 15; and recombinant H2B(1-116)-α-thioester 24. For the semisynthesis of
u(G76A)H2B, the ligation auxiliary was replaced with a cysteine (blue) and the photolytically
removable cysteine-protecting group was replaced with a thiazolidine (green). The resultant
ubiquitylated proteins differ only at position 76 of ubiquitin (yellow). Dashed lines indicate
junctions formed by EPL reactions. R = CH2CH2CH2C(O)NHCH3; R’ = CH3; R’’ =
CH2CH2SO3H.
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Figure 4.2. Characterization of peptide 27. A) Structure of peptide 27. B) RP-HPLC
chromatogram and C) ESI-MS spectra of purified peptide 27. [(M+H)+ observed = 1,115.9 Da.
(M+H)+ expected = 1,115.3 Da.]. An asterisk represents MS fragmentation of peptide 27.
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cysteine facilitates ligation to ubiquitin and following desulfurization results in the G76A
mutation. Transient protection of the N-terminal cysteine in 27 as a thiazolidine restricts
ubiquitin ligation to the desired site.
In the first step of the synthesis, an excess of peptide 27 was ligated to recombinant
ubiquitin(1-75)-α-thioester, 15 (Figure 2.6), generated by thiolysis of the corresponding intein
fusion protein (Figure 4.3, step a). Thioester 15 was quantitatively converted into ubiquitylated
peptide 28 within two hours (Figure 4.4A). Treatment with methoxylamine in situ at pH 5 for 12
h led to complete conversion of the thiazolidine to a cysteine, affording branched protein 29
(Figure 4.3, step a and 4.4B). Notably, purification was unnecessary between the first two
synthetic steps, further increasing the overall efficiency of the semisynthetic strategy and
limiting losses. Protein 29 was then ligated to an excess of H2B(1-116)-α-thioester, 24 (Figure
2.12), yielding full-length ubiquitylated H2B bearing a cysteine at each of the ligation junctions,
30 (Figure 4.3, step c and 4.4C). Raney nickel (Yan and Dawson, 2001) or radical-initiated (Wan
and Danishefsky, 2007) desulfurization smoothly converted both cysteines in 30 to alanines,
leaving the native A117 in H2B and a G76A mutation in ubiquitin, thus generating
u(G76A)H2B, 31 (Figure 4.4, step d and 4.4D). With this revised semisynthetic route, tens of
milligrams of ubiquitylated protein were routinely generated, without the need for specialized
instrumentation.

4.2. Validation of u(G76A)H2B as a surrogate for uH2B
We envisioned that a G76A mutation in ubiquitin would be tolerated by any biochemical
processes that recognize elements of ubiquitin and its target protein without specifically
engaging the isopeptide bond between them. In these cases, the ubiquitylated protein with the
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Figure 4.3. Semisynthesis of u(G76A)H2B. Semisynthetic scheme for the generation of
u(G76A)H2B. (a) EPL was used to ligate peptide 27 to ubiquitin(1-75)-α-thioester, 15, forming
branched protein 28; (b) Ligation product 28 was treated with methoxylamine at pH 5, affording
29. (c) Ligation of protein 29 to H2B(1-116)-α-thioester, 24, forming uH2BA117C/G76A, 30.
(d) Raney nickel or radical-initiated desulfurization of protein 30, forming u(G76A)H2B, 31.
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Figure 4.4. Characterization of products in the semisynthesis of u(G76A)H2B. RP-HPLC
chromatograms (top panels) and ESI-MS spectra (bottom panels) of the following intermediate
products: A) ligation product, 28 [(M+H)+ observed = 9,609 ± 2 Da (s.d.). (M+H)+ expected =
9,606 Da.]; B) deprotected ligation product, 29 [(M+H)+ observed = 9,593 ± 2 Da. (M+H)+
expected = 9,594 Da]; C) ligation product, 30 [(M+H)+ observed = 22,444 ± 5 Da. (M+H)+
expected = 22,443 Da.]; and D) desulfurization product, u(G76A)H2B, 31 [(M+H)+ observed =
22,380 ± 4 Da. (M+H)+ expected = 22,379 Da.]. Charge states are labeled. Crude RP-HPLC
spectrum is shown for protein in panel A.
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G76A mutation would likely be indistinguishable from the native protein. Conversely, we
reasoned that processes recognizing the isopeptide bond directly might be disrupted by the
mutation. Indeed, the ubiquitin G76A mutant is efficiently mobilized and transferred to target
proteins in vivo, but the conjugated product is resistant to many deubiquitylating enzymes
(DUBs) (Hodgins et al., 1992; Pickart et al., 1994). Surprisingly, u(G76A)H2B was recognized
and deubiquitylated by ubiquitin C-terminal hydrolase, UCH-L3, to a similar extent as the native
control (Figure 4.5A). Cleaved ubiquitin and ubiquitin G76A were identified by liquid
chromatography-mass spectrometry (LC-MS), verifying hydrolysis of the isopeptide bond
(Figure 4.5B and C). Furthermore, recognition of uH2B by a linkage-specific anti-uH2B
antibody was only slightly decreased by introduction of the G76A mutation (Figure 4.6A). Key
to our goals was the effect of the u(G76A)H2B mutation on the stimulation of Dot1L. In order to
test this, native uH2B and u(G76A)H2B were reconstituted into nucleosomes with recombinant
histone proteins (Figure 3.2) and 147 bp of the Widom 601 positioning sequence (Lowary and
Widom, 1998) and submitted to radioactive methyltransferase assays with Dot1L. u(G76A)H2B
stimulated methyltransferase activity to levels comparable to uH2B (Figure 4.6B), validating this
mutant as an equally acceptable surrogate for the native sequence in biochemical analysis.

4.3. Summary
In summary, we have developed a robust, scalable semisynthesis of ubiquitylated
proteins to overcome shortcomings of the strategy presented in chapter 2. By replacing an
auxiliary-mediated ligation with a traditional cysteine-mediated ligation, we efficiently generated
u(G76A)H2B on a scale of multiple tens of milligrams – an increase in excess of ten-fold over
the previous methodology. This streamlined semisynthetic strategy will also allow the facile and

87

a

Figure 4.5. Ubiquitin hydrolysis assay of uH2B and u(G76A)H2B. A) UCH-L3-mediated
hydrolysis of uH2B and u(G76A)H2B. Coomassie stained gel of assay samples quenched after
indicated times. + indicates addition of UCH-L3 at 0 min; ++ indicates addition of UCH-L3 at 0
and 10 min. B) and C) LC-MS spectrum of ubiquitin hydrolyzed from B) uH2B and C)
u(G76A)H2B by UCH-L3 (top panels) and the resultant deconvoluted masses (bottom panels).
Expected masses for ubiquitin and ubiquitinG76A are 8,566 and 8,580 Da, respectively. Charge
states are labeled.
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Figure 4.6. Validation of u(G76A)H2B as an uH2B surrogate. A) Western blot of uH2B and
u(G76A)H2B with linkage specific α-uH2B antibody (top panel). Western blot with α-ubiquitin
antibody (middle panel) and ponceau stain (bottom panel) represent loading controls. B) Dot1L
methyltransferase assay on uH2B and u(G76A)H2B containing nucleosomes. Nucleosomes
methylated with 3H SAM were separated on a 5% native gel and stained with ethidium bromide
(middle panel) prior to probing for 3H methyl incorporation by fluorography (top panel).
Quantification of methyltransferase activity was performed by liquid scintillation counting
(bottom panel). Error bars represent one s.d. (n = 3).
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rapid preparation of other ubiquitylated histones, and more broadly, other ubiquitylated proteins.
The G76A mutation introduced into ubiquitin by the semisynthetic strategy may impose
limitations in certain applications. Surprisingly, there was no observable effect of the mutation
on ubiquitin hydrolysis by UCH-L3. This may be the exception rather than the rule and in some
cases, the native ubiquitylated protein may be a more appropriate reagent for the biochemical
characterization of DUBs. Most importantly, the stimulation of Dot1L by uH2B was unaffected
by the G76A mutation, permitting the first systematic mechanistic investigation into the
methylation process, which is presented in the following chapter.
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Chapter 5: Structure activity relationship analysis of Dot1L stimulation
The ability to rapidly prepare u(G76A)H2B on a scale of tens of milligrams (presented in
chapter 4) removes limitations on detailed biochemical characterization of the roles of H2B
ubiquitylation in chromatin-templated processes. Because u(G76A)H2B is indistinguishable
from native uH2B by Dot1L, u(G76A)H2B can act as a surrogate in mechanistic analysis of the
resultant trans histone pathway. In this chapter, mechanistic insights from comprehensive kinetic
and structure activity relationship analyses will be discussed. Additionally, early attempts to
crystallize nucleosomes containing u(G76A)H2B will be presented.

5.1. Kinetic analysis of Dot1L-mediated monomethylation of nucleosomes
Disruption of H2B ubiquitylation in organisms from yeast to humans decreases levels of
higher order methylation of H3K79 without altering levels of monomethylation (Kim et al.,
2005; Shahbazian et al., 2005). However, in vitro ubiquitylation of H2B drastically increases the
level of Dot1L-mediated monomethylation and dimethylation in nucleosomes (Figure 3.8). This
pattern is observed with full-length Dot1L as well as the catalytic domain alone. We predicted
that analysis of steady-state kinetics would provide insight into the effect of uH2B on the ability
of Dot1L to perform the initial methylation of H3K79. Accordingly, nucleosomes containing
H2B or u(G76A)H2B were prepared with the 146 bp α-satellite palindromic sequence by
stepwise dialysis followed by purification by preparative native-PAGE (Figure 5.1) (Dyer et al.,
2004; Luger et al., 1997a). Initial rates of nucleosome methylation by Dot1Lcat were obtained by
measuring transfer of a radioactive methyl group from SAM, illustrating a vast rate enhancement
due to ubiquitylation (Figure 5.2A). At early time points, only monomethylation of H3K79 was
detected, allowing for the direct steady-state velocity analysis of the first methylation event
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Figure 5.1. Nucleosome formation with 146 bp palindromic α-satellite sequence. A) 146 bp
palindromic α-satellite sequence. B) Ethidium bromide stained 5% native gel of nucleosomes
formed with this sequence and containing H2B or u(G76A)H2B.
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Figure 5.2. Kinetic analysis of Dot1L-mediated monomethylation of nucleosomes. A)
Representative time course of Dot1Lcat-mediated methylation of 0.9 µM nucleosome bearing
H2B (squares) or u(G76A)H2B (diamonds). Linear regression models of the data are shown.
Error bars represent one s.d. (n = 2). B) ESI-MS chromatogram showing K79 monomethylation
(K79me1) in the absence of dimethylation for u(G76A)H2B nucleosomes at 1.8 µM. [M+2H]2+
charge states are labeled. An asterisk marks a contaminant that is not dimethylated K79. C)
Steady-state kinetic analysis of Dot1Lcat activity of nucleosomes bearing H2B (squares) or
u(G76A)H2B (diamonds). Fit of u(G76A)H2B data to the Michaelis-Menten model is shown.
Error bars represent one s. d. (n = 6). D) Kinetic analysis of methylation of nucleosomes bearing
H2B (squares) or u(G76A)H2B (diamonds) by excess Dot1Lcat. X-axis is shown in log10 scale to
emphasize early time points. Single exponential modeling of the data is shown. Error bars
represent one s.d. (n = 3).
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(Figure 5.2B). Under steady-state conditions (Figure 5.2C), Dot1Lcat clearly followed MichaelisMenten kinetics in the monomethylation of ubiquitylated nucleosomes (Km of 3.3 ± 0.6 µM and a
kcat of 1.16 ± 0.09 s-1). However, under all reasonable conditions tested, Dot1Lcat failed to show
any concentration dependence toward unmodified nucleosomes. This could result from an
exorbitantly high Km or an immeasurably low kcat. The latter could reflect an extremely slow
chemical step and/or a decreased rate of product release. To probe this further, we performed
Dot1Lcat methyltransferase reactions under single turnover-type conditions (Figure 5.2D). Even
at saturating levels, Dot1Lcat was far more efficient in methylation of ubiquitylated nucleosomes,
suggesting an increase in the velocity of the chemical step of the first methylation.

5.2. Structure activity relationship analysis of the stimulation of Dot1L by uH2B
A myriad of small chemical modifications to histones, such as acetylation,
phosphorylation, and methylation, have evolved to control accessibility of genomic loci and to
tune the recruitment and activity of effectors of genomic expression (Kouzarides, 2007; Taverna
et al., 2007). Given these established mechanisms, why would nature select such a large
modification in ubiquitin, when a smaller modification might suffice? To delve into this
question, we performed a structure activity relationship analysis of the role of ubiquitin in Dot1L
stimulation.
We first wondered whether the ubiquitin fold was essential to stimulate methyltransferase
activity. Could the mere acylation of H2BK120 be sufficient? We synthesized a truncated uH2B
(tr-uH2B) lacking the globular domain of ubiquitin (Figure 5.3A and B). First, peptide 32 was
synthesized corresponding to residues 117-125 of H2BA117C, with residues 72-76 of ubiquitin
attached to the ε-NH2 of K120 (Figure 5.4). Similar to peptides 21 and 27, orthogonal protection
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Figure 5.3. Semisynthesis of tr-uH2B. A) Schematic of tr-uH2B semisynthesis. (a) EPL was
used to ligate peptide 32 to H2B(1-116)-α-thioester, 24, to give tr-uH2BA117C, 33. (b)
Desulfurization of protein 33, yielding tr-uH2B, 34. B) Ubiquitin structure (1UBQ) (VijayKumar et al., 1987) represented by superimposed ribbon and mesh diagrams. The surface of the
five residues of ubiquitin included in tr-uH2B are shown in red. C) ESI-MS spectra of isolated truH2B, 34 [(M+H)+ observed = 14,400 ± 3 Da (s.d.). (M+H)+ expected = 14,399 Da.]
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Figure 5.4. Characterization of peptide 32. A) Structure of peptide 32. B) ESI-MS spectrum of
peptide 32. Charge states are labeled. [(M+H)+ observed = 1,582.8 Da. (M+H)+ expected =
1,582.8 Da.]
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of K120 allowed the C-terminal residues of ubiquitin to be installed through an isopeptide bond
with K120. The N-terminus of the ubiquitin branch was acetylated to prevent interference during
EPL. Ligation of 32 to H2B(1-116)-α-thioester, 24, yielded intermediate product 33 (Figure
5.3A, step a). The cysteine in protein 33 was desulfurized using Raney nickel, affording truH2B, 34 (Figure 5.3A, step b and 5.3C). Nucleosomes assembled with 147 bp of Widom 601
sequence containing tr-uH2B were assayed against Dot1L. However, the presence of tr-uH2B
did not lead to an increase in methyltransferase activity over that observed for unmodified
nucleosomes (Figure 5.5A and 5.5B), suggesting that the ubiquitin fold is necessary for Dot1L
stimulation.
We next asked whether a specific surface of ubiquitin was required, or whether a protein
of similar size and shape could substitute. We replaced ubiquitin with Smt3, the yeast homolog
of human small ubiquitin-like modifier 1 (SUMO1) (Figure 5.6A). Smt3 has a similar overall
fold to that of ubiquitin (Figure 5.6B), but only a 17% sequence identity (Mossessova and Lima,
2000). The HA-Smt3(2-97)-α-thioester, 18 (Figure 2.10), was substituted for the ubiquitin
thioester, 15, in the semisynthetic strategy. Ligation of peptide 27 to protein 18 afforded
branched protein 35 (Figure 5.6A, step a). Subsequent cysteine deprotection yielded intermediate
product 36, which was ligated to H2B(1-116)-a-thioester, 24, to give sH2B(cys), 37 (Figure
5.6A, steps b and c, and 5.6C). However, no protein was recovered after incubation with Raney
nickel. Therefore, the pre-desulfurization product, sH2B(cys), bearing an A117C mutation in
H2B and a G98C mutation in Smt3, was incorporated into nucleosomes. Unlike nucleosomes
containing the non-desulfurized uH2B(cys), 30, sH2B(cys) nucleosomes failed to stimulate
Dot1L to significant levels (Figure 5.5A and 5.5B). This result suggests that a surface of
ubiquitin is recognized specifically.

97

Figure 5.5. Structure activity relationship analysis of uH2B. A) Schematic of semisynthetic
uH2B structural variants. Top panel: H2B bearing the terminal five residues of ubiquitin attached
to K120 (tr-uH2B); middle panel: H2B modified with HA-Smt3 with A117C/G98C mutations
(sH2B(cys)); bottom panel: u(G76A)H2B with L8A/I44A double mutation (mut-uH2B). B)
Dot1L methyltransferase assay on uH2B structural variants. Nucleosomes containing uH2B(cys),
30, sH2B(cys), H2BA117C, or tr-uH2B methylated with Dot1L and 3H SAM were separated on
a 5% native gel and stained with ethidium bromide (middle panel) prior to probing for 3H methyl
incorporation by fluorography (top panel). Quantification of methyltransferase activity was
performed by liquid scintillation counting (bottom panel). C) Dot1L assay as in panel B
comparing u(G76A)H2B and mut-uH2B. Error bars represent one s.d. (n = 3-4).
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Figure 5.6. Semisynthesis of sH2B(cys). A) Schematic of sH2B(cys) semisynthesis. (a) EPL
was used to ligate peptide 27 to HA-Smt3(2-98)-α-thioester, 18, to give protein 35. (b) Ligation
product 35 was treated with methoxylamine at pH 5, affording protein 36. (c) Ligation of protein
36 to protein 24, forming sH2BA117C/G98C (sH2B(cys)), 37. B) Structural alignment of
ubiquitin (1UBQ, red) (Vijay-Kumar et al., 1987) and Smt3 (1EUV, green) (Mossessova and
Lima, 2000) shown in ribbon diagram. Structures and alignment rendered with PyMol. C) ESIMS spectra of isolated sH2B(cys), 37 [(M+H)+ observed = 26,228 ± 9 Da (s.d.). (M+H)+
expected = 26,224 Da.].
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We turned our attention to the interaction of ubiquitin with ubiquitin binding proteins. In
almost all cases reported, ubiquitin interactions involve a hydrophobic patch including leucine 8
(L8) and isoleucine 44 (I44) (Figure 5.7A) (Hurley et al., 2006). Mutation of one or both residues
to alanine typically abrogates binding (Beal et al., 1996; Kang et al., 2003; Shih et al., 2002). We
generated mut-uH2B containing the triple alanine mutant L8A/I44A/G76A by replacing thioester
15, with the corresponding thioester bearing the L8A/I44A double mutation (Figure 5.7C and
5.8). Ligation of peptide 27 to mutant thioester 38 afforded ubiquitylated peptide 39 (Figure
5.7C, step a). Deprotection of 39, giving 40, followed by ligation to protein 24, yielded
intermediate product 41 (Figure 5.7C, steps b and c). Radical-initiated desulfurization gave mutuH2B, 42 (Figure 5.7C, step d and 5.7B). Dot1L was able to methylate nucleosomes bearing
mut-uH2B to a similar degree as those bearing u(G76A)H2B (Figure 5.5A and C). Therefore, a
non-canonical interaction surface of ubiquitin seems to be involved in stimulation of Dot1L,
likely by binding to the nucleosome, Dot1L, or both.
If ubiquitin binds Dot1L leading to allosteric activation, ubiquitin added in trans might be
able to increase methylation of unmodified nucleosomes. However, at 1 mM exogenous
ubiquitin, no stimulation of Dot1L was observed (Figure 5.9). In contrast, if ubiquitin binds to
the nucleosome, mutations on the nucleosomal surface surrounding the site of ubiquitin
attachment might prevent stimulation of Dot1L activity by decoupling ubiquitylation with
changes to the nucleosomal structure. Previously, alanine scanning of the yeast nucleosome
revealed two mutants in the acidic patch of H2A that prevent H3K4 methylation, which is also
directly stimulated by uH2B (Kim et al., 2009), without an observable effect on ubiquitylation of
H2B (Nakanishi et al., 2008). We reasoned that if H3K4 methylation is coupled to uH2B through
a similar mechanism as H3K79 methylation, these mutations might disrupt Dot1L stimulation in
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Figure 5.7. Semisynthesis of mut-uH2B. A) Structure of ubiquitin (1UBQ) (Vijay-Kumar et al.,
1987) displayed as ribbon and mesh. The surfaces of L8 and I44 are emphasized in red. B) ESIMS spectra of isolated mut-uH2B, 42 [(M+H)+ observed = 22,293 ± 7 Da (s.d.) (M+H)+
expected = 22,295 Da.]. C) Schematic of mut-uH2B semisynthesis. (a) EPL was used to ligate
peptide 27 to ubiquitin(1-75)L8A/I44A-α-thioester, 38, to give protein 39. (b) Ligation product
39 was treated with methoxylamine at pH 5, affording protein 40. (c) Ligation of protein 40 to
protein 24, forming intermediate product 41. (d) Radical-initiated desulfurization of ligation
product 41, affording mut-uH2B, 42.
101

Figure 5.8. Characterization of ubiquitin(1-75)L8A/I44A-α-thioester, 38. A) RP-HPLC
chromatogram and B) ESI-MS spectrum of ubiquitin(1-75)L8A/I44A-α-thioester, 38. Charge
states are labeled. [(M+H)+ observed = 8,548 ± 1 Da (s.d.). (M+H)+ expected = 8,548 Da.]
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Figure 5.9. Dot1L assay with unmodified nucleosomes and ubiquitin in trans. Dot1L assay
with 3H SAM and unmodified nucleosomes with and without 1 mM exogenous ubiquitin. Assay
samples were separated by 5% native gel electrophoresis and visualized with ethidium bromide
staining (top panel). Quantification of 3H methyl incorporation was performed by liquid
scintillation counting (bottom panel). Error bars represent one s.d. (n = 4).
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our system. We prepared nucleosomes containing unmodified H2B or u(G76A)H2B in
combination with each of the mutations, H2AE64A and H2AN68A (Figure 5.10 and 5.11A).
Neither mutation altered Dot1L stimulation by uH2B (Figure 5.11B), indicating divergent roles
for uH2B in methylation of H3K4 and K79.
The basic patch of H4 is critical to the action of yeast Dot1 in telomeric silencing (Altaf
et al., 2007). Simultaneous mutation of two arginines in H4 at positions 17 and 19 to alanines
(H4R17/19A) nearly abolishes H3K79 methylation in yeast (Fingerman et al., 2007). We
wondered if the same pattern would hold true for human Dot1L and if ubiquitylation could
overcome any deficit in methylation due to the mutations. Nucleosomes were prepared
containing H4R17/19A (Figure 5.10 and 5.11A) and either unmodified H2B or u(G76A)H2B.
The H4R17/19A mutation decreased Dot1L activity on unmodified nucleosomes (Figure 5.11C).
A similar decrease was observed with nucleosomes containing u(G76A)H2B (Figure 5.11B).
Therefore, while conserved from yeast to humans, mutation of the basic patch seems to disrupt
Dot1 activity independently of ubiquitylation.

5.3. One ubiquitylation stimulates methylation of one nucleosomal H3
Thus far, Dot1L activity has only been studied in the context of homogenously
ubiquitylated nucleosomes, where each copy of H2B is ubiquitylated. Given a 1% prevalence of
uH2B in vivo (West and Bonner, 1980), statistically, it is likely that heterogeneously
ubiquitylated nucleosomes are predominant. This raises the question: can a nucleosome bearing
one ubiquitylated H2B stimulate Dot1L? If so, will the methyltransferase activity be confined to
one copy of H3, or is one uH2B sufficient to drive methylation of H3 on both sides of the
nucleosome? To address these questions, we reconstituted histone octamers, varying the ratio of
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Figure 5.10. Characterization of histone mutants. ESI-MS spectra of the following purified
recombinant histone mutants: A) H2AE64A [(M+H)+ observed = 13,894 ± 3 Da (s.d.). (M+H)+
expected = 13,893 Da.]; B) H2AN68A [(M+H)+ observed = 13,907 ± 3 Da. (M+H)+ expected =
13,908 Da.]; and C) H4R17/19A [(M+H)+ observed = 11,067 ± 3 Da. (M+H)+ expected = 11,067
Da.]. Charge states are labeled.
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Figure 5.11. Dot1L assays on mutant nucleosomes. A) Surface representation of nucleosome
structure (1KX5) (Davey et al., 2002) with H2A, H2B, H3, and H4 shown in green, blue, red,
and orange, respectively. Amino acids in each histone are emphasized by darker shades. B)
Dot1L methyltransferase assay on mutant nucleosomes containing H2B or u(G76A)H2B.
Nucleosomes methylated with 3H SAM were separated by 5% native-PAGE and stained with
ethidium bromide (middle panel) prior to probing for 3H methyl incorporation by fluorography
(top panel). Quantification of methyltransferase activity was performed by liquid scintillation
counting (bottom panel). Error bars represent one s.d. (n = 3). C) Representation of liquid
scintillation counting data in panel B, illustrating the effect of the H4R17/19A (RA) mutant on
Dot1L-mediated methylation of unmodified nucleosomes.
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H2B to u(G76A)H2B. Electrophoretic analysis of the purified octamers confirmed incorporation
of appropriate levels of unmodified and ubiquitylated H2B (Figure 5.12A). Separation of
nucleosomes formed with each octamer sample by native gel electrophoresis verified
independent assortment of the two forms of H2B, with singly ubiquitylated nucleosomes
exhibiting an intermediate electrophoretic mobility when compared to doubly ubiquitylated and
unmodified nucleosomes (Figure 5.12B, bottom panel). Methyltransferase assays showed a
linear relationship between the level of u(G76A)H2B in a nucleosome and the activity of Dot1L,
suggesting that one ubiquitylation stimulates methylation of only one H3K79 (Figure 5.12B and
C). However, whether uH2B stimulates methylation of the same nucleosomal surface or the
opposite surface cannot be determined from this set of experiments (Figure 5.12D). As further
validation of this result, a pool of nucleosomes reconstituted from octamers containing an equal
mixture of unmodified and ubiquitylated H2B, have two singly ubiquitylated nucleosomes for
every one doubly ubiquitylated nucleosome; yet, half of the methyltransferase activity observed
by fluorography occurred on the doubly ubiquitylated nucleosomes (Figure 5.12B).

5.4. Forays into crystallography of nucleosomes containing u(G76A)H2B4
High-resolution structural characterization of ubiquitylated nucleosomes would provide
indisputable evidence for or against an allosteric change in the nucleosome resulting from H2B
ubiquitylation. An assortment of nucleosomal structures have been solved using X-ray
crystallography since the first high resolution structure was reported in 1997 (Luger et al.,
1997a). These structures include nucleosomes bearing histones from different organisms (Clapier
et al., 2008; Tsunaka et al., 2005; White et al., 2001), varying DNA sequences
4

This work was performed as part of a close collaboration with Matthew Bick in the Laboratory
of Molecular Biophysics at the Rockefeller University.
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Figure 5.12. Investigation of ubiquitylation/methylation stoichiometry. A) Octamers formed
with varying ratios or u(G76A)H2B and H2B were separated on a 15% SDS-polyacrylamide gel
and stained with Coomassie. B) Nucleosomes formed with octamers in panel A, were methylated
with Dot1L and 3H SAM. Assay samples were separated by native electrophoresis and stained
with ethidium bromide (bottom panel) followed by probing for 3H methyl incorporation by
fluorography (top panel). The position of nucleosomes bearing 0, 1, or 2 ubiquitins is indicated.
C) Quantification of assay samples by liquid scintillation counting, plotted relative to the fully
ubiquitylated sample. The blue line (rel. CPM = (fub); where fub is the fraction of u(G76A)H2B)
represents the case where each u(G76A)H2B stimulates methylation of only one H3K79 side
chain in the same nucleosome. The red line (rel. CPM = -(fub)2 + 2(fub)) represents a case where
each u(G76A)H2B stimulates methylation of both H3K79 side chains in the same nucleosome.
Error bars represent one s.d. (n = 4). D) Superimposed structures of the nucleosome (1KX5)
(Davey et al., 2002) and ubiquitin (1UBQ, red) (Vijay-Kumar et al., 1987). H2B and H3 are
colored blue and orange respectively. Methylation is either targeted to the same nucleosomal
face as ubiquitin or the opposite face.
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(Bao et al., 2006; Davey et al., 2002; Ong et al., 2007), histone variants (Suto et al., 2000) and
methyllysine analogs (MLAs) (Lu et al., 2008), as well as complexes between nucleosomes and
small ligands (Barbera et al., 2006; Edayathumangalam et al., 2004; Suto et al., 2003; Wu et al.,
2008) and higher order chromatin structures (Schalch et al., 2005). However, despite diverse
structural differences, an overwhelming similarity in optimized crystallography conditions is
observed. Invariably, nucleosomes have been crystallized in potassium cacodylate at pH 6.0 with
25-40 mM KCl and 35-50 mM MnCl2 (or in one case MgCl2). We hoped that these conditions
would also allow the crystallization of nucleosomes containing u(G76A)H2B.
The 146 bp palindromic α-satellite sequence (Figure 5.1A) was selected for
u(G76A)H2B nucleosome formation. As this sequence has been used repeatedly in nucleosome
crystallization and structure determination (Barbera et al., 2006; Lu et al., 2008; Luger et al.,
1997a; Muthurajan et al., 2004; Suto et al., 2000; Suto et al., 2003; White et al., 2001), it offers a
suitable starting point for u(G76A)H2B nucleosome crystallization and would best facilitate a
molecular replacement structural solution. Sixty-four copies of half of the 146 bp α-satellite
palindrome were inserted into a vector5 and amplified in E. coli. The sequence was isolated
following digestion from the vector, allowing formation of multiple milligrams of the mature
palindrome in high purity (Figure 5.13).
Nucleosome formation with this DNA and octamers containing H2B or u(G76A)H2B
was then optimized. Even with strong positioning sequences, nucleosomes formed by dialysis
exist in multiple translational states relative to the DNA (Dyer et al., 2004). Typically, this
variability can be resolved by heating. Therefore nucleosomes were formed using different ratios
of octamer to DNA and heated to 37 °C or 55 °C for 2 h (Figure 5.14A and B). Conditions
5
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the Rockefeller University.
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Figure 5.13. Preparation of 146 bp palindromic α-satellite DNA sequence. A) Schematic of
146 bp α-satellite palindromic DNA preparation. 64 copies were digested from a vector and
purified by PEG precipitation and G50 resin gel filtration. Fragments were ligated with T4 ligase
and subsequently digested with EcoRV to generate the mature palindromic sequence. B)
Ethidium bromide stained agarose gel of PEG precipitation. Desired fragment remains soluble,
while vector precipitates. C) Ethidium bromide stained gel of ligation showing laddering of
DNA. D) Ethidium bromide stained gel of EcoRV digested mature palindromic DNA.
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Figure 5.14. Optimization of nucleosome formation and purification. Small-scale
nucleosome (MN) formation using indicated ratios of octamers containing A) H2B or B)
u(G76A)H2B to DNA. Following reconstitution, nucleosomes were heated for 2 h at indicated
temperatures and heat shifted nucleosomes were separated by 5% native-PAGE and stained with
ethidium bromide. In both cases, a 1.0:1.0 octamer:DNA ratio and 55 °C incubation were
selected as optimal conditions. Nucleosomes containing C) H2B and D) u(G76A)H2B were
reconstituted on a large-scale and purified by 5% preparative native-PAGE. Ethidium bromide
stained 5% native gels of fractions are shown. E) Overexposed image of gel in panel C to
highlight purification from contaminants. DNA observed in pure nucleosome fractions results
from decomposition during electrophoresis.
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resulting in the greatest homogenous yields of nucleosome with minimal excess DNA were
selected. Nucleosomes were formed on large-scale using these optimized conditions and purified
by preparative native-PAGE (Figure 5.14C, D, and E). These purified nucleosomes were
concentrated for use in crystallization trials.
Three separate crystallization screens were performed using wild type, unmodified
nucleosomes and a range previously optimized crystallization conditions (Figure 5.15). Several
conditions resulted in formation of crystals (Figure 5.16A). These crystals exhibited lowresolution diffraction patterns and contained appropriate ratios of histone proteins (Figure 5.16B
and C). This validates the quality of the nucleosome preparations for use in crystallographic
studies. Unfortunately, under the same conditions, no crystallization of nucleosomes containing
u(G76A)H2B was observed (Figure 5.17). As ubiquitylation is a larger change than any reported
previously in a nucleosome structure, different conditions might be required to crystallize
ubiquitylated nucleosomes. As such, a screen was performed using the Qiagen Nucleix kit
optimized for the crystallization of protein-nucleic acid complexes. This screen was also
unsuccessful. Further screening is required to determine optimal conditions for crystallization of
nucleosomes containing u(G76A)H2B; however, the notion that this line of investigation can
even be considered is a testament to the power of the semisynthetic approach presented in
chapter 4.

5.5. Summary
In this chapter, insights into the mechanism of the stimulation of Dot1L by uH2B have
been presented. Kinetic analysis shows an extraordinary enhancement in Dot1L activity over a
wide range of nucleosome concentrations. This enhancement owes from an increase in the
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Figure 5.15. Crystal screens with unmodified nucleosomes. Three crystal screens were
performed with unmodified nucleosomes using a range of conditions previously optimized for
nucleosome crystallization. The concentrations of KCl and MnCl2 in the reservoir were varied as
indicated. Green and red boxes denote presence and absence of crystals, respectively, after three
weeks. MN = mononucleosome; NCP = nucleosome core complex. These terms are used
interchangeably.
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Figure 5.16. Characterization of crystals of unmodified nucleosomes. A) Three different
crystal morphologies were observed. B) Diffraction pattern generated from crystal in panel A,
left. C) Crystals in panel A, center, were washed twice with reservoir solution and dissolved in
SDS-PAGE loading buffer and separated by 8-25% SDS-PAGE and stained with Coomassie.
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Figure 5.17. Crystal screens with nucleosomes containing u(G76A)H2B. Three crystal
screens were performed with u(G76A)H2B nucleosomes using a range of conditions previously
optimized for nucleosome crystallization. The concentrations of KCl and MnCl2 in the reservoir
were varied as indicated. Red denotes absence of crystals after three weeks. MN =
mononucleosome; NCP = nucleosome core complex. These terms are used interchangeably.
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chemical step of methylation, which must result from a change in the structure of the Dot1LH3K79 active site complex. While the ubiquitin fold was required to translate ubiquitylation of
H2B into heightened H3K79 methylation, mutation of the canonical ubiquitin binding surface
had no effect on Dot1L activity, suggesting a role for a non-canonical surface. Additionally, it
was demonstrated that each uH2B within the nucleosome stimulates methylation of one H3K79.
Further investigation, possibly structural in nature, will be necessary to fully elucidate the
mechanisms linking uH2B and Dot1L-mediated H3K79 methylation. Thus far, efforts to
crystallize nucleosomes containing u(G76A)H2B have been unsuccessful.
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Chapter 6: Discussion
6.1. Semisynthesis of ubiquitylated H2B
In this thesis, two semisynthetic strategies for the regioselective ubiquitylation of H2B
have been presented. Both rely on a pair of orthogonal EPL reactions employing a branched
synthetic peptide and two protein α-thioesters to construct the ubiquitylated proteins. The first
strategy, presented in chapter 2, allowed the preparation of native uH2B (Figure 2.11). Due to
the absence of cysteines in both H2B and ubiquitin, two traceless protein ligations were required
to generate the native branched protein. A photolytically removable ligation auxiliary facilitated
the ligation of a C-terminal H2B peptide to the ubiquitin sequence and following ligation was
removed upon UV irradiation, leaving the native isopeptide junction. A traditional cysteinemediated ligation was then used to add the remainder of H2B to the ubiquitylated peptide. To
accomplish this, an A117C mutation was incorporated into the synthetic peptide. Following
ligation, C117 was reduced to the native alanine using Raney nickel, affording native uH2B in
low milligram quantities.
In chapter 4, a scalable semisynthesis of u(G76A)H2B was presented to overcome
shortcomings of the native strategy (Figure 4.3). By replacing the auxiliary-mediated ligation
with a traditional cysteine-mediated ligation, we efficiently generated u(G76A)H2B on a scale of
multiple tens of milligrams – an increase in excess of ten-fold over the native strategy.
Moreover, by eliminating the sluggish auxiliary-mediated ligation and subsequent purification,
the time required to generate ubiquitylated H2B was halved (not including time invested in
synthesis of the ligation auxiliary). Eliminating the need for photolytic removal of protecting
groups not only further enhanced the scalability of the semisynthesis, but also negated the need
for specialized optics. Most importantly, all materials required for the solid phase synthesis of
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peptide 27 (Figure 4.2) are commercially available, obviating time-intensive solution phase
organic synthesis and significantly increasing the accessibility of this methodology.
Both strategies will allow the preparation of other ubiquitylated histones, and more
broadly, other ubiquitylated proteins. This is especially important in systems where the natural
abundance of ubiquitylated proteins is low or where ubiquitin conjugating enzymes are unknown
or unavailable. Additionally, as we have illustrated in this thesis, chemical control of both
ubiquitin and the target protein permits detailed analysis of the mechanisms underlying signaling
through monoubiquitylation. Currently, work is underway to prepare H2A ubiquitylated at K119
to interrogate its role in heterochromatic gene silencing.6
The native and G76A ligation strategies should be considered complementary approaches
to the study of protein monoubiquitylation. In discovery and validation experiments it is often
ideal to have the native sequence surrounding the isopeptide bond to most closely mimic cellular
processes. However, the quantity of material required for mechanistic investigations, including
kinetics and structural biology, are inaccessible by the native ligation strategy. Thus, it is
reasonable to use the G76A mutant if it can be shown to be an acceptable surrogate for the native
sequence. For quantitative analyses, it is important that the mutation has no significant effect on
downstream function, but for qualitative analyses, a similar trend is sufficient to warrant the
substitution. In contrast to most ubiquitin binding domains that recognize defined regions of the
ubiquitin fold (Hurley et al., 2006), proteins that specifically engage the isopeptide bond are
likely to exhibit detrimental effects on activity as a result of the G76A mutation. For example,
the ubiquitin G76A mutant is efficiently mobilized and transferred to target proteins in vivo, but
the conjugated product has increased stability, likely due to decreased susceptibility to
6

This is an ongoing collaboration with Sarah Whitcomb in the Laboratory of Chromatin Biology
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deubiquitylating enzymes (Hodgins et al., 1992; Pickart et al., 1994). We expected that the G76A
mutation would render the ligation product increasingly stable to ubiquitin hydrolysis in vitro.
Surprisingly, there was no observable effect of the mutation on ubiquitin hydrolysis by UCH-L3
(Figure 4.5). This may be the exception rather than the rule, and native ubiquitylated proteins
may be more appropriate reagents for the biochemical characterization of DUBs.
There are also situations where significant changes to the isopeptide linkage are
advantageous. One example is in structure activity relationship analyses, such as those presented
in chapter 5. Another example includes fishing experiments in cell lysates for interacting partners
of monoubiquitylated proteins. In the latter case, an isopeptide bond that is stable to the UCHs
and DUBs present in lysates is desirable – preventing unwanted hydrolysis of the semisynthetic
ubiquitylated protein. While the G76A mutation may increase stability in some cases, it is
insufficient for this purpose. Fortunately, the G76A ligation strategy can be extended to
incorporate further changes into the ubiquitin C-terminal sequence. The G75A/G76P double
mutation is a reasonable option, as the G76P mutation alone prevents mobilization of ubiquitin
from linear fusions and is likely to result in the near complete stability of the isopeptide bond
(Bachmair et al., 1986; Varshavsky, 2005). The G75A/G76P double mutant could be prepared
through ligation of an ubiquitin(1-74)-α-thioester and a peptide or protein with the Cys-Pro
sequence coupled to the ε-NH2 of a lysine side chain. To complete the semisynthesis, the
cysteine at position 75 of ubiquitin could be reduced to an alanine.
EPL-based strategies for the preparation of ubiquitylated proteins are best suited to
ubiquitylation sites in N- and C-terminal regions of proteins. Preparation of a protein
ubiquitylated at an internal site requires a third orthogonal ligation. Recently, we have developed
a disulfide-directed approach for the ubiquitylation of H2B to circumvent this limitation of EPL
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(Figure 6.1).7 First, an ubiquitin(1-76)-intein fusion was reacted with 2-aminoethanethiol to
generate full-length ubiquitin bearing a C-terminal thiol. This protein was subsequently reacted
with a recombinant H2BK120C mutant with a disulfide-activated thiol to generate an uH2B
mimic, uH2Bss. Replacement of a methylene in K120 of uH2B with a disulfide through this
strategy lengthens the side chain by one atom (corresponding to ~2.4 Å) (Figure 6.1, bottom
panel). However, nucleosomes containing uH2Bss stimulate Dot1L activity to levels comparable
with nucleosomes containing uH2B or u(G76A)H2B. This strategy could be readily applied to
the ubiquitylation of proteins at internal sequences, provided an orthogonal cysteine can be
introduced into the protein.

6.2. Semisynthesis of polyubiquitylated proteins
An obvious question emerging from the semisynthesis of a monoubiquitylated protein is
whether or not the technology can be extended to the preparation of polyubiquitylated proteins.
This is a non-trivial problem. However, three possible routes to the polyubiquitylation of target
proteins can be envisioned. The first route, involves the use of E1/E2/E3 ubiquitylation
machinery to extend ubiquitin chains on a semisynthetic ubiquitylated protein (Figure 6.2, top
panel).8 Different lengths of ubiquitin chains could be separated by preparative SDS-PAGE
and/or size exclusion chromatography. Alternatively, the enzymatic ubiquitin polymerization
could be performed on an ubiquitin(1-75)-α-thioester. The resultant polyubiquitin chains could
be separated as described above, and the purified polyubiquitin thioesters used in EPL with a
desired target protein (Figure 6.2, bottom panel). If the thioester linkage is not stable during the
7
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Figure 6.1. Disulfide-directed ubiquitylation. The recombinant ubiquitin(1-76)-intein fusion
was reacted with 2-aminoethanethiol, affording ubiquitin with a C-terminal thiol, A (top panel).
The thiol of H2BK120C was activated with 2,2’-dithiobis(5-nitropyridine), yielding mixed
disulfide, B (second panel). Reaction of A with B led to formation of the disulfide-conjugated
uH2B, uH2Bss (third panel). Inset at bottom illustrates the difference between uH2B and
uH2Bss. Gn = guanidinium.
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Figure 6.2. Enzymatic approaches for the preparation of a polyubiquitylated protein. Two
possible approaches for the preparation of polyubiquitylated proteins can be envisioned
harnessing E1 and specific E2s and E3s. A semisynthetic ubiquitylated protein can be used as a
substrate for E1/E2/E3-mediated ubiquitylation (top panel). Alternatively, the ubiquitin(1-75)-αthioester can be used as a substrate (bottom panel). Following ubiquitin polymerization, the
polyubiquitin thioester can be used in an EPL reaction with a target protein.
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ubiquitylation reaction or the ubiquitin(1-75)-α-thioester is used by the ubiquitylation
machinery, a split intein at the C-terminus of ubiquitin(1-75) could be employed. These
approaches rely on the specificity of the ubiquitylation machinery to generate a given ubiquitin
linkage. This could be bypassed using a purely synthetic system (Figure 6.3). To accomplish this,
a peptide containing residues 46-75, an A46C mutation, and a protected cysteine linked through
an isopeptide bond with K48 or K63, could be synthesized with a safety catch linker. Following
ligation to a synthetic ubiquitin(1-45)-α-thioester, the safety catch linker could be used to
generate the branched ubiquitin(1-75)-α-thioester. This thioester could be ligated to a
semisynthetic protein bearing an isopeptide-linked cysteine. Subsequent rounds of deprotection
of the isopeptide-linked cysteine and ligation to the branched ubiquitin thioester would allow
ubiquitin polymerization. The terminal ligation could be performed with the linear ubiquitin(175)-α-thioester. Desulfurization of this intermediate product would afford the polyubiquitylated
protein with G76A mutations in each ubiquitin monomer. This is a challenging undertaking, but
would allow direct chemical control of the ubiquitin branch points.

6.3. Mechanistic insights into the stimulation of Dot1L by uH2B
Prior to the initiation of the work in this thesis, three models had been proposed to
explain the stimulatory effect of uH2B on methylation of H3K79 observed in vivo (Figure 3.1).
In the first model, ubiquitin acts as a wedge to open up chromatin structure and increase
accessibility of H3K79 to Dot1L. In chapter 2, native uH2B was used to demonstrate a direct
stimulation of Dot1L-mediated methylation of H3K79 within a nucleosome (Figure 3.6). This
does not rule out a role for the wedge model, but minimally suggests that another mechanism
contributes to uH2B-mediated Dot1L activation. Interestingly, using the disulfide-directed
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Figure 6.3. Synthetic approach for the preparation of a polyubiquitylated protein. A
peptide containing residues 46-75 of ubiquitin, an A46C mutation, and an isopeptide linked
protected cysteine conjugated to K48 or K63 is synthesized with a safety catch linker (ub-C).
Ligation to a synthetic peptide-α-thioester containing residues 1-45 of ubiquitin (ub-N) is
followed by removal of the linker protecting group and formation of the branched ubiquitin(175)-α-thioester. This thioester is ligated to a semisynthetic protein bearing an isopeptide-linked
cysteine. Sequential deprotection of the isopeptide-linked cysteine and ligation to the branched
ubiquitin thioester allows ubiquitin polymerization. The final ubiquitin is ligated using the linear
ubiquitin(1-75)-α-thioester. Desulfurization converts C46 of each ubiquitin monomer to the
native alanine and each C76 to the G76A mutant affording the G76A polyubiquitylated protein.
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ubiquitylation strategy, uH2Bss was incorporated into nucleosome arrays and shown to prevent
Mg+2-dependent compaction of the 30 nm fiber analogous to acetylated H4K16.9 Ongoing
experiments are underway to investigate the effect of this structural change on the accessibility
of H3K79 to Dot1L.
The second model proposes that Dot1L recognizes ubiquitin in the context of the
nucleosome and is thereby recruited specifically to nucleosomes containing uH2B. However, in
electrophoretic mobility shift assays, Dot1Lcat interacts with the nucleosome regardless of its
ubiquitylation state (Figure 3.10). This interaction was observed with nucleosome concentrations
at and below those used in methyltransferase assays. Additionally, the interaction of Dot1Lcat
with uH2B containing nucleosomes was easily competed with unmodified nucleosomes. This is
consistent with in vivo results demonstrating that Dot1 associates with chromatin irrespective of
H2B ubiquitylation in S. cerevisiae (Shahbazian et al., 2005). This suggests that there is not a
significant difference in the affinity of Dot1L for ubiquitylated- relative to unmodified
nucleosomes. It is formally possible that in the absence of uH2B, Dot1L forms a non-productive
complex with the nucleosome at a site or an ensemble of sites distinct from the productive site
including H3K79. When H2B is ubiquitylated, the productive interaction could become
increasingly favored. However, it seems unlikely that the distinct interaction surfaces would act
competitively in a gel-shift assay.
The third model invokes one or more secondary factors responsible for translating the
effect of uH2B into methylation of H3K79. Given that Dot1L and Dot1Lcat (Figures 3.6 and 3.7),
prepared from Sf9 and E. coli cells, respectively, are both stimulated by uH2B, it is extremely
unlikely that an extra factor present in both enzyme preparations is responsible for linking uH2B
9
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to H3K79 methylation. Therefore, while other proteins including Cps35 and proteasomal
ATPases may enhance the stimulation of Dot1L by uH2B, they are not required. It would be
interesting to test whether or not the presence of Cps35 enhances activity of Dot1L in vitro in an
uH2B-dependent manner. Thus far, efforts to express the human ortholog of Cps35, WDR82, in
a soluble form in E. coli have been unsuccessful. Expression using baculovirus in Sf9 cells may
be more fruitful. Furthermore, WDR82 is a component of the human Set1-containing H3K4
methyltransferase complex, that we have also shown to be stimulated by semisynthetic uH2B in
vitro (Kim et al., 2009). It is possible that the Set1 complex and Dot1L work synergistically,
through WDR82, in performing simultaneous methylation of H3K4 and K79. This is readily
testable in our in vitro system.
As each of the previously proposed models is insufficient to explain the stimulation of
Dot1L by semisynthetic uH2B in our experiments, new models are required. It seems likely that
ubiquitylation of H2B results in an allosteric change in the nucleosome or Dot1L, either
increasing the accessibility of H3K79 to Dot1L or the intrinsic catalytic activity of Dot1L itself
(Figure 3.11). The activity of Dot1L was unaffected by the G76A mutation. Therefore, we used
nucleosomes containing u(G76A)H2B to perform the first systematic mechanistic investigation
into the methylation process. Kinetic experiments performed with a large excess of Dot1L
revealed an impressive enhancement in the chemical step of the methylation reaction due to the
presence of ubiquitylated H2B. This suggests a conformational change in the active site complex
of Dot1L bound to H3K79. Based on structure activity relationship analysis, we propose that the
interaction of a non-canonical surface of ubiquitin (i.e. not including I44) with the catalytic
domain of Dot1L or the nucleosome itself, initiates this allosteric change, favoring methylation
(Figure 3.11). From our experiments it cannot be concluded if the allostery occurs within the
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nucleosome, Dot1L, or both. If ubiquitylation of H2B allosterically regulates Dot1L, a composite
interaction surface of ubiquitin and the nucleosome is likely to be required, as ubiquitin alone is
insufficient to stimulate methyltransferase activity in trans. In this case, ubiquitylation of H2B
will likely stimulate methylation on the same nucleosomal surface. If ubiquitylation alters the
nucleosomal structure, this change is only propagated to one copy of H3 within the nucleosome
and could reasonably stimulate methylation of either nucleosomal surface. Structural
investigation of this complex system, aided by semisynthetic u(G76A)H2B, may shed further
light on this aspect of the mechanism.
Current work is ongoing to further elucidate the structural requirements of ubiquitin for
Dot1L stimulation. Using the disulfide-directed strategy, two different Ubls, Nedd8 and Hub1,
which have 55 and 26% sequence identity to ubiquitin, respectively, were attached to
H2BK120.10 While Nedd8 shows nearly complete stimulation of Dot1L relative to ubiquitin,
Hub1 fails to stimulate Dot1L. In conjunction with the structure activity relationship analysis
presented in chapter 5, this allows the residues of ubiquitin that are potentially required for
Dot1L stimulation to be focused – that is, residues shared between ubiquitin and Nedd8 that are
not shared with Smt3 or Hub1 (Figure 6.4). Future work, involving alanine-scanning
mutagenesis coupled to methyltransferase assays of these remaining residues, will define the
required binding surface. It is surprising that disruption of the canonical binding surface of
ubiquitin fails to diminish Dot1L activity (Figure 5.5). This raises the possibility that multiple
surfaces of ubiquitin are interpreted simultaneously by parallel pathways, thereby necessitating
the recognition of non-canonical surfaces. This could explain the evolutionary need for such a
large modification in this instance. Further investigation of the role of the surfaces of uH2B in
10
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Figure 6.4. Elements of ubiquitin potentially required for Dot1L stimulation. A surface
representation of ubiquitin (1UBQ) (Vijay-Kumar et al., 1987). Amino acids conserved between
ubiquitin and Nedd8 (not including L8 and I44) and not conserved between ubiquitin and Smt3
or Hub1 based on structural alignment, are colored blue. These residues are potentially required
for Dot1L stimulation. All other amino acids are colored yellow and unlikely to be required for
Dot1L stimulation. Conservation based on homology.
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H3K79 methylation and its myriad of other downstream processes, using the structural variants
described above, will put this hypothesis to the test.
In the case of H3K79 methyltransferase activity, the non-canonical surface of ubiquitin
could be required for interactions with the nucleosome, Dot1L, or both. An interaction with the
nucleosome could be investigated by crystallography as attempted in chapter 5. Alternatively,
NMR using a segmentally-labelled uH2B could be employed. Chemical shift perturbations in
ubiquitin attached to the nucleosome relative to free ubiquitin or free uH2B would be suggestive
of an intranucleosomal interaction. Moreover, because the chemical shifts of ubiquitin are
assigned, NMR results could be directly compared with mutagenesis results. In contrast, an
interaction of ubiquitin or uH2B with Dot1L is more difficult to interrogate. It could be studied
qualitatively using pull-down experiments or quantitatively by surface plasmon resonance (SPR),
fluorescence anisotropy, or isothermal titration calorimetry (ITC). However, given that 1 mM
exogenous ubiquitin fails to diminish Dot1L activity toward ubiquitylated nucleosomes (Figure
5.9), it is likely that any direct interaction with ubiquitin will be of low affinity and difficult to
detect. Any potential interaction with Dot1L may only be productive when ubiquitin is
constrained to the nucleosomal surface. In fact, introduction of three extra glycine residues at the
C-terminus of ubiquitin using the disulfide-directed technology significantly diminishes
stimulation of Dot1L, suggesting a strong entropic penalty in the system.11 As such, it may be
best to interrogate a potential Dot1L-ubiquitin interaction within the context of the nucleosome.
A Dot1Lcat-nucleosome co-crystal structure would be most revealing in this case, though perhaps
the most challenging undertaking. It is possible that monitoring NMR chemical shift

11
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perturbations while titrating Dot1Lcat into a segmentally-labelled uH2B nucleosome could also
give insight into this potential mechanism.

6.4. uH2B and the degree of H3K79 methylation
uH2B increases Dot1L- and Dot1Lcat-mediated mono- and dimethylation of H3K79 in
vitro (Figure 3.8). This is contradictory to in vivo results in which monomethylation of H3K79 is
unaffected by disruption of H2B ubiquitylation (Kim et al., 2005; Shahbazian et al., 2005).
Steady-state kinetic analysis of Dot1L monomethyltransferase activity on ubiquitylated
nucleosomes allowed for the extrapolation of kinetic parameters from the Michaelis-Menten
model. The observed Km is similar to values calculated for other histone lysine
methyltransferases acting on peptide and protein substrates (Chin et al., 2006; Collazo et al.,
2005; Dirk et al., 2007; Eskeland et al., 2004; Patnaik et al., 2004; Trievel et al., 2002); however,
the kcat of Dot1L on ubiquitylated nucleosomes is 10 to 100 times greater than reported values
for these other reactions, suggesting a rate enhancement on nucleosomal substrates. Similar to
yeast Dot1 (Frederiks et al., 2008), Dot1L appears to be a distributive enzyme, as evidenced by
its ability to monomethylate an excess of substrate without measurable accumulation of
dimethylation. Although a direct comparison of kinetic parameters of Dot1L on ubiquitylated
and unmodified nucleosomes was not possible, it is clear that Dot1L is able to monomethylate
uH2B bearing nucleosomes to a much greater extent than unmodified nucleosomes. Again, this
seems contradictory to in vivo experiments where levels of H3K79 monomethylation are
apparently unaffected by genetic disruption of H2B ubiquitylation (Kim et al., 2005; Shahbazian
et al., 2005). We propose that accumulation over time or parallel pathways may compensate
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specifically for any deficit in monomethylation of H3K79 in the absence of H2B ubiquitylation
in vivo.
Dimethylation was never observed on unmodified nucleosomes in our assays. This could
be a consequence of the low activity of Dot1L. In this distributive system, monomethylation
must build up to significant levels before dimethylation can be detected. Alternatively, it is
possible that conversion of monomethylated H3K79 to the dimethylated state is precluded in the
absence of uH2B. This could be tested directly using nucleosomes bearing chemically
monomethylated H3K79. The cysteine-directed methyllysine analog strategy (Simon et al.,
2007) would be best suited for this purpose.

6.5. Asymmetric nucleosome formation
By titrating the level of u(G76A)H2B within nucleosomes, it was demonstrated that one
ubiquitylated H2B leads to methylation of only one nucleosomal H3K79 (Figure 5.12). As
described above, elucidating the side of the nucleosome that is methylated, relative to ubiquitin,
may provide insight into the mechanism underlying Dot1L stimulation. This is a surprisingly
difficult question to answer. While affinity purification strategies exist to assemble nucleosomes
simultaneously bearing two different copies of a given histone protein (Li and Shogren-Knaak,
2008), these strategies cannot direct the relative position of two histones within the nucleosome.
But perhaps, complementary mutations could be introduced into histone-histone interfaces to
ensure that two or more given histones are localized to the same surface of the nucleosome – not
unlike the elegant bump-hole approach to generate orthogonal kinase-ATP pairs (Liu et al.,
1998; Shah et al., 1997). For example, one could imagine the introduction of mutations in H3
and H4 which alone prevent H3-H4 interaction, but when combined restore this interaction
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(Figure 6.5). The reconstitution of nucleosomes with a mixture of the mutant and wild-type
proteins would result in the defined placement of the mutants relative to each other within the
nucleosome. This could potentially be performed throughout the nucleosome until a system
existed where the position of each histone protein within the nucleosome could be directly
predicted, effectively removing any stoichasticity from nucleosomal assembly. This would allow
the placement of uH2B on the same or opposite surface relative to an H3K79R mutant to
definitely illustrate the spatial nature of uH2B/H3K79me stoichiometry.
While this may seem a lofty goal, nature has provided evidence of its practicality; the
histone variant, macroH2A preferentially forms asymmetric nucleosomes with one copy of
macroH2A and one copy of the canonical H2A in in vitro reconstitution experiments
(Chakravarthy and Luger, 2006). A priori, it is difficult to predict the magnitude of mutations
necessary to establish such a complementation system. A stretch of four amino acids is critical in
the case of macroH2A-H2A hybrid nucleosomes, but this is likely to be interface dependent.
Although these mutations could be designed rationally through close inspection of the
nucleosome structure, a high throughput screen might be more promising. This screen could be
undertaken using the histone shuffle system in S. cerevisiae (Ahn et al., 2005). This system
readily allows the replacement of the canonical histone sequences with mutant sequences.
Targeted mutations in one histone at a desired interface could be made and inviable mutants
screened for complementation with a library of mutants of the interacting histone.
Complementary mutant pairs with observable phenotypes could be excluded. The remaining
pairs could be sequenced and the behavior of the pairs containing the subtlest changes could be
tested in vitro. Ideally, complementary mutations would function without significant effects on
nucleosome stability and function.
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Figure 6.5. Complementary mutants for preparing asymmetric nucleosomes.
Complementary mutations are introduced into a histone-histone interface. Each mutant alone
prevents nucleosome formation. When these mutants are introduced simultaneously, the requisite
interaction surface is restored.
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6.6. Preparation of custom nucleosomal arrays
A strategy allowing the asymmetric ligation of nucleosomes was presented in chapter 3.
Structurally distinct nucleosomes were reconstituted bearing DNA linkers with complementary
non-palindromic overhangs (Figure 3.9). The non-palindromic nature of the DNA overhangs,
allowed ligation of preassembled nucleosomes to afford dinucleosomes with defined components
at each position. This approach was used to demonstrate that the stimulation of Dot1L by uH2B
is strictly intranucleosomal.
This technology could be readily applied to the preparation of longer arrays of
nucleosomes. This could be accomplished using two approaches. The first would involve the
simultaneous ligation of multiple nucleosomes each bearing orthogonal overhangs to define
nucleosome order (Figure 6.6, top panel). The advantage of this approach is expediency,
ensuring nucleosomal stability during ligation. However, obtaining homogeneous samples may
be challenging due to incomplete ligations. A second approach, invoking sequential chain
assembly on a solid support, analogous to solid phase peptide synthesis, could overcome this
limitation (Figure 6.6, bottom panel). Chain assembly begins with a nucleosome biotinylated on
one side of the DNA. Subsequent rounds of digestion and ligation with intervening washes
would allow the sequential assembly of nucleosomes. An enzyme such as SapI, which contains a
recognition sequence completely removed by digestion could be used universally, similar to
Fmoc- or Boc-based protection strategies in peptide synthesis. Following completion of chain
assembly, the nucleosome array could be used directly on the solid support, or cleaved using a
unique restriction site between the first nucleosome and the biotin handle. This strategy would
require more time for array synthesis, but under appropriately low salt conditions, histone
rearrangement could be limited.
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Figure 6.6. Strategies for the preparation of custom nucleosome arrays. Nucleosome arrays
with position-specific structural differences could be prepared using two different strategies. In a
one-pot method (top panel), nucleosomes containing non-palindromic, orthogonal,
complementary DNA overhangs could be ligated simultaneously. X and X’ represent
complementary sequences. Alternatively, a sequential chain assembly could be used (bottom
panel). Rounds of digestion and ligation on a solid support would allow the stepwise assembly of
a nucleosome array. Following array completion, cleavage of the DNA sequence between the
solid support and the first nucleosome releases the array into solution.
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Combined with the bump hole strategy for asymmetric nucleosome formation, this would
allow the preparation of nucleosome arrays with unprecedented chemical control. These arrays
could be used to interrogate the roles of histone PTMs in chromatin-templated processes in a
position-specific manner. As understanding of histone PTMs at the nucleosome level grows, this
positional chemical control will become increasingly valuable.

6.7. Perspective
Using novel semisynthetic strategies to prepare ubiquitylated H2B in combination with
biochemical analysis, a direct role for uH2B in the intranucleosomal stimulation of Dot1Lmediated H3K79 methylation was demonstrated. However, while previously proposed
mechanisms were ruled out, much remains unclear about the specific role of uH2B in this
complex system. Experiments proposed above will help narrow the remaining possibilities,
heightening mechanistic understanding of this trans-histone crosstalk pathway. As both H2B
ubiquitylation and H3K79 methylation are integral to the control of gene expression and DNA
damage repair, a full elucidation of their functions serves to advance our understanding of the
roles of histone PTMs in development and disease. Moreover, given the pathogenic role of
H3K79 methylation in a large subset of human leukemias, a more complete understanding of this
pathway will undoubtedly unearth potential therapeutic approaches to combat MLL-fusion
leukemias.
More broadly, we propose that the application of the semisynthetic technologies
described within this thesis presents an invaluable tool in the isolation of functions of individual
histone PTMs. As more is elucidated at the single PTM level, combinations of PTMs can be
introduced simultaneously to interrogate cooperative roles in chromatin-templated processes. We
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anticipate this combinatorial approach to engineer defined chromatin substrates with increasing
complexity, will play a crucial role in the hypothesis-driven dissection of the mechanisms
underlying a potential histone code (Strahl and Allis, 2000).
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Methods
General methods
Amino acid derivatives unless otherwise noted, pre-loaded Wang resin, and coupling reagents
were purchased from Novabiochem. E. coli BL21(DE3) and pLysS cells were purchased from
Novagen. 3H S-adenosyl methionine, was obtained from GE Healthcare. Restriction enzymes, T4
ligase, pTXB1 vector, and chitin resin were obtained from New England Biolabs. Criterion 15%
and 4-20% Tris HCl, and Criterion 5% TBE gels were purchased from Biorad. Centricons were
purchased from Sartorius. PCR purification and gel extraction kits were purchased from Qiagen.
All other chemical reagents unless otherwise noted were purchased from Sigma-Aldrich or
Fisher Scientific. Analytical and semi-preparative scale reverse-phase HPLC (RP-HPLC) were
performed on a Hewlett-Packard 1100 series instrument using Vydac C18 columns (4 x 150 mm;
10 x 250 mm) at 1 and 4 mL/min, respectively. Unless otherwise noted, all analytical gradients
were 0-73% B over 30 min (A: 0.1% trifluoroacetic acid (TFA) in water; B: 90% acetonitrile,
0.1% TFA in water). Preparative and process scale RP-HPLC were performed on a Waters
DeltaPrep 4000 system connected to a Waters 486 tunable detector using Vydac C18 columns
(22 x 250 mm; 50 x 250 mm) at 15 and 30 mL/min, respectively. Size-exclusion, ion exchange,
and GSH affinity chromatography were performed on an AKTA FPLC system from GE
Healthcare equipped with a P-920 pump and a UPC-900 monitor. ESI-MS was performed on a
SciexAPI-100 single quadrupole mass spectrometer. Linear peptide synthesis was performed on
a Liberty synthesizer equipped with a Discovery microwave module from CEM. Primer
synthesis and DNA sequencing were performed by Integrated DNA Technologies and Genewiz,
respectively.
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Synthesis of photolytically removable ligation auxiliary
The ligation auxiliary, 1, was synthesized as previously described with minor modifications
(McMinn and Greenberg, 1996; Pellois and Muir, 2005).
4-(4-Formyl-2-methoxyphenoxy)-butyric acid methyl ester (3). To a solution of vanillin, 2 (22.8
g, 150 mmol), in acetonitrile (400 mL), was added potassium carbonate (49.8 g, 360 mmol),
tetrabutylammonium iodide (11.1 g, 30 mmol), and 4-chlorobutyric acid methyl ester (21.95 mL,
180 mmol) and the mixture was refluxed under argon for 20 h. The mixture was filtered and the
precipitate was washed with ethyl acetate (4 x 100 mL). Combined organic layers were
concentrated in vacuo and redissolved in diethyl ether (300 mL), washed with water (2 x 50 mL),
and dried in vacuo to afford ester 3 (15.5 g, 62 mmol, 41%). Compound 3: Rf = 0.38 (silica gel,
33% ethyl acetate in hexanes); 1H NMR (400 MHz, CDCl3): δ 9.86 (s, 1H, C(O)H), 7.45 (s, 1H,
Har), 7.42 (s, 1H, Har), 7.00 (s, 1H, Har), 4.18 (t, 2H, OCH2), 3.93 (s, 3H, OCH3), 3.71 (s, 3H,
COOCH3), 2.56 (m, 2H, CH2CO), 2.13 (m, 2H, CH2).
4-(4-Formyl-2-methoxy-5-nitrophenoxy)-butyric acid methyl ester (4). To a stirred mixture of
glacial acetic acid (125 mL) and fuming nitric acid (40 mL) on ice, was added dropwise 4-(4formyl-2-methoxyphenoxy)-butyric acid methyl ester, 3 (15.5 g, 62 mmol), in glacial acetic acid
(35 mL). The mixture was stirred on ice for 10 min and at room temperature for an additional 6
h, after which the mixture was poured over ice (150 mL), extracted with diethyl ether (4 x 150
mL), washed with saturated sodium bicarbonate (~10 x 300 mL), brine (2 x 300 mL), dried
(MgSO4), and concentrated in vacuo. The residue was crystallized from diethyl ether, affording
nitrated product 4 (10.7 g, 36 mmol, 58%). Compound 4: Rf = 0.29 (silica gel, 30% ethyl acetate
in hexanes); 1H NMR (400 MHz, CDCl3): δ 9.86 (s, 1H, C(O)H), 7.45 (s, 1H, Har), 7.42 (s, 1H,
Har), 7.00 (s, 1H, Har), 4.18 (t, 2H, OCH2), 3.93 (s, 3H, OCH3), 3.71 (s, 3H, COOCH3), 2.56 (m,
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2H, CH2CO), 2.13 (m, 2H, CH2).
4-(2-Methoxy-5-nitro-4-vinyl-phenoxy)-butyric acid methyl ester (5). To a suspension of
methyltriphenylphosphonium bromide (6.5 g, 18.2 mmol) in THF (30 mL), a solution of sodium
hexamethyldisilazide (18.2 mL, 1 M in THF, 18.2 mmol) was added dropwise over 30 min at 0
°C and stirred for 1 h. A solution of 4-(4-formyl-2-methoxy-5-nitrophenoxy)-butyric acid methyl
ester, 4 (4.2 g, 14.0 mmol), in THF (40 mL) was then added dropwise and the mixture stirred at
room temperature for an additional 16 h. The solvent was then evaporated and the residue
dissolved in chloroform (25 mL). The organic phase was washed with a saturated solution of
ammonium chloride (2 x 25 mL), brine (2 x 300mL), dried (Na2SO4) and concentrated in vacuo.
Flash column chromatography of the residue (silica gel, 30% ethyl acetate in petroleum ether)
yielded styrene 5 (2.4 g, 8.1 mmol, 58%). Compound 5: Rf = 0.54 (silica gel, 30% ethyl acetate
in petroleum ether); 1H NMR (400 MHz, DMSO-d6): δ 7.56 (s, 1H, Har), 7.19 (s, 1H, Har), 7.09
(dd, J = 17.3, 11 Hz, 1H, H2), 5.88 (d, J = 17.3 Hz, 1H, H1b), 5.45 (d, J = 11.1 Hz, 1H, H1a), 4.14
(t, J = 6.3 Hz, 2H, OCH2), 3.94 (s, 3H, OCH3), 3.61 (s, 3H, COOCH3), 2.48 (m, 2H, CH2CO),
2.01 (m, 2H, CH2). 13C NMR (400 MHz, DMSO-d6): δ 173.75, 153.94, 148.17, 140.78, 133.02,
128.00, 119.15, 110.64, 109.35, 68.74, 57.18, 52.22, 30.69, 24.83. HRMS (FAB); m/z:
calculated for C14H18O6N: 296.1134; found: 296.1135 ([MH+]).

4-[4-(1-tert-Butoxycarbonylamino-2-hydroxy-ethyl)-2-methoxy-5-nitro-phenoxy]-butyric acid
methyl ester (6). To a stirred solution of tert-butylcarbamate (2.0 g, 16.8 mmol) in n-propanol
(20 mL), sodium hydroxide (33 mL 0.5 M in water, 16.5 mmol) and tert-butyl hypochlorite (1.9
mL) were added and the resulting mixture was stirred for 5 min. The flask was then put in a
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slurry of ice water and (DHQ)2PHAL (211 mg, 0.27 mmol, in 20 mL of n-propanol), styrene 5
(1.6 g, 5.4 mmol, in 80 mL of n-propanol), and K2OsO2(OH)4 (70 mg, 0.2 mmol) were
sequentially added. The resulting mixture was stirred for 16 h at 4 °C. The product was extracted
with ethyl acetate (2 x 100 mL), the combined organic extracts washed with brine (2 x 500 mL),
dried (MgSO4), and evaporated. Flash column chromatography of the residue (silica gel, 5%
methanol in dichloromethane (DCM)) followed by crystallization in chloroform/hexanes
afforded alcohol 6 (1.2 g, 2.7 mmol, 50%). Compound 6: Rf = 0.38 (silica gel, 5% methanol in
DCM); 1H NMR (400 MHz, CDCl3): δ 7.63 (s, 1H, Har), 7.02 (s, 1H, Har), 5.62 (s, 1H, NH), 5.46
(m, 1H, CHNH), 4.12 (t, J = 6.0 Hz, 2H, OCH2), 3.96 (m, 2H, CH2OH), 3.95 (s, 3H, OCH3),
3.71 (s, 3H, COOCH3), 3.50 (s, 1H, OH), 2.56 (t, J = 7.2 Hz, 2H, CH2CO), 2.19 (q, J = 6.7 Hz,
2H, CH2), 1.42 (s, 9H, tBu).

13

C NMR (400 MHz, CDCl3): δ 173.74, 155.81, 154.16, 147.58,

68.66, 65.39, 56.80, 53.68, 52.12, 51.28, 30.76, 28.69, 24.66. HRMS (FAB); m/z: calculated for
C19H29O9N2: 429.1873; found: 429.1872 ([MH+]).
4-[4-(2-Acetylsulfanyl-1-tert-butoxycarbonylaminoethyl)-2-methoxy-5-nitro-phenoxy]-butyric
acid methyl ester (7). Diisopropyl azodicarboxylate (0.92 mL, 4.7 mmol) was added to an icecold solution of triphenylphosphine (1.2 g, 4.7 mmol) in THF (30 mL). The mixture was stirred
under nitrogen for 30 min, during which time a white precipitate formed. A solution of alcohol 6
(1.0 g, 2.3 mmol) in THF (20 mL) and thioacetic acid (0.33 mL, 4.7 mmol) was added dropwise
and the mixture was stirred for 17 h at room temperature. The solvent was evaporated, the
residue dissolved in methanol (200 mL) and left to stand at 0 °C for 16 h. The precipitate was
filtered and the solvent evaporated. Flash column chromatography of the residue (silica gel, 40%
ethyl acetate in petroleum ether) afforded thioester 7 (1.0 g, 2.1 mmol, 91%). Compound 7: Rf =
0.50 (40% ethyl acetate in petroleum ether); 1H NMR (400 MHz, CDCl3): δ 7.63 (s, 1H, Har),
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7.01 (s, 1H, Har), 5.69 (s, 1H, NH), 5.00 (m, 1H, CHNH), 4.12 (t, J = 6.0 Hz, 2H, OCH2), 3.98 (s,
3H, OCH3), 3.71 (s, 3H, COOCH3), 3.35 (m, 2H, CH2S), 2.57 (t, J = 7.2 Hz, 2H, CH2CO), 2.40
(s, 3H, SCOCH3), 2.20 (q, J = 6.7 Hz, 2H, CH2), 1.41 (s, 9H, tBu). 13C NMR (400 MHz, CDCl3):
δ 197.78, 173.76, 155.81, 154.34, 147.73, 139.37, 70.53, 68.65, 56.88, 52.13, 33.93, 30.94,
30.76, 28.67, 24.66, 22.34. HRMS (FAB); m/z: calculated for C21H31O9N2S: 487.1750; found:
487.1749 ([MH+]).
4-[4-(1-tert-Butoxycarbonylamino-2-tert-butyldisulfanylethyl)-2-methoxy-5-nitro-phenoxy]butyric acid (8). To a solution of thioester 7 (500 mg, 1.0 mmol) in methanol (30 mL) was added
sodium methoxide (2.0 mL, 0.5 M in methanol, 1.0 mmol). The mixture was stirred under
nitrogen for 15 min. 2-methyl-2-propanethiol (3.4 mL, 30 mmol) was added and the mixture
stirred under constant oxygen bubbling overnight. A solution of sodium hydroxide (15 mL, 1.0
M in water, 15 mmol) was then added and the mixture stirred for another 3 h. The solution was
acidified with hydrochloric acid (20 mL, 1.0 M in water, 20 mmol) and extracted with ethyl
acetate (2 x 50 mL). The organic phase was washed with brine (2 x 25 mL), dried (MgSO4), and
concentrated in vacuo. Flash column chromatography of the residue (silica gel, 40% ethyl acetate
in petroleum ether) afforded disulfide 8 (467 mg, 0.9 mmol, 90%). Compound 8: Rf = 0.26
(silica gel, 40% ethyl acetate in petroleum ether); 1H NMR (400 MHz, CDCl3): δ 7.62 (s, 1H,
Har), 7.03 (s, 1H, Har), 5.56 (m, 1H, CHNH), 4.14 (t, J = 6.0 Hz, 2H, OCH2), 3.95 (s, 3H, OCH3),
3.30 (d, J = 13.0 Hz, 2H, CH2S), 2.60 (t, J = 7.2 Hz, 2H, CH2CO), 2.20 (m, 2H, CH2), 1.41 (s,
9H, tBu), 1.34 (s, 9H, S-tBu). 13C NMR (400 MHz, CDCl3): δ 177.70, 154.26, 147.56, 140.72,
132.62, 110.48, 100.00, 68.55, 56.84, 51.19, 48.73, 30.60, 30.24, 30.18, 28.66, 24.66. HRMS
(FAB); m/z: calculated for C22H35O8N2S2: 519.1835; found: 519.1837 ([MH+]).
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4-[4-(1-Amino-2-tert-butyldisulfanyl-ethyl)-2-methoxy-5-nitro-phenoxy]-N-methyl-butyramide
(1). To a stirred solution of thioester 8 (438 mg, 0.844 mmol) in DCM (10 mL) at room
temperature was added PyBOP (439 mg, 0.844 mmol) and N,N-diisopropylethylamine (DIEA)
(0.43 mL, 2.53 mmol). After an additional 5 min of stirring, methylamine (4.22 mL, 8.44 mmol,
2M in THF) was added to the mixture and the reaction was allowed to proceed for a further 10 h
at room temperature, affording amide 9. At this stage, the solvent was removed in vacuo and the
residue dissolved in a mixture of TFA (9.5 mL), triisopropylsilane (TIS) (0.25 mL), and water
(0.25 mL). The resulting solution was stirred at room temperature for 1 h to effect complete
removal of the Boc-protecting group. The removal of water by lyophilization yielded crude
amide 1, which was purified by preparative RP-HPLC using a 20-45% B gradient over 60 min,
to obtain the pure compound in 36% isolated yield over two steps. 1H NMR (400 MHz, CDCl3):
δ 7.55 (s, 1H, Har), 7.29 (s, 1H, Har), 6.13 (m, 1H, NHCH3), 5.35 (m, 1H, CHNH2), 4.12 (t, 2H,
OCH2), 4.11 (s, 3H,OCH3), 3.33 (d, 2H, CH2S), 2.78 (d, 3H, CH3NH), 2.41 (t, 2H, CH2CO), 2.15
(m, 2H,CH2), 1.33 (s, 9H, S-tBu). 13CNMR(400 MHz, CDCl3): δ 173.90, 154.51, 148.62, 141.78,
124.74, 111.11, 109.78, 69.06, 57.08, 49.06, 42.46, 32.96, 30.12, 26.72, 25.12, 22.29. HRMS
(ESI-FT); m/z calculated for C18H29O5N3S2: 432.1622, found 432.1609 ([MH+]).
Solid phase peptide synthesis
Synthesis of peptide 14. The peptide corresponding to the C-terminus of human H2B with an
A117C mutation, TKCVTKYTSSK, was manually synthesized on a 0.5 mmol scale employing the
9-fluorenylmethoxycarbonyl (Fmoc) Nα-protection strategy. Starting with the pre-loaded FmocLys(Boc)-Wang resin (806 mg, 0.62 mmol/g), each successive amino acid was coupled in 4.4 molar
excess. Deprotection of the Fmoc group was achieved with 20% piperidine in N,Ndimethylformamide (DMF) (5 mL, 3 x 5 min). Coupling reactions were undertaken for a minimum of
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1 h with a mixture of Fmoc-amino acid (2.2 mmol), 2-(1H-benzotriazole-1-yl)-1,1,3,3tetramethyluronium hexafluorophosphate (HBTU) (2 mmol), and DIEA (4.4 mmol) in DMF. The εNH2 of Lys6, which represents Lys120 in full-length H2B, was orthogonally protected with the 1(4,4-dimethyl-2,6-dioxocyclohexylidine)-3-methylbutyl (ivDde) group. Thr1 was coupled as BocThr(tBu)-OH to preclude deprotection of the α-amino group during removal of the ivDde group. The
N-terminal residues Thr1 and Lys2 were not incorporated efficiently upon single coupling and
required multiple reactions with aggressive coupling reagents such as benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate (PyBOP), or, diisopropylcarbodiimide (DIC) in
the presence of 1-hydroxybenzotriazole (HOBt). Nα-deprotection times for these residues were also
increased to 2 x 20 min followed by 1 x 5 min.
Peptidyl resin 10 was treated with 2% hydrazine in DMF (v/v) for 5 x 30 min, followed by a
longer incubation for 8 h to effect removal of the ivDde group from Lys6. The resultant peptidyl
resin 11 (550 mg, 0.33 mmol) was then coupled to bromoacetic acid (366.8 mg, 2.64 mmol) with
DIC (333 mg, 2.64 mmol) in DMF (4 mL) for 30 min at room temperature. The coupling was
repeated once, affording bromoacetylated peptidyl resin 12, and the resin was dried. After swelling in
1.4 mL DMF, peptidyl resin 12 (250 mg, 0.15 mmol) was reacted with 1.75 equivalents of auxiliary
1 (112.6 mg, 0.261 mmol) in the presence of DIEA (252.3 mg, 1.95 mmol) and 1,8-

diazobicycloimide (DBU) (10.2 mg, 0.07 mmol) for 96 h at room temperature with the exclusion of
light, yielding peptidyl resin 13. The reaction progress was followed by test cleavages of 5-10 mg of
resin after 48 h, 72 h, and 96 h. After conjugation to the ligation auxiliary, simultaneous cleavage and
deprotection in 10 mL TFA:TIS:H2O:Anisole (92.5:2.5:2.5:2.5) for 2 h, afforded peptide 14, which
was purified by semi-preparative RP-HPLC to yield 10.2 mg. Auxiliary-conjugated peptide 14 was
verified by ESI-MS [(M+H)2+ observed 860 Da. (M+H)2+ expected 859.5 Da.].
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Synthesis of peptide 21. The sequence corresponding to residues 117-125 of Xenopus H2B with

an A117C replacement was synthesized on a pre-loaded Wang resin using manual solid-phase
peptide synthesis as described above. Standard tbutyl side-chain protection was used throughout
with the following exceptions; the ε-amino group of K120 was protected with the 4-methyltrityl
(Mtt) group, and the thiol group of C117 was protected with an o-nitrobenzyl group. Nα(tbutoxycarbonyl)-S-(o-nitrobenzyl)-L-cysteine (Boc-Cys(ONB)) used in the peptide synthesis
was prepared as previously described (Smith et al., 2002; Wang et al., 1977). The glycyl linker
and ligation auxiliary were installed on the solid phase as described above following Mtt
deprotection. Briefly, the Mtt group on K120 was deprotected by successive incubations of the
peptidyl-resin with 1% TFA in DCM containing 1% TIS for 10 min intervals, until no yellow
color evolved. Bromoacetic acid (222 mg, 1.6 mmol) was triple coupled to the ε-NH2 of K120
with DIC (1.6 mmol) for 3 x 1 h. Ligation auxiliary 1 (32.6 mg, 76 mmol) and DIEA (1.4 mmol)
were added to this resin (120 mg, 76 mmol) suspended in 600 µL DMF. The alkylation was
allowed to proceed for 72 h at room temperature, after which, the resin was dried. Following
simultaneous deprotection and cleavage from the resin with TFA:TIS:H2O (95:2.5:2.5) for 3 h,
peptide 21 was purified by RP-HPLC on a preparative scale using a 28-38% B gradient over 45
min, yielding 10.8 mg peptide. Peptide 21 was characterized by ESI-MS [(M+H)+ observed:
1,606.8 Da. (M+H)+ expected: 1,607.9 Da.].
Synthesis of peptides 27 and 32. For peptides 27 and 32, the sequence corresponding to residues

117-125 of Xenopus H2B with an A117C substitution was synthesized on a pre-loaded Wang
resin using automatic solid-phase peptide synthesis. Standard tbutyl side-chain protection was
used throughout with the following exceptions; the ε-NH2 of K120 was protected with the Mtt
group, and the thiol group of C117 was installed as an Nα-(tbutoxycarbonyl)-thiazolidine (Boc-
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thiazolidine, Bachem). For peptide 27, the Mtt group on K120 was deprotected as described
above followed by coupling with Boc-S-trityl-cysteine. Simultaneous deprotection and cleavage
from the resin (as described above for peptide 21), afforded peptide 27, which was purified by
RP-HPLC on a process scale using a 6-18% B gradient over 60 min, yielding 56 mg peptide
from 0.25 mmol resin. Peptide 27 was characterized by ESI-MS [(M+H)+ observed: 1,115.9 Da.
expected: 1,115.3 Da.].
For peptide 32, the sequence corresponding to residues 72-76 of ubiquitin was
synthesized on the ε-NH2 of K120 following Mtt deprotection. This ubiquitin branch was N-αacetylated by incubation with acetic anhydride:DIEA:DMF (15:15:70) for 10 min. Following
cleavage from the resin (as above), the resulting crude mixture was dissolved in 0.5 M aqueous
methoxylamine, pH 5, for 3.5 h at room temperature to deprotect the N-terminal cysteine.
Deprotected peptide 32 was purified by RP-HPLC on a preparative scale using a 10-25% B
gradient over 45 min. Peptide 32 was characterized by ESI-MS [(M+H)+ observed: 1,582.8 Da.
(M+H)+ expected: 1,582.8 Da.].

Preparation of protein α-thioesters
Construction of ubiquitin(1-75) expression plasmid. The first 75 residues of the human ubiquitin
gene were amplified by PCR using the primers Hub13-FP (5’GGGAATTCCATATGCAGATCTTCGTGAAGACTC-3’) and Hub13-RP (5’GAATATATGCTCTTCCGCAACCTCTGAGACGGA-3’) with the plasmid pFIR-CMV-ub-IRESlnGFP (Ho lab, Rockefeller University) as the template DNA. The PCR product was purified,
digested with NdeI and SapI restriction enzymes, and ligated into the identically digested pTXB1
vector. The resulting plasmid, pHub(1-75), which encodes ubiquitin(1-75) fused at its C-terminus

to the GyrA intein and a chitin binding domain, was verified by DNA sequencing.
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Construction of HA-Smt3(2-97) expression plasmid. DNA encoding residues 2-97 of the yeast
SUMO protein, Smt3, was amplified by PCR from the plasmid JM11a-4 (Muir lab, Rockefeller
University) employing the primer HASmt3-FP (5’-GGAATTCCATATGTACCCGTATGATGTCCC
AGA-3’) bearing the NdeI restriction site and a sequence encoding the HA epitope
(MYPYDVPDYA) and the primer HASmt3-RP (5’-GGTGGTTGCTCTTCCGCAACCAATCTGTT
CTCT-3’) bearing the SapI restriction site. The purified PCR product was digested and ligated into
the pTXB1 as described above and the resultant plasmid, pHASmt3(2-97), which encodes HA-

Smt3(2-97) fused at its C-terminus to the GyrA intein and a chitin binding domain, was verified
by DNA sequencing.

Construction of H2B(1-116) expression plasmid. A truncated Xenopus H2B gene, containing
residues 1-116, was PCR amplified using primers H2B-FP (5’-GGAATTCCATATGCCTGAGC
CAGCCAAGTCCGCTCCAGCCCCG-3’) and H2B116-RP (5’- GGTGGTTGCTCTTCCGCAC
TTGGTGCCCTCGGACAC-3’) and a Xenopus H2B expression plasmid (Luger et al., 1997b) as
a template. Following digestion by NdeI and SapI, the fragment was ligated into a similarly
digested pTXB1 vector, and the resulting plasmid, pRMH2B-N, which encodes H2B(1-116)
fused at its C-terminus to the GyrA intein and a chitin binding domain, was verified by DNA
sequencing.
Construction of ubiquitin(1-75)L8A/I44A expression plasmid. Ubiquitin(1-75) containing the
L8A/I44A double mutation was prepared with the QuikChange Multi Site-directed Mutagenesis
kit (Stratagene) with the following primers: UbL8A (5’-GCAGATCTTCGTGAAGACTGCGAC
TGGTAAGACCATCACT-3’) and UbI44A (5’- CTGACCAGCAGAGGTTGGCCTTTGCTGG
GAAACAGC-3’) and pHub(1-75) as a template, according to manufacturer’s instructions,
generating pHub(1-75)L8A/I44A, which was verified by DNA sequencing.
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Preparation of ubiquitin(1-75)-α -thioester. Ubiquitin(1-75)-α-thioester, 15, was prepared on a
small scale using shaking flasks and on a large scale using a fermenter. E. coli BL21(DE3) cells
transformed with the plasmid pHub(1-75), were grown in 6 L Luria-Bertani medium supplemented
with 100 µg/mL ampicillin at 37 °C with shaking at 250 rpm until an OD600 of 0.6-0.8 was reached.
Overexpression was induced by the addition of 0.5 mM isopropyl-β-D-1-thiogalactopyranoside
(IPTG) and the cells were grown for an additional 6 h at 25 °C. The cells were then harvested by

centrifugation at 10 kg for 30 min and the cell pellet was resuspended in buffer A (50 mM Tris HCl,
200 mM NaCl, 1 mM EDTA, pH 7.2). The cells were lysed by passage through a French Press and
the soluble fraction separated from insoluble cellular debris by centrifugation at 18.5-20 kg for 20
min. After filtration through a 0.45 µm filter, supernatants were bound to a 20 mL chitin column,
pre-equilibrated with 200 mL of buffer A, for 2 h at 4 °C. The resin was washed with 700 mL of
buffer A, followed by 60 mL buffer B (50 mM Tris HCl, 200 mM NaCl, and 1 mM EDTA, pH 7.5).
Ubiquitin(1-75) was cleaved from the intein-CBD fusion by incubation with 30 mL of cleavage
buffer (buffer B containing 100 mM of the sodium salt of 2-mercaptoethanesulfonic acid (MESNa))
for 87 h. The eluted ubiquitin(1-75)-α-thioester was subsequently purified by semi-preparative RPHPLC, employing a gradient of 30-45% B over 45 min. This yielded 10.2 mg of the ubiquitin(1-75)α-MES. The identity of thioester 15 was verified by ESI-MS [(M+H)+ observed 8,632 ± 2 Da (s.d.).
(M+H)+ expected 8,632 Da.].

Ubiquitin(1-75)-α-MES was also prepared on large scale using a BioFlo 300 Benchtop
Fermenter operating in fermentation mode (New Brunswick Scientific). The fermenter was
inoculated with E. coli BL21(DE3) transformed with pHub(1-75). Cells were grown at 37 °C in
Superbroth (MP Biomedicals) until an OD600 of 21 was reached. Protein expression was induced
with 0.5 mM IPTG at 25 °C for 6 h under continuous supplementation with 50% glucose and 3x
Superbroth and oxygen enrichment. pH was maintained at 7.0 with 5 N NaOH. After
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centrifugation at 6.8 kg for 15 min, the cell pellet was resuspended in 500 mL buffer B
supplemented with 0.1 mM phenylmethylsulfonylfluoride (PMSF) and 0.2 mg/mL
deoxyribonuclease (DNase) and lysed by passage through a French press. The insoluble material
was removed by centrifugation at 26 kg for 30 min and the supernatant was incubated overnight
at 4 °C with chitin resin (300 mL) pre-equilibrated in lysis buffer. The resin was washed with 2 L
of buffer A and then incubated with cleavage buffer for 74 h, resulting in thiolysis of the intein
fusion, forming ubiquitin(1-75)-α-MES, 15. The column was eluted and the resin was washed
with 200 mL cleavage buffer. The thiolysis reaction was repeated and the combined elution
fractions further purified by process RP-HPLC using a 30-45% B gradient over 60 min, yielding
300 mg of lyophilized protein.
Preparation of HA-Smt3(2-97)-α -thioester. E. coli BL21(DE3) cells transformed with the plasmid
pHASmt3(2-97), were grown in 6 L Luria-Bertani medium and purified as described above for
ubiquitin(1-75). Cleavage was performed for 42 h and eluted HA-Smt3(2-97)-α-MES, 18, was
purified by semi-preparative RP-HPLC, employing a 30-60% B gradient over 45 min. The identity of
thioester 18 was verified by ESI-MS [(M+H)+ observed 12,414 ± 3 Da (s.d.). (M+H)+ expected
12,414 Da.].

Preparation of H2B(1-116)-α -thioester. E. coli BL21(DE3) cells transformed with pRMH2B-N
were grown in 6L Luria-Bertani medium at 37 °C until an OD600 of 0.6 was reached, and protein
expression was induced by the addition of 0.5 mM IPTG and allowed to continue at 25 °C for 16
h. Cells were harvested and lysed as described above. The cleared cell lysate was filtered and
incubated overnight at 4 °C with chitin resin (35 mL) pre-equilibrated in buffer A. The resin was
washed with 200 mL of buffer A and 700 mL buffer C (50 mM Tris HCl, 200 mM NaCl, 1 mM
EDTA, pH 7.4). The resin was then incubated with cleavage buffer 2 (50 mM Tris HCl, 200 mM
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NaCl, 1 mM EDTA, 100 mM MESNa, pH 7.4) for 70 h, resulting in thiolysis of the intein
fusion, forming H2B(1-116)-α-MES, 24. The column was eluted and the resin was washed with
2 x 25 mL cleavage buffer 2. The thiolysis reaction was repeated and the combined elution
fractions further purified by preparative RP-HPLC using a 42-52% B gradient over 45 min,
yielding 25 mg protein. The identity of thioester 24 was verified by ESI-MS [(M+H)+ observed
12,991 ± 3 Da (s.d.). (M+H)+ expected 12,991 Da.]. Mass spectrometry indicates that the non-

native N-terminal methionine used for expression of 24 was processed during recombinant
expression, leaving the native N-terminal sequence.
Preparation of ubiquitin(1-75)L8A/I44A-α -thioester. E. coli BL21(DE3) cells transformed with
pHub(1-75)L8A/I44A were grown in 6 L Luria-Bertani medium at 37 °C until an OD600 of 0.6
was reached, and protein expression was induced by the addition of 0.5 mM IPTG and allowed
to continue at 25 °C for 8 h. The cells were harvested, lysed, and cleared as described above.
Cleared lysates were incubated overnight at 4 °C with chitin resin (20 mL) pre-equilibrated in
buffer A. The resin was washed with 100 mL of buffer A followed by 200 mL buffer C. The
resin was then incubated with 20 mL cleavage buffer 2 for 48 h, resulting in thiolysis of the
intein fusion, forming ubiquitin(1-75)L8A/I44A-α-MES, 38. The column was eluted and the
resin was washed with 20 mL cleavage buffer 2. The thiolysis reaction was repeated twice and
the combined elution fractions further purified by preparative RP-HPLC using a 25-55% B
gradient over 45 min. The identity of thioester 38 was verified by ESI-MS [(M+H)+ observed:
8,548 ± 1 Da (s.d.). (M+H)+ expected: 8,548 Da.].
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Modification of peptides with ubiquitin and Ubls
Ligation of peptide 14 to ubiquitin(1-75)-α -thioester, 15. In a typical reaction, purified peptide 14
(1 mg, 0.58 µmol) was dissolved in 70 µL of a buffer containing 3 M guanidinium HCl, 300 mM
sodium phosphate pH 7.8, and 50 mM tris(2-carboxyethyl)phosphine (TCEP), and incubated for 35
min at 25 °C to remove the S-tbutyl protection group on the ligation auxiliary. To the solution of
reduced peptide was then added thioester 15 (1 mg, 0.12 µmol) dissolved in 70 µL of ligation buffer
1 (3 M guanidinium chloride, 300 mM sodium phosphate, 100 mM MES, pH 7.8). Upon mixing,
the pH of the resultant solution was found to be ~7.5, and the ligation was allowed to proceed with
gentle shaking for 5 days at 4 °C. The extent of reaction was checked periodically by withdrawing 1
µL aliquots of the ligation mixture, dilution into 50 µL of 25% B and analysis by analytical RPHPLC. At the end of 5 days, the ligation product was reduced with TCEP and purified by analytical
RP-HPLC using a 25-55% B gradient over 30 min to yield 0.5 mg of ligation product 16. The
identity of ligation product 16 was verified by ESI-MS [(M+H)+ observed: 10,120 ± 2 Da (s.d.).

(M+H)+ expected: 10,120 Da.].
Ligation of peptide 14 to HA-Smt3(2-97)-α -thioester, 18. Purified peptide 14 (1 mg, 0.58 µmol)
was dissolved in 70 µL of reduction buffer described above to remove the S-tbutyl protection group

on the ligation auxiliary. To the solution of reduced peptide was then added 18 (1.4 mg, 0.11 µmol)
dissolved in 70 µL of ligation buffer 1. Ligation was allowed to proceed with gentle shaking for 7
days and the extent of reaction was analyzed by analytical RP-HPLC. After 7 days, the ligation
product was reduced with TCEP and purified by analytical RP-HPLC employing a gradient of 3447% B over 30 min to yield 0.7 mg of pure 19. The identity of ligation product 19 was verified by
ESI-MS [(M+H)+ observed: 13,901 ± 5 Da (s.d.). (M+H)+ expected: 13,900 Da.].

Photolysis of ubiquitylated ligation product 16. For large-scale photolysis, the purified and
lyophilized ligation product 16 was taken up in a photolysis buffer (50 mM Tris HCl, 150 mM NaCl,
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1 mM DTT, pH 7.5) at a final concentration of 80 mM and mixed by vortexing prior to photolysis.
Alternatively, a RP-HPLC fraction corresponding to the ligation product could also be employed in
photolysis experiments with no observable changes in the product pattern. A 50-100 µL solution of
16 was briefly exposed to a He-Cd laser at 325 nm for 3-4 bursts of light of ~5 s duration with
vortexing between exposures. The photolyzed ligation product 17 was purified by analytical RPHPLC using a 0-73% B gradient over 30 min. The identity of photolysis product 17 was verified by
ESI-MS [(M+H)+ observed: 9,793 ± 4 Da (s.d.). (M+H)+ expected: 9,793 Da.].

Photolysis of sumoylated ligation product 19. The photolysis of ligation product 19 was performed
as described above for the ubiquitylated peptide, 16. The identity of photolysis product 20 was
verified by ESI-MS [(M+H)+ observed: 13,573 ± 4 Da (s.d.). (M+H)+ expected: 13,573 Da.].

Semisynthesis of uH2B
Ligation of peptide 21 to ubiquitin(1-75)-α -thioester, 15. The ligation reaction between peptide,
21, and ubiquitin(1-75)-α-MES, 15, was performed using conditions similar to those described
above. In a typical reaction, purified peptide 21, (1.1 mg, 0.69 µmol) was dissolved in 180 µL of
buffer containing 3 M guanidinium chloride, 300 mM sodium phosphate pH 7.8, 50 mM TCEP,
and incubated at room temperature for 30 min to remove the S-tbutyl protection group on the
ligation auxiliary. The resulting reduced peptide was added to ubiquitin(1-75)-α-MES, 15 (17.1
mg, 1.98 µmol), dissolved in ligation buffer 1. The reaction volume was increased to 950 µL
with ligation buffer 1 and the pH was adjusted to 7.8 using NaOH. After 120 h at 4 °C, the
reaction was quenched with 1 mL of 50% HPLC buffer B containing 100 mM TCEP. Ligation
product 22 was purified using preparative HPLC with a 32-42% B gradient over 45 min, yielding
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4.0 mg of lyophilized protein. ESI-MS was used to verify the identity of the ligation product
[(M+H)+ observed: 10,008 ± 1 Da (s.d.). (M+H)+ expected: 10,009 Da.].
Photolysis of ubiquitylated ligation product 22. In a typical reaction, ligation product 22 (3.5
mg, 0.35 µmol) was dissolved in 1.5 mL of photolysis buffer (25% HPLC buffer B containing 10
mM semicarbazide, 10 mM DTT, 10 mM ascorbic acid, and 2 mM cysteine) (Smith et al., 2002).
The resulting solution was irradiated at 365 nm for 4 h using a collimated light source (Oriel)
equipped with a 200 W Hg lamp. Irradiance (4 mW/cm2) was measured by using a model 840-c
monochromic photometer. Selective irradiation at 365 nm was achieved by using an analytical
line filter (9.4 nm bandwidth, Oriel). Irradiation effected removal of the ligation auxiliary and the
S-o-nitrobenzyl protecting group, forming branched protein 23. Semi-preparative RP-HPLC
purification of protein 23 was accomplished using a 0-73% B gradient over 45 min, yielding 2.5
mg of lyophilized protein 23. Removal of the two photolytic groups was verified by ESI-MS
[(M+H)+ observed: 9,547 ± 2 Da (s.d.). (M+H)+ expected: 9,548 Da.].
Ligation of ubiquitylated peptide 23 to H2B(1-116)-α -thioester, 24. In a typical reaction,
photolysis product, 23 (2.5 mg, 0.25 µmol), and H2B(1-116)-α-MES, 24 (5.0 mg, 0.38 µmol),
were dissolved in ligation buffer 1 to a final volume of 225 µL. The pH of the resulting solution
was increased to 7.8 with NaOH and the reaction was allowed to proceed for 78 h prior to
quenching with 225 µL of 50% HPLC buffer B containing 100 mM TCEP. The ligation product,
25, was purified using semi-preparative RP-HPLC with a 42-52% B gradient over 45 min,
yielding 3.0 mg of uH2BA117C, 25. The identity of the ligation product was verified by ESI-MS
[(M+H)+ observed: 22,395 ± 3 Da (s.d.). (M+H)+ expected: 22,397 Da.].
Raney nickel mediated desulfurization of ligation product 25. Raney nickel reduction was used
to convert C117 of protein 25 to the native alanine (Pentelute and Kent, 2007; Yan and Dawson,

153

2001). In a typical reaction, uH2BA117C, 25, (1.3 mg, 58 nmol) was dissolved in 3 mL
desulfurization buffer 1 (6 M guanidinium chloride, 200 mM sodium phosphate, 35 mM TCEP,
pH 7.0). Raney nickel was prepared by adding 200 mg NaBH4 to a stirred solution of 1.2 g of
nickel acetate in 6 mL of water. After 5 min, the Raney nickel was filtered, washed with 200 mL
water and added to the solution of uH2BA117C, 25. The reaction progress was followed by RPHPLC and ESI-MS. An identical amount of fresh Raney nickel was added after 6 h and the
reaction was found to be complete at 8.5 h. (Note, much longer reaction times (over 24 hours)
led to a second desulfurization reaction on methionine.) The Raney nickel was pelleted by
centrifugation and washed with 4 x 0.5 mL desulfurization buffer. The reaction supernatant and
washes were combined, added to an equivalent volume of 50% HPLC buffer B, and purified
using semi-preparative RP-HPLC with a 42-52% B gradient over 45 min, yielding 1.1 mg of
uH2B, 26. uH2B was characterized by ESI-MS [(M+H)+ observed: 22,366 ± 4 Da (s.d.). (M+H)+
expected: 22,365 Da.].

Semisynthesis of u(G76A)H2B
Ligation of peptide 27 to ubiquitin(1-75)-α -thioester, 15. The ligation reaction between peptide,
27, and ubiquitin(1-75)-α-MES, 15, was performed using conditions similar to those previously
optimized for the corresponding auxiliary-mediated reaction. In a typical reaction, purified
peptide 27, (19.9 mg, 17.9 mmol) and protein 15 (45.7 mg, 5.3 mmol) were combined in 2.5 mL
of ligation buffer 2 (6 M guanidinium chloride, 300 mM sodium phosphate, 100 mM MESNa, 50
mM TCEP, pH 7.8). The pH was adjusted to 7.8 using 5 N NaOH and the reaction was allowed
to proceed for 4 h at room temperature. After 2 h, reaction completion, forming intermediate
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product 28, was verified by RP-HPLC and ESI-MS [(M+H)+ observed = 9,609 ± 2 Da (s.d.).
(M+H)+ expected = 9,606 Da.].
Cysteine deprotection of ubiquitylated ligation product 28. To crude ligation product 28 was
added 2.5 mL 50% HPLC buffer B and 0.72 mL 4 M methoxylamine, to reach a final
concentration of 0.5 M. The pH of the resulting solution was increased to 5 with 5 N NaOH.
Following incubation for 12 h at room temperature to allow complete deprotection of the
cysteine, product 29, was purified by preparative RP-HPLC using a 25-55% B gradient over 45
min, yielding 27.3 mg purified protein. The identity of the purified protein 29 was verified by
ESI-MS [(M+H)+ observed = 9,593 ± 2 Da (s.d.). (M+H)+ expected = 9,594 Da.].
Ligation of ubiquitylated peptide 29 to H2B(1-116)-α -thioester, 24. In a typical reaction,
protein 29 (29.9 mg, 3.1 mmol), and H2B(1-116)-α-MES, 24 (52.6 mg, 4.0 mmol), were
dissolved in ligation buffer 2 to a final volume of 1.6 mL. The pH of the resulting solution was
increased to 7.8 with 5 N NaOH and the reaction was allowed to proceed for 48 h. Fresh TCEP
was then added to a final concentration of 50 mM. The ligation product, 30, was purified using
semi-preparative RP-HPLC with a 35-52% B gradient over 45 min, yielding 38.4 mg of protein
30. The identity of the ligation product was verified by ESI-MS [(M+H)+ observed = 22,444 ± 5
Da (s.d.). (M+H)+ expected = 22,443 Da.].
Desulfurization of ligation product 30. The 38.4 mg of protein 30 was converted to 30 mg
u(G76A)H2B, 31, using two complementary desulfurization methodologies. Raney nickel
reduction was used to convert C117 and C76 of protein 30 to alanines (Pentelute and Kent, 2007;
Yan and Dawson, 2001). In a typical reaction, protein 30 (8.0 mg, 0.36 mmol) was dissolved in 3
mL desulfurization buffer 1. Raney nickel was prepared as described above and added at 0 h, 6.5
h, 10 h, and 13.5 h. The reaction progress was followed by RP-HPLC and ESI-MS. After 22 h,
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the Raney nickel was pelleted by centrifugation and washed. The reaction supernatant and
washes were combined, added to an equivalent volume of 50% HPLC buffer B, and purified
using semi-preparative RP-HPLC with a 42-52% B gradient over 45 min, yielding 4.0 mg of
u(G76A)H2B, 31. Protein 31 was characterized by ESI-MS.
Protein 30 was also desulfurized by the previously reported radical-initiated methodology
(Chiang et al., 2009; Wan and Danishefsky, 2007). In a typical reaction, protein 30 (9.0 mg, 0.40
mmol) was dissolved in 500 µL desulfurization buffer 2 (6 M guanidinium chloride, 200 mM
sodium phosphate, pH 7.0). To this solution was added 10 µl ethane thiol, 750 µl 0.5 M TCEP
(dissolved in desulfurization buffer followed by pH adjustment to 7.0), 50 µl 2-methyl-2-propane
thiol, and 12.5 µl 0.2 M VA-061 (Wako Chemicals) (dissolved in methanol), and the mixture
was incubated in a 37 °C water bath. The reaction progress was followed by RP-HPLC and ESIMS. After 24 h, the product was purified using semi-preparative RP-HPLC with a 42-52% B
gradient over 45 min, yielding 7.6 mg of u(G76A)H2B, 31. Protein 31 was characterized by ESIMS [(M+H)+ observed = 22,380 ± 4 Da (s.d.). (M+H)+ expected = 22,379 Da.].

Semisynthesis of uH2B structural variants
Synthesis of tr-uH2B, 34. Peptide 32 (0.6 mg, 0.38 µmol) and H2B(1-116)-α-MES, 24 (2.1 mg,
0.16 µmol), were dissolved in ligation buffer 2 to a final volume of 160 µL. The pH of the
resulting solution was increased to 7.8 with 5 N NaOH and the reaction was allowed to proceed
for 19 h prior to adding fresh TCEP to a final concentration of 25 mM. The ligation product, 33,
was purified using semi-preparative RP-HPLC with a 42-52% B gradient over 45 min, yielding
1.1 mg of protein. Protein 33 (1.1 mg, 76 nmol) was desulfurized using Raney nickel as
described above and purified using semi-preparative RP-HPLC with a 42-52% B gradient over
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45 min, yielding 0.3 mg of tr-uH2B, 34. Protein 34 was characterized by ESI-MS [(M+H)+
observed = 14,400 ± 3 Da (s.d). (M+H)+ expected = 14,399 Da.].
Synthesis of sH2B(cys), 37. To generate sH2B(cys), HA-Smt3(2-97)-α-MES, 18, was
substituted for ubiquitin(1-75)-α-MES in the first step of the synthesis. Peptide 27 (5.7 mg, 5.1
mmol) and protein 18 (8.4 mg, 0.68 mmol) were combined in 338 µL of ligation buffer 2. The
pH was adjusted to 7.8 using 5 N NaOH and the reaction was allowed to proceed for 4 h at room
temperature, forming ligation product 35. To this solution was added 338 µL 50% HPLC buffer
B and 169 µL 4 M methoxylamine and the pH was adjusted to 5. After 12 h at room temperature
the deprotected protein, 36, was purified by semipreparative RP-HPLC using a 35-60% B
gradient, yielding 8.1 mg of product. Protein 36 (6.8 mg, 0.51 mmol) and protein 24 (5.6 mg,
0.43 mmol) were combined in 254 µL of ligation buffer 2. After 52 h at room temperature, fresh
TCEP was added to a final concentration of 20 mM and the ligation product was purified by
semi-preparative RP-HPLC using a 42-52% B gradient over 45 min, yielding 5.5 mg sH2B(cys),
37 [(M+H)+ observed = 26,228 ± 9 Da (s.d.). (M+H)+ expected = 26,224 Da.]. No protein was
recovered following Raney nickel desulfurization of protein 37 using procedures detailed above.
Synthesis of mut-uH2B, 42. To generate mut-uH2B, ubiquitin(1-75)L8A/I44A-α-MES, 38, was
substituted for ubiquitin(1-75)-α-MES in the first step of the synthesis. Peptide 27 (0.6 mg, 0.54
mmol) and protein 38 (5.0 mg, 0.58 mmol) were combined in 160 µL of ligation buffer 2. The
pH was adjusted to 7.8 using 5 N NaOH and the reaction was allowed to proceed for 2 h at room
temperature, forming ligation product 39. To this solution was added 160 µL 50% HPLC buffer
B and 46 µL 4 M methoxylamine and the pH was adjusted to 5. After 12 h at room temperature
the deprotected protein, 40, was purified by semipreparative RP-HPLC using a 32-42% B
gradient, yielding 2.4 mg of product. Protein 40 (0.8 mg, 80 nmol) and protein 24 (1.2 mg, 90
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nmol) were combined in 50 µL of ligation buffer. After 41 h at room temperature, fresh TCEP
was added to a final concentration of 20 mM and the ligation product was purified by
semipreparative RP-HPLC using a 42-52% B gradient over 45 min, yielding 0.2 mg protein 41.
Radical initiated desulfurization was performed on protein 41 (200 µg, 9.0 nmol) as described
above using 1/5th the total reaction volume and the product was purified by analytical RP-HPLC
using a 0-73% B gradient over 30 min, yielding 150 µg mut-uH2B, 42 [(M+H)+ observed =
22,293 ± 7 Da (s.d.). (M+H)+ expected = 22,295 Da.].

Preparation of recombinant histones
Cloning of full-length H2B and histone mutants. The three N-terminal residues of H2B (PEP)
were added to the Xenopus H2B expression plasmid (Luger et al., 1997b). The DNA encoding
residues 1-125 of H2B was PCR amplified using primers H2B-FP described above and H2B-RP
(5’-CGGGATCCTTACTTGGCGCTGGTGTACTTG-3’) and the H2B plasmid described above
as a template. Following digestion with NdeI and BamHI, the H2B gene was ligated into a
similarly digested pET vector from the Xenopus H2A expression plasmid (Luger et al., 1997b).
The H3K79R, H2AE64A, H2AN68A, and H4R17/19A point mutations were generated with a
QuikChange II XL kit (Stratagene) using the following primers: H3K79R-FP (5’-GCTCAGGAC
TTCAGGACCGACCTGCGC-3’), H3K79R-RP (5’-GCGCAGGTCGGTCCTGAAGTCCTGA
GC-3’);

H2AE64A-FP

(5’-CTGACCGCTGAGATTTTGGCATTGGCCGGGAATG-3’),

H2AE64A-RP (5’-CATTCCCGGCCAATGCCAAAATCTCAGCGGTCAG-3’); H2AN68A-FP
(5’-TTTGGAATTGGCCGGGGCTGCGGCCCGTGATAAC-3’), H2AN68A-RP (5’-GTTATC
ACGGGCCGCAGCCCCGGCCAATTCCAAA-3’); H4R17/19A-FP (5’-CTGGGTAAAGGTG
GTGCTAAAGCTCACGCTAAAGTTCTGCGTGACAACA-3’) and
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H4R17/19A-RP

(5’-

TGTTGTCACGCAGAACTTTAGCGTGAGCTTTAGCACCACCTTTACCCAG-3’) and the
corresponding Xenopus histone expression plasmids as templates. The resulting mutations were
verified by DNA sequencing.
Expression and purification of histones. Recombinantly expressed Xenopus histones H2A,
H2B, H3, H4, H3K79R, H2AE64A, H2AN68A, and H4R17/19A were prepared similarly to
previously reported (Luger et al., 1999). For protein expression, E. coli BL21(DE3)pLysS cells
transformed with the appropriate histone expression plasmid, were grown in 3-6 L 2xTY media
at 37 °C until an OD600 of 0.6 was reached, and protein expression was induced by the addition
of 0.5 mM IPTG at 37 °C for 2-3 h. Cells were harvested and lysed as described above for
protein α-thioesters. The insoluble fractions of the bacterial lysates were washed twice with 20
mL wash buffer (20 mM Tris HCl, 200 mM NaCl, 1 mM EDTA, 1 mM 2-mercaptoethanol, pH
7.5) and once with 20 mL of triton wash buffer (20 mM Tris HCl, 200 mM NaCl, 1 mM EDTA,
1 mM 2-mercaptoethanol, 1% triton, pH 7.5). DMSO (1 mL) was then added to the pellets and
after 15 min, 15-50 mL of extraction buffer (7 M guanidinium chloride, 20 mM Tris HCl, 200
mM NaCl, 1 mM EDTA, 1 mM 2-mercaptoethanol, pH 7.5) was added and the suspension
stirred for a further 15-30 min before clearing by centrifugation at 26 kg for 30 min. The
supernatants were purified using a Sephacryl S-200 column (approximately 1 L bed volume),
eluting with extraction buffer. Purified fractions were combined, dialyzed into water containing 2
mM DTT, and lyophilized. Histones were further purified using process RP-HPLC with a 4060% B gradient over 60 min (with the exception of H3K79R for which a 45-65% B gradient was
used). The identity of all purified histones was verified by ESI-MS.
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Ubiquitin hydrolysis assay
Purified ubiquitylated H2B peptide, 17, was dissolved in 200 µL of ubiquitin hydrolase assay buffer
(50 mM Tris HCl, 150 mM NaCl, 1 mM DTT, pH 7.5) to a final concentration of ~100 µM and
reacted with recombinant human ubiquitin C-terminal hydrolase L3 (UCH-L3, Boston Biochem).
Typically, 4.5 µg of UCH-L3 (7 µL of 25 µM stock solution) were incubated in reduction buffer (50
mM Tris HCl, 150 mM NaCl, 12 mM DTT, pH 8.0) for 15-20 min at room temperature. To the
reduced UCH-L3 was then added 17 in 78 µL of assay buffer. The mixture was incubated for 8 h at
37 °C. A similar control assay was also conducted, which included all the assay components except
UCH-L3. The reactions were quenched after 8 h by the addition of 1 µL TFA and analyzed by
analytical RP-HPLC in order to identify the hydrolysis products. Ubiquitin(1-76) was identified by
ESI-MS [(M+H)+ observed 8564 ± 3 Da (s.d.). (M+H)+ expected 8566 Da.] The released cH2B
peptide was identified using a LTQ ion trap mass spectrometer (ThermoFinnigan) [(M+H)2+
observed 623.33 Da. (M+H)2+ expected 623.30 Da.]. The correct sequence was further confirmed by
MS-MS analysis, which generated 9b- and 10y-type ions.

For ubiquitin hydrolysis from ubiquitylated proteins, UCH-L3 was diluted to 5 µM in
reduction buffer and incubated at room temperature for 15 min. Reduced UCH-L3 (1 µM) was
then combined with either uH2B, 26, or u(G76A)H2B, 31, (both 10 µM), respectively, in 25 µL
ubiquitin hydrolase assay buffer and transferred to a 37 °C water bath. After 2 and 10 min, 5 µL
of each of the samples was removed for analysis by SDS-PAGE. At 10 min, the concentration of
UCH-L3 was doubled and a final 5 µL sample was removed after 30 min. Controls were
performed without histone and without UCH-L3. Samples were separated on a Criterion 15%
Tris HCl gel and stained with Coomassie. An equivalent reaction was performed on 2.5x scale
and submitted to LC-MS analysis using a QStar QQTOF LC-MS (Applied Biosystems) to verify
hydrolysis of the isopeptide bond.
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α-uH2B Western blot
250 and 125 ng of uH2B and u(G76A)H2B were separated on a Criterion 15% Tris HCl gel and
transferred to a PVDF membrane using Towbin’s buffer supplemented with SDS (192 mm
glycine, 25 mm Tris-HCl, 10 % methanol, 0.2% SDS, pH 8.3). A Western blot was performed
using a linkage specific α-uH2B antibody (cat. # MM-0029, Medimabs) at 1:3,000. The blot was
stripped and probed with an α-ubiquitin antibody (cat. # MAB701, R & D Systems) at 1:1,000.
The blot was then stained with Ponceau.

Octamer reconstitution
Histone octamers were formed as previously described (Luger et al., 1999). Briefly, individual
histones were dissolved in unfolding buffer (7 M guanidinium chloride, 20 mM Tris HCl, 10
mM DTT, Complete EDTA-free Protease Inhibitor Cocktail (Roche), pH 7.5) at 2-4 mg/mL.
Histones were combined in equimolar amounts based on UV quantitation (combined protein
ranged from 0.75 to 18 mg), and the solution was diluted to 1 mg/mL with unfolding buffer. The
resulting mixture was dialyzed into refolding buffer (2 M NaCl, 10 mM Tris HCl, 1 mM EDTA,
1 mM DTT, pH 7.5) (3 changes of 2 L each). Crude octamer assemblies were concentrated in
Vivaspin 2 and 20 centricons (3-10 kDa MWCO) and purified using a Superdex 200 size
exclusion column (10/300 column for <10 mg, 16/60 column for >10 mg), eluted with refolding
buffer supplemented with Complete EDTA-free Protease Inhibitor Cocktail. Octamer quality
was verified by 15% or 18% SDS-PAGE, followed by Coomassie staining. Octamer samples
were stored at -80 °C in 20% glycerol.
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Preparation of DNA for nucleosome formation
Preparation of 147 bp of the Widom 601 sequence. A plasmid containing 12 copies of 177 bp of
the 601 sequence (Dorigo et al., 2003) was purified using a Plasmid Giga kit (Qiagen). The 177
bp repeat was digested from the vector using EcoRV sites flanking the segment. The desired
segment was selectively precipitated by incrementally increasing the concentration of PEG-6000
from 4% to 8.5%, followed by centrifugation at 26 kg to separate precipitated DNA. ScaI
digestion and gel purification using a QIAquick Gel Extraction Kit (Qiagen) afforded a 177 bp
fragment of the 601 sequence, 1_177_601. PCR amplification of the central 147 bp region of
1_177_601 was accomplished using primers 147-FP (5’-CTGGAGAATCCCGGTGCCGAGG3’) and 147-RP (5’-ACAGGATGTATATATCTGACACG-3’), and gel-purified 1_177_601 as a
template. Purification of the PCR product using a QIAquick PCR purification kit (Qiagen)
yielded 1_147_601. This PCR product served as template in further PCR amplification of the
sequence.
Preparation of Widom 601 DNA with complementary overhangs. 5’ and 3’ DNA fragments for
dinucleosome formation were generated using PCR amplification as described above. The 5’ and
3’ fragments were designed to contain 3’ and 5’ DraIII restriction sites, respectively, allowing for
the formation of complementary overhangs. The DNA segment for 5’ mononucleosome
formation,

601-5’,

was

generated

using

the

primers

147-FP

and

5’-RP

(5’-

ATTGAGCACCCCGTGGGATCTTACATGCACAGGATG-3’) and 1_177_601 DNA as the
template. The DNA segment for 3’ mononucleosome formation, 601-3’, was generated using 3’FP (5’-ATTGAGCACGGGGTGCGGCCGCCCTGGAG-3’) and 147-RP primers. The PCR
amplified fragments (110 µg) were digested with DraIII (700 U) using NEB Buffer 3 (1 mL) for
6 h at 37 °C, followed by purification using a QIAquick PCR Purification kit. When ligated, the
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resulting 601-5’ and 601-3’ sequences connect two identical 147 bp regions of the 601 sequence,
separated by a 30 bp linker.
Preparation of 146 bp of the α -satellite palindromic sequence. For large-scale nucleosome
reconstitutions (for kinetics and crystallography), the palindromic α-satellite sequence was
prepared similarly to previously reported (Dyer et al., 2004). Briefly, half of the α-satellite
palindromic sequence was amplified by PCR using template DNA sequences α-sat-tempforward (5’-ATCAATATCCACCTGCAGATTCTACCAAAAGTGTATTTGGAAACTGCTCC
ATCAAAAGGCATGTTCAGCGGAATTC-3’) and α-sat-temp-reverse (5’-GAATTCCGCTGA
ACATGCCTTTTGATGGAGCAGTTTCCAAATACACTTTTGGTAGAATCTGCAGGTGGA
TATTGAT-3’) and primers α-sat-forward (5’-CGGGATCCGATATCAATATCCACCTGCAG3’) and α-sat-reverse (5’-AAGGAAAAAAGCGGCCGCAGATCTGAATTCCGCTGAACATG
CCTTTTG-3’). The PCR product was digested with BamHI and NotI and ligated into a similarly
digested pCDNA3 vector. The resultant vector was digested with BamHI and NotI, allowing the
α-satellite sequence to be isolated. The vector was also digested with BglII and NotI, allowing
the pCDNA3 vector containing one copy of the α-satellite sequence to be isolated. These
digestion products were ligated together, generating a vector with two head to tail copies of the
α-satellite sequence, while obliterating the internal restriction site. This process was repeated
until a vector containing 64 head to tail copies of the α-satellite sequence, pαSat64 was
generated.
E. coli DH5α cells (Invitrogen) transformed with pαSat64 were amplified in the
fermenter as described above for 15 h at 37 °C. Harvested cells were purified using a Plasmid
Giga kit according to manufacturer’s instructions to yield in excess of 40 mg of plasmid. Purified
pαSat64 was digested with EcoRI and EcoRV to excise the α-satellite sequence. The vector was
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removed by precipitation with 7.5% PEG-6000. The α-satellite sequence was ethanol
precipitated and further purified away from the small fragments of DNA between the EcoRI and
EcoRV restriction sites by gel filtration using a G50 sepharose (GE Healthcare). This sequence
was self ligated with T4 ligase and then digested once more with EcoRV to generate ~6 mg of
the mature 146 bp α-satellite palindromic sequence following purification by chloroform
extraction and ethanol precipitation.

Nucleosome formation
Small-scale nucleosome reconstitution by dilution. Mononucleosomes were formed using a
previously described step-wise dilution procedure (Owen-Hughes et al., 1999). Briefly, octamers
and DNA (1_147_601, 601-5’, or 601-3’) were combined in 10 µL high salt refolding buffer to a
final concentration of 3-5 µM. After incubation at 37 °C for 15 min, 3.3 µL of dilution buffer 1
(10 mM HEPES, 1 mM EDTA, 0.5 mM PMSF, pH 7.9) was added and the temperature was
dropped to 30 °C. Further dilutions of 6.7, 5, 3.6, 4.7, 6.7, 10, 30, and 20 µL, respectively, were
then performed every 15 min. A final dilution with 100 µL of dilution buffer 2 (10 mM Tris HCl,
1 mM EDTA, 0.1% NP-40, 5 mM DTT, 0.5 mM PMSF, 20% glycerol, pH 7.5) was carried out.
After an additional 15 min, the nucleosomes were concentrated using Vivaspin 500 centricons
(3-10 kDa MWCO) at 4 °C. Nucleosome formation was verified by separation on a Criterion 5%
TBE gel run in 0.5x TBE, followed by ethidium bromide staining. Nucleosomes were stored at 80 °C. Nucleosomes formed in this manner were used for all experiments except kinetics and
crystallography.
Large-scale nucleosome reconstitution by dialysis. For kinetics experiments, large-scale
nucleosome reconstitution was performed with the 146 bp α-satellite palindromic DNA sequence
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following procedures similar to those previously reported (Dyer et al., 2004). Briefly, octamers
were mixed with α-satellite DNA in ratios optimized using the small-scale reconstitution
protocol described above, at 5 µM DNA concentration, and the NaCl concentration was adjusted
to 2 M. The resultant solution was dialyzed against 400 mL initial buffer (1.4 M KCl, 10 mM
Tris HCl, 0.1 mM EDTA, 1 mM DTT, pH 7.5) at 4 °C for 70 min. The dialysate was diluted
with final buffer (10 mM KCl, 10 mM Tris HCl, 0.1 mM EDTA, 1 mM DTT) to reach a final
KCl concentration of 1.2 M and dialysis was continued for 70 min. Subsequent dialysis steps of
at least 2 h in 1.0 M KCl, 70 min in 0.8 M KCl, and 70 min in 0.6M KCl, were followed by two
dialysis steps of at least 3 h each in final buffer. Nucleosomes were concentrated to
approximately 200 µL in Vivaspin 2 centricons and purified using a Model 491 Prep Cell from
Biorad as previously described (Dyer et al., 2004). Fractions deemed pure on a 5% TBE native
gel were combined and concentrated to 30 µM using Vivaspin 500 centricons. This material was
used directly in crystallography screens, described below. Aliquots for kinetics assays were
stored in 20% glycerol at 15 µM concentrations at -80 °C.

Dinucleosome formation
Dinucleosome ligations were performed as previously described (Zheng and Hayes, 2003). In a
typical ligation reaction, 5’ and 3’ mononucleosomes (6.25 pmol) were combined in 200 µL of
1x ligation buffer (New England Biolabs) and 3,600 U of T4 ligase were added. After 1 h at
room temperature, the ligated nucleosomes were concentrated using Vivaspin 500 centricons (310 kDa MWCO) and dinucleosome formation was verified using a 5% TBE gel as described
above.

165

Formation of chromatinized plasmid
Chromatinized plasmids were assembled using a previously described procedure (Ito et al., 1999)
and plasmid (An et al., 2004). Micrococcal nuclease assays were used to verify equivalent
chromatin reconstitution with uH2B and H2B.

Preparation of Dot1L
The cDNA for Dot1L was obtained as a gift from Yi Zhang. After modification to include an Nterminal FLAG-epitope, the gene was subcloned into the pFASTBAC1 vector (Invitrogen) and
the baculovirus was generated according to the manufacturer’s instructions. Sf9 cells were
infected with the baculovirus and the resulting cell extracts were subjected to standard
purification procedures as described below. Sf9 cells (700 mL at a density of 1 million cells per
mL) were infected with fresh virus (7.5 mL) three days prior to collection by centrifugation at
430 g for 5 min. Cells were washed with phosphate buffered saline and centrifuged again.
Washed cells were resuspended in 18 mL lysis buffer (20 mM Tris HCl, 500 mM NaCl, 4 mM
MgCl2, 0.4 mM EDTA, 20% glycerol, 1 mM PMSF, 2 mM DTT, pH 7.9), and disrupted with
3x10 strokes with a dounce homogenizer (A pestle) with a 10 min break between sets of 10.
After removal of cell debris by centrifugation at 22.5 kg for 15 min, the supernatant was adjusted
to 0.1% NP-40 and 300 mM NaCl, by dilution with 20 mM Tris HCl containing 10% glycerol,
and the resulting solution was incubated with 400 µL M2-agarose (Sigma) for 3.5 h at 4 °C. The
agarose was washed four times with 10 mL wash buffer (20 mM Tris HCl, 150 mM NaCl, 2 mM
MgCl2, 0.2 mM EDTA, 15% glycerol, 0.1% NP-40, 1 mM PMSF, 1 mM DTT, pH 7.9). Each
wash was followed by centrifugation at 400 g for 1 min. The third wash was left on a rotator for
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10 min at 4 °C. Bound Dot1L was eluted with 3x100 µL wash buffer containing 0.5 mg/mL 3x
FLAG peptide (Sigma).

Preparation of Dot1Lcat
The catalytic domain of Dot1L encoding residues 1-416 was amplified from MSCN-hDot1L (gift
from Y. Zhang, UNC School of Medicine) using primers 416-FP (5’CGGGATCCCATCACCATCATCATCACATGGGGGAGAAGCTGGAGCTG-3’) and 416-RP
(5’-GGAATTCCTACTTCTTGGGGCGCCCGCGC-3’). The resulting sequence was digested
with BamHI and EcoRI and ligated into a similarly digested pGexTEV vector (pGex2T with the
thrombin recognition sequence replaced with a TEV sequence). Ligated vector, pGexTEVhDot1L416, was verified by DNA sequencing. E. coli BL21(DE3) cells transformed pGexTEVhDot1L416, were grown in 6 L Luria-Bertani medium at 37 °C until mid-log phase, and protein
expression of the Dot1Lcat GST fusion protein was induced by the addition of 0.5 mM IPTG at
18 °C for 18 h. Cells were harvested and lysed as described above. Cleared cell lysates were
continuously loaded onto a GST-Prep FF 16/10 column (GE Healthcare) at 1 mL/min for 3 h.
The column was washed with 200 mL of 20 mM Tris HCl, 150 mM NaCl, 1 mM EDTA, 2 mM
DTT, pH 7.5 and eluted with 200 mL of the same buffer containing 5 mM glutathione. Fractions
deemed pure by SDS-PAGE were stored in 20% glycerol at -80 °C. Impure fractions were
diluted with an equal volume of start buffer (20 mM Tris HCl, 1 mM EDTA, 2 mM DTT, pH
7.5) and loaded onto a HiTrap SP HP 1 mL column (GE Healthcare). After washing with 10 mL
start buffer, Dot1Lcat was eluted with a 10 mL linear gradient from start buffer to end buffer (20
mM Tris HCl, 1 mM EDTA, 2 mM DTT, 1 M NaCl, pH 7.5). Pure fractions were stored at -80
°C in 20% glycerol. For single-turnover type reactions, Dot1Lcat was concentrated using
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Vivaspin 500 centricons to greater than 5 µM as determined by quantification against BSA
standards by SDS-PAGE.

Methyltransferase assays
Mono- and dinucleosome assays. Mono- and dinucleosomes (4.25 pmol) were combined with
Dot1L (0.12 pmol) or Dot1Lcat (0.18 pmol) in 25 µL of assay buffer (20 mM Tris HCl, 4 mM
EDTA, 0.5 mM DTT, 1 mM PMSF, pH 7.9). To initiate the reaction, 3H S-adenosyl methionine
(SAM) (1 mCi, 14.25 pmol) was added and the reaction was allowed to proceed at 30 °C for 1 h.
After 1 h, 20 µL of each sample were separated on a 5% TBE gel as described above and stained
with ethidium bromide. After visualization, the gel was fixed with 25% isopropanol, 10% acetic
acid in water, followed by a 30 min incubation with Amplify solution (GE Healthcare). Dried
gels were visualized by fluorography. The remaining 5 µL of reaction mixture were spotted on
Whatman p81 filter paper, washed 3 x 10 min with sodium carbonate, pH 9, and dried. Filter
papers were added to 5 mL Ready Safe Liquid Scintillation Cocktail (Beckman Coulter). The
samples were vortexed for 10 sec and counted using a LKB Wallac 1209 RackBeta Primo Liquid
scintillation counter.
Chromatinized template assays. 350 ng chromatinized template formed with octamers
containing H2B or uH2B were incubated with 15 ng Dot1L in 40 µl assay buffer containing 3H
SAM at 30 °C for 1 h. Assay samples were separated by 15% SDS-PAGE and fluorography was
performed as described above.
Mass spectrometric analysis of methyltransferase assays. Methyltransferase assays were
performed similar to that described above but on twice the scale using cold SAM (1 mM).
Assays were incubated at 30 °C for 3 h, concentrated in a Vivaspin 500 centricon (10 kDa
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MWCO), separated on a Criterion 15% Tris HCl gel, and Coomassie stained. The Coomassiestained H3 bands were excised from the gel and destained with 200 mM ammonium bicarbonate.
Tryptic digestion was initiated with the addition of 25 ng/µL Sequence Grade Modified Trypsin
(Promega) in ammonium bicarbonate buffer. The protein was digested for at least 16 h at 37 °C.
The digestion products were mixed with 0.5 µ L of 10 mg/mL α-cyano-4-hydroxysuccinnamic
acid in 50% acetonitrile containing 0.1% TFA, and applied to a MALDI plate. MALDI mass
spectra were recorded with a PerSeptive Voyager-DE STR MALDI time-of-flight mass
spectrometer operated in the reflectron mode. Ion intensity of the tryptic fragment of H3
containing residues 40-49 was used to scale the intensities of the methylated peptides for
comparison of separate samples.
Kinetics assays. Serial two-fold dilutions of nucleosomes from 7.5 µM to 230 nM were
preformed in methyltransferase assay buffer (20 mM Tris HCl, 4 mM EDTA, 1 mM DTT, pH
7.9) supplemented with 1.6 µM 3H SAM at 4 °C. Each solution was aliquoted into individual
PCR tubes. The reaction was initiated by the addition of Dot1Lcat (2 nM, 4 nM, and 6 nM) and
subsequent transfer to a 30 °C water bath. For nucleosomes containing u(G76A)H2B, 5 µL assay
samples were quenched at 3 min by the addition of 10 µL 0.2 % TFA and spotted on filter paper
for liquid scintillation counting as described above. For unmodified nucleosomes, 10 µL assay
samples were quenched at 15 min and quantified as above. Each concentration of nucleosome
was assayed against each concentration of Dot1Lcat in duplicate. Counts from reactions
containing no Dot1Lcat were subtracted from each sample. Conversion of CPM to moles of
methylation was performed using LC-MS/MS with isotopically-labelled synthetic standards.
Unmodified and monomethylated peptides containing residues 73-83 of H3 and a d5 isotopicallylabelled Phe78 (Fmoc-Phe(d5)-OH from Cambridge Isotopes) were added into gel slices
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containing assay samples. Propionylation, trypsin digestion, and propionylation were performed
as previously described (Garcia et al., 2007). Relative quantities were determined by
standardizing spectral counts of modified tryptic peptides to synthetic isotopically-labelled
peptides following LC-MS/MS using a Dionex U3000 capillary/nano-HPLC system (Dionex)
directly interfaced with the Thermo-Fisher LTQ-Orbitrap mass spectrometer (Thermo Fisher). In
a typical experiment, a conversion factor (F) of 2.15*10-16 mol/CPM was calculated. Values of
vo/ET were calculated using equation (1),

v o F(CPM obs − CPM background )
=
ET
t *ET

(1)

where vo is the initial velocity, ET is the molar quantity of Dot1Lcat in the volume quantified, and
€
t is time in seconds. Kinetic parameters for the methylation of ubiquitylated nucleosomes were
obtained by fitting to the non-linear Michaelis-Menten equation (2) using profit 6.1.1 with the
Levenberg-Marquardt algorithm:
vo
k [S]
= cat
E T K m + [S]

(2)

!
where [S] is the concentration of nucleosome. Time courses were fit to linear regression models

to verify steady-state conditions.
Assays performed with an excess of Dot1Lcat were set up as follows: Nucleosome and
Dot1Lcat were combined in methyltransferase assay buffer supplemented with 1 µM 3H SAM and
4 µM cold SAM, at 250 nM and 5 µM concentrations, respectively. The reaction was initiated by
transferring to a 30 °C water bath. Samples were removed, quenched, and counted as described
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above. The observed CPM value at 0 sec was subtracted from the observed CPM value after 15,
30, 60, 120, 300, 600, and 6,000 sec. The corrected value was multiplied by 5 to account for
dilution with cold SAM and divided by the number of microliters quantified. The appropriate
conversion factor (F) was applied to calculate methyltransferase activity at each time point. The
resultant curves were fit to a single exponential model (3) using profit 6.1.1.

Activity = ae−bt + c

(3)

€ analysis of methylation levels, assays were submitted to trypsin
For mass spectrometric

digestion without propionylation as described above. Tryptic peptides were analyzed by LCMS/MS as described above.
Asymmetric mononucleosome assays. Octamers were prepared as described above using
mixtures of u(G76A)H2B and H2B. Incorporation of the appropriate levels of ubiquitylated and
unmodified H2B was verified by separation on a Criterion 15% Tris HCl gel, followed by
Coomassie staining. Nucleosomes were reconstituted on a small scale as described above and
analyzed on a Criterion 5% TBE gel. Each nucleosome sample was subjected to
methyltransferase assays as described above. Results, relative to homogenously ubiquitylated
nucleosomes, were compared to theoretical values for each model tested, assuming negligible
methylation of unmodified nucleosomes. If each u(G76A)H2B stimulates methylation of one
H3K79 within the nucleosome, the simple linear model (4) is expected.

Rel. CPM = fub

€
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(4)

where fub is fraction of H2B that is ubiquitylated. Assuming independent assortment of
u(G76A)H2B and H2B, if each u(G76A)H2B stimulates methylation of both H3K79 within the
nucleosome, the non-linear model (5) is expected.

2

Rel. CPM = fub + 2(fub )(1− fub )

(5)

€
which simplifies to equation
(6).

2

Rel. CPM = -fub + 2fub

(6)

€ shift assays
Electrophoretic mobility
Mononucleosomes (3.0 pmol), Dot1Lcat (0-4.5 pmol) and cold SAM (10 nmol) were combined in
30 µL of assay buffer. After 1 h at 30 °C, samples were separated on a 5% TBE gel as described
above and visualized with ethidium bromide staining. Proteins were transferred to a PVDF
membrane as described above and a Western blot was performed against GST using goat α-GST
(1: 1000, cat # 27-4577-50, GE Healthcare) and HRP-conjugated rabbit α-goat (1:2000, cat #
0449, Dako).
For radiolabelled gel-shift competition experiments, 1_147_601 (10 µL at 250 µM) was
end-labelled with

32

P using

32

P-ATP (8 µL) (Perkin Elmer; Waltham, MA) and polynucleotide

kinase (50 units) (New England Biolabs) in 50 µL 1x PNK buffer for 3 h at 37 °C. Radiolabelled
nucleosomes were prepared as described above by dilution at 2 µM starting concentrations.
Radiolabelled nucleosomes (0.64 pmol), hDot1Lcat (3.2 pmol), and cold nucleosomes (0-3.2
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pmol) were incubated and separated as described above. Dried gels were imaged by
phosphorimaging on a Typhoon 8400 (GE Healthcare).

Crystal screening
Crystal screen 1. Preparative gel fractions containing pure nucleosomes reconstituted with either
H2B or u(G76A)H2B and α-satellite DNA were concentrated to 4 and 6 mg/mL, respectively,
using Vivaspin 500 centricons. A fraction of the u(G76A)H2B nucleosome was diluted to 3
mg/mL in preparative gel elution buffer. Reservoirs were prepared as shown in Figures 5.15 and
5.17, containing 20 mM potassium cacodylate, 25-40 mM KCl, and 35-49 mM MnCl2, pH 6.0.
Hanging drops were prepared containing 1 µL of each nucleosome sample and 1 µL of each
reservoir solution. Crystal growth was followed for three weeks.
Crystal screen 2. Preparative gel fractions containing pure nucleosomes reconstituted with either
H2B or u(G76A)H2B and α-satellite DNA were dialyzed against three changes of 20 mM
potassium cacodylate, pH 6.0. Dialyzed nucleosomes were concentrated to 4 mg/mL in Vivaspin
500 centricons. Reservoirs were prepared as shown in Figures 5.15 and 5.17, containing 20 mM
potassium cacodylate, 25-40 mM KCl, and 35-49 mM MnCl2, pH 6.0. Hanging drops were
prepared containing 1 µL of each nucleosome sample and 1 µL of each reservoir solution.
Crystal growth was followed for three weeks.
Crystal screen 3. Preparative gel fractions containing pure nucleosomes reconstituted with either
H2B or u(G76A)H2B and α-satellite DNA were dialyzed against three changes of 20 mM
potassium cacodylate, pH 6.0. Dialyzed nucleosomes were concentrated to 4 mg/mL in Vivaspin
500 centricons. Reservoirs were prepared as shown in Figures 5.15 and 5.17, containing 20 mM
potassium cacodylate, 32.5-37.5 mM KCl, and 37-45 mM MnCl2. pH 6.0. Hanging drops were
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prepared containing 1.8 µL of each nucleosome sample and 0.2 µL of each reservoir solution at a
20x concentration. Crystal growth was followed for three weeks.
Crystal screen 4. Preparative gel fractions containing pure nucleosomes reconstituted with
u(G76A)H2B and α-satellite DNA were dialyzed against three changes of 10 mM Tris HCl, 10
mM NaCl, 0.1 mM EDTA, 1 mM DTT, and 0.1 mM potassium cacodylate, pH 7.5. The dialyzed
nucleosome sample was concentrated to 5 mg/mL using a Vivaspin 500 centricon. Sitting drops
were prepared containing 1 µL of nucleosome and 1 µL of each reservoir sample of the Nucleix
kit (Qiagen). Crystal growth was followed for three weeks.
Crystal diffraction. A crystal from screen 1 was looped and soaked in reservoir solution
supplemented with 24% 2-methyl-2,4-propanediol (Qiagen) and 2% trehalose, prior to freezing
in liquid nitrogen. Diffraction data was collected using a Rigaku/MSC microMax 007HF
generator equipped with Varimax optics, an X-stream cryosystem and a RaxisIV++ detector.
SDS-PAGE analysis. The solution surrounding a cluster of crystals was wicked away. The
cluster was washed with 2 x 2 µl reservoir solution. Washes and crystals dissolved in SDS
loading dye were analyzed by SDS-PAGE using an 8-25% Fast gel (GE Healthcare) followed by
Coomassie staining.
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